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Our ever-increasing understanding of how proteins fold has allowed the design of completely new 
peptides and proteins from first principles. So-called de novo protein design opens opportunities for the 
generation of novel biomaterials with easily tuneable properties. For instance, there are now several 
examples of de novo designed self-assembling peptide systems that form hydrogels for in vitro cell 
culture and tissue engineering. However, owing to the relative infancy of these systems, they have not 
been as well explored as similar scaffolds derived from natural sources or synthetic polymers. Studies 
often do not exploit the biggest asset of such designed systems – an ability to tune scaffold properties 
through a fundamental understanding of its makeup. 
This thesis presents work to tune the chemical and physical properties of one such self-assembling 
peptide hydrogel; hydrogelating self-assembling fibres (hSAFs). This scaffold consists of two de novo 
designed α-helical peptides that form a heterodimeric coiled coil and subsequently fibrous structures. I 
demonstrate that this scaffold can support the growth of primary neurons and that, by modifying the 
sequence of the underlying peptides, I can generate scaffolds with varying viscoelastic properties. In 
addition, I show that both peptides and proteins can be incorporated into the scaffold, in a spatially 
controllable manner. Primary neuronal responses to these scaffolds are assessed to demonstrate the 
applicability of hSAFs as a modular and tuneable scaffold for neurons. 
Another area in which de novo protein design might be utilised is the construction of novel biosensors. 
Recently, the Woolfson group demonstrated the differential binding of lipophillic small molecules to 
de novo designed α-helical peptide assemblies with solvent accessible pores. Here, I use an array of 
these peptides to differentiate between different fatty acids. 
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1.1 De novo designed self-assembling peptides 
De novo  design of α-helical coiled coils 
Natural proteins form an astonishing number of intricate and complex 3-dimensional shapes using only 
the information provided in their primary amino-acid sequences. While these tertiary and quaternary 
structures are diverse, proteins generally consist of well-defined secondary structural elements. The 
most common of these are the α helix and β strand. Our understanding of how these elements fold has 
enabled the rational and computational design of completely new peptide and protein structures from 
first principles (1, 2). Over the last few decades, so-called de novo protein design has yielded completely 
novel protein folds and assemblies, not seen in nature (1). 
Nonetheless, the de novo design of peptides and proteins that fold to predefined structures determined 
by the designer is non-trivial (1). Its success relies on a firm understanding of the structural motif that 
one wishes to create (2). The α-helical coiled coil is one of the most abundant structural motifs in nature, 
with a very well-defined relationship between sequence and structure (2). Thus, the coiled coil has been 
one of the most fruitful targets for de novo protein design (3-6). 
Coiled coils consist of two or more amphipathic α-helices that wrap around each other about a central 
hydrophobic core. Dimeric assemblies are common in nature (2). Here, hydrophobic (h) and polar (p) 
amino acids are spaced in a heptad repeat pattern of hpphppp. These repeats are named abcdefg (2). As 
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there are 3.6 residues per turn in an α helix, polar residues project out and away from the dimer interface, 
while hydrophobic residues project in, towards the central axis (Figure 1.1.1). 
 
Figure 1.1.1: Dimeric coiled-coil structure. A: Crystal structure of CC-Di, a parallel homodimeric coiled coil 
designed by the Woolfson group (PDB code = 4DZM) (3). B: Cut through of a section of each helix, with a and 
d residues in the core highlighted (cyan). This shows a classic dimer interface: Ile at a and Leu at d. An Asn at a 
in a single heptad helps to specify dimer assembly. C: Helical wheel diagram showing the arrangement of polar 
(black) and hydrophobic (cyan) residues around each helix. 
Examples of completely de novo designed homo and heterodimeric coiled coils are now relatively 
common (3, 7-9). Peptides that form trimeric and tetrameric coiled coils have also been designed (3, 4, 
6), as well as pentamers, hexamers, heptamers and octamers (5, 6, 10, 11), which are extremely rare in 
natural protein structures. Thus, de novo design has allowed the creation of a range of coiled-coil 
assemblies that form predefined structures with astonishing precision (Figure 1.1.2). These novel 
peptides and proteins are beginning to be used as tools for applications away from the field of protein 
design. These include: scaffolds for tissue engineering and cell culture (12); artificial catalysts (13); 
receptors for ligand binding (14); protein-protein interaction domains within cells (15, 16); and capsid-
like assemblies for drug delivery (17). The Woolfson group has been particularly instrumental in both 
the design and application of coiled-coil peptides. 
In addition, non-coiled coil de novo designed peptide and protein assemblies are being similarly widely 
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α (21), all β (19, 24) and mixed α/β proteins (25) (Figure 1.1.2). These designs are being used: as in-
cell switchable systems for directing cellular processes (20); for virus-like particle assembly (26, 27); 
for the generation of novel fluorescent proteins (19); as catalysts (18); and as membrane proteins (28, 
29). Therefore, the potential of protein design to create tools with real-world applications is beginning 
to be realised. 
 
Figure 1.1.2: Examples of de novo designed peptides and proteins. A: CC-Hept, a heptameric coiled coil designed 
by the Woolfson group (PDB code = 4PNA) (5). B: An all-α toroid tandem repeat protein designed by the Baker 
group (PDB code = 4YXZ) (21). C: A β-barrel protein designed by the Baker group that binds the small-molecule 
DFHBI, resulting in green fluorescence (PDB code = 6D0T) (19). D: Top7, a 93-residue α/β protein designed by 
the Baker group (PDB code = 1QYS) (25). E: A pentameric transmembrane coiled-coil peptide designed by the 
DeGrado group (PDB code = 6MQ2) (30). F: An all-β jellyroll structure designed by the Baker group (PDB code 
= 6E5C) (24). 
Self-assembly of higher order peptide structures  
Nature uses the self-assembly of proteins into larger structures for a range of purposes, including: actin 
and tubulin oligomerisation in the cytoskeleton (31); collagen fibrillization in the extracellular matrix 
(ECM) (32); and viral capsid formation (33). Similarly, de novo design has yielded peptides and proteins 
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that self-assemble into larger structures. Among the most common of these are fibres (34, 35), 
nanotubes (36-38), cages (17, 39) and 2D arrays (40). For the rest of this section, I will focus on fibre 
and nanotube-forming peptides, as these are the most relevant to this work. 
In 2000, Pandya et al. reported the design of a pair of α-helical peptides that self-assemble into 
30 – 70 nm diameter fibrous structures, named self-assembling fibres (SAFs) (34) (Figure 1.1.3A). The 
two peptides (SAF-p1 and SAF-p2) form a heterodimeric coiled coil with an off-set interface, inferred 
by oppositely charged polar residues (Lys or Glu) at the g and e positions. This leads to patches of 
opposite charge along each of the four heptad α helices, such that heptads 3 and 4 of SAF-p1 pair with 
heptads 1 and 2 of SAF-p2, and vice versa (34, 41). Asn residues at a in the fourth and second heptad 
of SAF-p1 and SAF-p2, respectively, hydrogen bond. This helps to direct parallel heterodimers, rather 
than antiparallel homodimers (34). Assembly in this way leads to dimers with sticky ends for further 
heterodimers to associate. This drives the longitudinal self-assembly of dimers into fibres. 
Complementary charged residues at b, c and f are proposed to promote fibre-fibre interactions and 
lateral assembly of fibres into thick fibrils (42, 43). 
Another example of coiled-coil peptide fibre self-assembly is the pentameric peptide fibres reported by 
Potekhin et al. (44). Here, assembly is proposed to proceed through the staggered helical arrangement 
of a single peptide in a pentameric arrangement, though the authors provided little structural information 
to support this. Coiled coils have also been designed to form nanotubes, which differ from fibres in that 
they contain a core region not occupied by peptide. The group of Conticello have modified the designed 
heptameric coiled coil, GCN4-pAA, so that it forms nanotubes (37). Here, the acetyl and amine caps 
(typically incorporated into peptides to increase stability) are removed from the peptide termini and 
oppositely charged residues are incorporated in the N and C terminal heptads. This leads to 
complementary electrostatic interactions between the N and C termini of GCN4-pAA and results in 
end-to-end self-assembly of the peptides into nanotubes (37). Inspired by this work, the Woolfson group 
have redesigned their discrete tetrameric, pentameric, hexameric and heptameric peptides to self-
assemble into nanotubes (36) (Figure 1.1.3C). Like Conticello, they have achieved this by removing 
the acetyl and amine caps from the peptide termini, resulting in nanotubes with various morphologies. 
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In addition, Egelman et al. have redesigned two previously described coiled-coil peptides (45) to form 
large cylindrical assemblies (38). 
 
Figure 1.1.3: Examples of de novo designed self-assembling peptide systems. A: The SAFs designed by the 
Woolfson group. SAF-p1 and SAF-p2 form a heterodimeric coiled coil with oppositely charged sticky ends that 
drive fibre assembly (34). B: The Baker group DHF38 repeat protein and the cryo electron microscopy structure 
of a section of the nanotubes it forms (35) (PDB code = 6e9y). C: The nanotubes formed by uncapped CC-Hex 
(PDB code = 3R46), a hexameric coiled coil designed by the Woolfson group (36). D: Crystal structure of the 
MAX1 peptide designed by the Schneider group, accompanied by the crystal structure of a section of the fibres 
resulting from peptide self-assembly (46) (PDB code = 2n1e). 
Coiled coils are by no means the only peptide motifs used for fibre self-assembly. Shen et al. have used 
de novo designed α-helical repeat proteins with computationally designed interfaces to generate fibres 
of varied diameter (35) (Figure 1.1.3B). In addition, many peptides have been designed that form 
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amyloid-like fibrils and nanotubes. Kaltofen et al. have described computationally designed 
amyloidogenic βαβ peptides (47), while the Schneider group rationally designed amyloid-forming 
peptides termed MAX (48) (Figure 1.1.3D). Amyloid-like structures have also been formed from a large 
number of short aromatic peptide sequences (49, 50). While some of these cannot strictly be regarded 
as ‘designed’ – owing to their extremely short sequences – their simplicity demonstrates the propensity 
of peptides to self-assemble. 
Another class of self-assembling peptide are amphiphilic peptides. These typically consist of a 
hydrophillic head group – comprising polar amino acids – and a hydrophobic tail – comprising either 
hydrophobic amino acids or an alkyl chain. The Zhang group have designed surfactant-like peptides 
A6D, V6D, A6D2 and L6D2 that form nanotubes (51), while Stupp’s group have reported the formation 
of fibrils with controllable geometry from tetrameric peptides with alkyl tails (52, 53). Alternatively, 
amphiphilic peptides can be designed by alternating polar and hydrophobic residues, yielding peptides 
that form β-structure (48, 54). For example, the Hartgerink group have designed multidomain peptides 
consisting of charged terminal residues separated by an amphiphilic region, comprising alternating 
hydrophobic and hydrophilic amino acids (55). These peptides form β-strand assemblies and fibrous 
structures. Other notable examples are the aforementioned MAX peptides designed by Schneider and 
colleagues (48) and the RAD16 and EAK16 peptides designed by Zhang’s group (56), both of which are 
covered in more detail in Chapter 1.3. 
Many of these self-assembling fibrous and nanotube systems have been used as novel biomaterials for 
a range of purposes. Among the most common are cytoscaffolds for tissue engineering and cell culture, 
with which Chapters 1 – 5 of this thesis are concerned.
 
1.2: Biomaterials for cell culture and tissue engineering 
The extracellular matrix (ECM) 
The ECM is a gel-like mix of proteins, proteoglycans and polysaccharides that surrounds cells, 
maintaining tissue structure, supporting cell growth, and directing cell signalling (57) (Figure 1.2.1). 
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Generally speaking, it can be thought of as containing three principle components: structural molecules, 
which maintain tissue structure and support inhabiting cells; adhesion molecules, which form a physical 
link between the ECM and encapsulated cells; and other signalling molecules, such as growth factors, 
of which there are many with myriad purposes in different tissues (57). Structural molecules include 
fibrous proteins, such as collagens, as well as polysaccharides like hyaluronic acid (HA) (57). Common 
adhesion molecules include laminin and fibronectin (58). These contact transmembrane receptors at the 
cell surface, known as integrins, triggering downstream signalling cascades that direct cytoskeletal 
remodelling and changes in cellular morphology, motility and growth (59). Additional signalling 
molecules are often associated with the ECM. For example, many growth factors are physically bound 
to heparan sulphate proteoglycans, which are thought to act as a sink to concentrate these signalling 
molecules at particular locations (60-62). 
 
Figure 1.2.1: Schematic diagram showing the primary molecular components of the ECM and their interactions. 
ECM molecular makeup and gross architecture varies between tissue types  
The molecular makeup of the ECM varies significantly between tissue types – and in some cases disease 
states – leading to gross differences in tissue properties (63). For example, skeletal muscle is highly 
organised and contains a high level of fibrous proteins, such as collagens I-III and elastin (64). In 
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contrast, brain tissue has a low content of fibrous protein and instead contains high levels of HA (65). 
These molecular differences result in large differences in overall tissue properties: muscle tissue is 
relatively rigid, with a high tensile strength, while brain tissue is relatively soft (63). 
The elasticity of a particular tissue is measured by its elastic modulus, which is a measure of the 
resistance to deformation (or stiffness) of a material (measured in Pascals (Pa)) (63, 66). Bone, for 
example, is rigid and very resistant to deformation. Therefore, it possesses a much higher elastic 
modulus than muscle tissue, which in turn has an elastic modulus greater than brain tissue (Figure 1.2.2) 
(63, 66, 67). 
 
Figure 1.2.2: Diagram showing how elastic modulus varies between tissue types (66, 68). 
Neural tissue – encompassing both the central nervous system (CNS) and neural tracts of the peripheral 
nervous system – is some of the softest tissue in the mammalian body. It is generally considered to 
range in elastic modulus from 0.1 – 1 kPa (69-71). The principle structural components of brain tissue 
are glycosaminoglycans (GAGs), of which HA is the most abundant (65). HA is composed of repeating 
disaccharide units of N-acetylglucosamine and N-glucoronic acid that can reach up to 25,000 repeating 
units in length (72). HA binds many ECM-constituent proteoglycans (72, 73), such as heparan sulphate 
proteoglycans, which bind to growth factors containing heparan binding motifs (e.g. basic fibroblast 
growth factor (bFGF) and the hedgehog proteins) (60, 62). This facilitates binding of these proteins to 
their receptors and establishes growth factor gradients required for tissue patterning (60). Finally, 
chondroitin sulphate proteoglycans are a further family of brain-constituent proteoglycans that cross-
link the ECM structure and contribute to the overall elasticity of brain tissue (74, 75). 
Hydrogels can be used to model the ECM in vitro  
Given the relative complexity of the ECM, its interaction with cells and variation between tissue types, 
it is surprising that most in vitro cell culture is performed in a monolayer culture on plastic or glass. 
These inert, 2-dimensional and rigid environments do not reflect the ECM in vivo (76). Certain cell 
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types behave completely differently in monolayer culture. The classic example is chondrocytes, which 
dedifferentiate and divide aberrantly when cultured on plastic or glass (77). Therefore, efforts have been 
made to design materials that more accurately model the ECM. Hydrogels are self-supporting, porous, 
gel-like materials that have a high water content. This allows solutes to pass freely through their 3D 
structure. These properties are analogous to the ECM and make hydrogels ideally suited for supporting 
cell growth in vitro (78). In the seminal study by Benya and Shaffer, chondrocytes regained their 
differentiated phenotype when cultured in an agarose gel (77). Many mammalian cells (e.g. neurons, 
adipocytes, cancer cell lines and muscle cells) have now been shown to behave aberrantly in 2D 
compared with 3D (i.e. within hydrogels) culture (78-80). 
The number of different hydrogels used as cytoscaffolds for cell culture is vast. However, generally 
these materials can be separated into those composed of naturally occurring ECM components, and 
those that are synthetic (80). These each have their own advantages and disadvantages that will be 
outlined in the following sections. 
Naturally occurring ECM mimics 
Initial efforts to mimic the ECM in vitro utilised gels formed from whole-ECM extracts. For example, 
tumour basement membrane was isolated from Engelbreth-Holm-Swarm (EHS) tumour cells and 
shown to support cell growth (81). Owing to their ease of production and compatibility with diverse 
cell types, these extracts are now marketed as in vitro cell culture tools (e.g. MatrigelTM) and widely 
used by the scientific community (82-86).  
More commonly, specific ECM components are isolated that form hydrogels in vitro. Contributing 25% 
of the dry mammalian protein mass, collagen is the most abundant of the ECM constituents (31). 
Collagen fibres consist of three polyproline type II helices that wrap around each other, forming a rope-
like structure with high tensile strength (87) (Figure 1.2.3C). Collagen can be relatively easily extracted 
from various tissue types and organisms and, therefore, numerous studies have utilised collagen gels 
for culturing various cell types (88, 89). The abundance of collagen in vivo also make it an ideal vehicle 
for cell transplantation and collagen-based materials have been widely utilised for tissue engineering 
purposes (90). Collagen-based materials are FDA-approved for wound healing applications (91). 




Figure 1.2.3: Examples of naturally occurring ECM components used for cytoscaffold generation. A: The N-
acetylglucosamine, N-glucoronic acid repeating unit of HA. B: The D-galactose, 3,6-anhydro-L-galactopyranose 
repeating unit of agarose. C: Crystal structure of the collagen triple helix (92) (PDB code = 1BKV). D: Crystal 
structure of a fibrin dimeric unit (93) (PDB code = 1N73).  
HA has also served as an attractive building block with which to form cytoscaffolds. Unlike collagen, 
HA polymers typically require additional cross-linking for gelation (94). This provides the user with 
greater control over the gelling process. Variants of HA have been synthesised, incorporating different 
chemical groups into the disaccharide unit (95-97). In doing this, the mechanism of cross-linking can 
be controlled and additional chemical groups can be introduced to tune the growth of encapsulated cells 
(95, 96, 98, 99). Other notable examples of naturally occurring ECM-mimicking materials include fibrin 
(Figure 1.3.3D), agarose (Figure 1.3.3B) and alginate (77, 100-103).  
Utilising natural ECM components for cytoscaffold formation has distinct advantages. These systems 
most closely mimic the ECM in vivo and often contain naturally occurring growth factors and adhesion 
molecules that provide support to cultured cells (76). These natural ECM components often gel without 
the addition of gelling agents or further engineering (76). However, there are disadvantages to using 
these natural systems. First, the makeup of these gels is inherently complex and can suffer from batch-
to-batch variation (76). For example, basement membrane extracts contain numerous ECM 
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preparations (85). Second, components of these gels are often difficult to modify in order to tune gel 
elastic modulus or introduce additional chemical ligands (91) (certain natural polysaccharides, such as 
HA, are notable exceptions to this). Third, the presence of extracellular growth factors and other ECM 
components cannot be easily manipulated (91). Synthetic alternatives have been investigated to 
overcome these disadvantages. 
Synthetic polymer ECM-mimicking materials 
The principle advantage of using synthetic ECM-mimicking hydrogels is the ability to construct the 
material from the bottom-up. The user has control over the starting material, mechanism of gelation, 
and can tune the mechanical and chemical properties with relative ease (91). Therefore, a range of 
synthetic materials have been used for cytoscaffold generation. The two primary groups are synthetic 
polymer and self-assembling peptide hydrogels. 
 
Figure 1.2.4: Common synthetic polymer building blocks used for cytoscaffold generation: Polyethylene glycol 
(A), polylactic acid (B), poly(lactic-co-glycolic acid) (C), PEG-maleimide (D), PEG-thiol (E) and 4-arm PEG-
azide (F). 
Synthetic polymers consist of repeating units of synthetic monomeric building blocks, of which 
polyethylene glycol (PEG), polyacrylamide, polylactic acid (PLA), poly(lactic-co-glycolic acid) 
(PLGA) and poly-N-isopropylacrylamide (PNIPAAm) are some of the most common (104) 
(Figure 1.2.4). Generally, these are crosslinked to trigger the gelling process (80, 104). As they lack 
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a cell-supporting scaffold from the bottom-up. In addition, they are highly modifiable and a range of 
different polymer types – functionalised with various chemical groups – are commercially available 
(Figure 1.3.4). As such, synthetic polymers have been extensively utilised as cytoscaffolds for a range 
of cell types (106-111) and some are FDA approved as scaffolds for tissue engineering (104). 
Composite gels incorporating both synthetic polymer and natural ECM constituents have also been 
developed (112, 113). These provide the user with an additional level of control and combine the 
benefits of working with synthetic and natural systems.
 
1.3 Biomaterials from self-assembling peptides and proteins 
Peptides and proteins possess properties that make them ideally suited to biomaterial generation. First, 
chemical additives are often not required for the self-assembly process to occur. Second, the biological 
nature of the molecules involved means that self-assembling structures can be formed within cells for 
particular applications (114). Third, the inherent variety of the amino acid building blocks (20 natural 
and many more unnatural residues) means that a variety of structures can be formed with unique 
properties. Finally, peptide self-assembly is largely driven by relatively weak non-covalent interactions 
– hydrogen bonds, hydrophobic contacts, salt bridges and van der Waals forces – meaning these systems 
have the potential to be reversible and dynamic (115). Thus, self-assembling peptides and proteins have 
been exploited for biomaterial generation. 
Biomaterials from engineered natural proteins 
Natural and engineered self-assembling proteins have been used to generate novel biomaterials. E coli 
secrete the 13 kDa protein CsgA, which self-assembles into amyloid fibres known as curli pili. These 
form a key component of E. coli biofilms (116). CsgA has been used as a building block for the 
formation of tuneable biomaterials (116). As it is bacterially expressed, CsgA has been engineered to 
incorporate various peptide tags to tune fibre assembly and incorporate proteins into the structure (117, 
118). 
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Y. pestis produce the ~15 kDa immunoglobulin-like fold protein capsular antigen fraction 1 (Caf1), 
which self-assembles into fibres through non-covalent interactions (119). These fibres form a hydrogel 
that surrounds the bacterium and protects it from phagocytosis by host immune cells (120). Caf1 can 
be bacterially expressed and so is amenable to engineering. Roque et al. have engineered Caf1 fibres to 
allow crosslinking with PEG, leading to hydrogel formation (121) (Figure 1.3.1A). The group 
incorporated bioactive peptide ligands into the Caf1 protein, allowing these hydrogels to be used for 
mammalian cell culture (121, 122). In addition, by varying the protein concentration and using different 
PEG crosslinkers, the elastic modulus of these gels can be varied between ~10 – 2300 Pa, rendering 
them suitable for a range of cell types (123).  
 
Figure 1.3.1: Engineered self-assembling protein systems. A: Crystal structure of the Caf1 dimer (blue, cyan) 
that forms a fibrous scaffold (blue and cyan dots). This scaffold can be stabilised with a 4-arm PEG-NHS 
crosslinker to form a scaffold (PDB code = 1P5U (124)) Adapted from (121, 123). B: SpyTag- and SpyCatcher-
containing fusion proteins form a self-supporting hydrogel via the covalent interaction between SpyTag and 
SpyCatcher. Adapted from (125) (PDB code = 4MLI). 
Other groups have utilised proteins that do not normally form fibres as the basis for novel biomaterials 
(125, 126). For example, hydrogels have been based on the SpyTag-SpyCatcher system reported by 
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Howarth and colleagues (125, 127) (Figure 1.3.1B). Sun et al. have expressed SpyTag and SpyCatcher 
(a peptide and protein that form a covalent complex via an isopeptide bond) modules in E. coli that 
form a hydrogel with an elastic modulus of ~300 Pa when mixed (125). Owing to the bacterial 
expression of these modules, bioactive peptides and proteins can be incorporated to promote 
mammalian cell growth (125). 
Biomaterials from designed peptides  
As eluded to in Section 1.1, our ability to design peptides with predefined structures has led to the 
design of novel materials from de novo designed peptides (Table 1.3.1). Two of the first examples of 
fully synthetic self-assembling peptide hydrogels are the RAD16 and EAK16 peptides designed by Zhang 
and co-workers (54, 56). These peptides consist of alternating hydrophobic and polar amino acids that 
form β-strand assemblies in aqueous solution. Upon the addition of monovalent cations present in most 
buffers and cell culture medium, these fibres form a self-supporting hydrogel. These matrices support 
the attachment of a variety of cell types (54, 56) and are now marketed commercially, as Puramatrix, 
for cell culture purposes. 
Name Sequence α/β Ref. 
RAD16 RARADADA RARADADA β (56) 
EAK16 AEAEAKAK AEAEAKAK β (56) 
MAX1 VKVKVKVKVDPPTKVKVKVKV β (48) 
- K2(TL)6K2 β (128) 
- Fmoc-FF β (129) 
- KYF β (130) 
- K160V40 - (131) 
- (15C alk)-CCCCGGGS(Ph)RGD - (132) 
hSAF-p1 KIAALKA KIAALKA EIAALEW ENAALEA α (12) 
Table 1.3.1: Examples of hydrogel-forming designed peptides. 15C alk indicates a 15-carbon alkyl chain. 
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A similar approach has been taken by Schneider and co-workers to design the MAX peptides. These 
contain alternating Lys and Val residues that also form β-structured assemblies in solution (48, 133). 
Alterations to the peptide sequence (yielding MAX1 – 8) allow the elastic modulus of MAX peptide 
gels to be tuned (133). These gels support the growth of mammalian cells (133).  
Peptide amphiphiles are also used to generate hydrogels. For example, Nowak et al. have synthesised 
various peptide sequences containing long stretches of polar (Lys or Glu) followed by hydrophobic 
(Leu or Val) residues (131). These form soft gels (1 – 200 Pa) with either β-sheet or α-helical structure, 
depending on the sequence. Peptides with alkyl tails, designed by Stupp and co-workers, also form 
hydrogels (132). Recently, the group have described the co-assembly of these peptides with DNA to 
form intricate twisted ribbon structures and scaffolds that support astrocyte growth (134). Similarly, the 
self-assembling amphiphilic peptides designed by the Hartgerink group can be either covalently or non-
covalently crosslinked to form hydrogels (135). The group have demonstrated that stem cell 
proliferation is promoted on gels comprised of certain amphiphilic sequences (e.g. K2(SL)6K2GRGDS), 
but not others (e.g. K2(TL)6K2GRGDS) (128). 
A great deal of attention has been given to shorter peptide sequences that self-assemble, often into 
amyloid-like fibrils. These consist of two or three amino acids, often with the addition of an N-terminal 
protecting group, such as a fluorenylmethyloxycarbonyl (Fmoc) (49, 50, 129, 130, 136). For example, 
the Xu group have designed a series of Fmoc-dipeptides (e.g. Fmoc-DAla-DAla and Fmoc-Gly-Gly) that 
form gels at different peptide concentrations, pH values and in response to the addition of vancomycin 
(137). These sequences have distinct advantages compared to longer peptides like RAD16 with regard 
to synthesis. However, the mechanism by which they self-assemble is often difficult to determine and 
identifying which sequences will form hydrogels is largely serendipitous. The Ulijn group have 
described a combination of computational and experimental approaches to address these issues and used 
these to predict optimum tripeptide sequences for self-assembly and hydrogel formation (130).  
These gels have been utilised for cell culture. Zhou et al. combined Fmoc-FF and Fmoc-RGD to form 
a gel that promoted human adult dermal fibroblast growth (138). Similarly, the Ulijn group 
demonstrated differential chondrocyte responses to different hydrophobic Fmoc-dipeptide sequences 
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(129). Chronopoulou et al. have demonstrated that microglial cell growth and proliferation is promoted 
by encapsulation within an Fmoc-FFF gel (139). While the number of different sequence permutations 
are vast (49, 50, 129, 137-139), it should be noted that – in relation to cell culture – such gels are not 
typically taken past the early stages of initial characterisation and demonstrating cell growth. 
Hydrogelating self-assembling fibres (hSAFs) 
 
Figure 1.3.2: hSAF self-assembly. A: hSAF peptide sequences showing offset heterodimer assembly, directed 
by salt bridges between oppositely charged Glu and Lys residues, and a hydrogen bond (dotted line) between Asn 
residues. B: Schematic diagram of hSAF gel assembly. 1: Heterodimeric peptide self-assembly. 2: Longitudinal 
assembly of dimers into fibres via the recruitment of further peptides. 3: Lateral assembly of fibres into thicker 
fibrils. 4: Entangling of fibrils to form an interconnected network. Adapted from (12, 34). 
The SAF system (described in Section 1.1) developed by the Woolfson group has been redesigned to 
form hydrogels (Figure 1.3.2). Here, the sticky end longitudinal assembly principle of the SAFs is 
retained, but the charged residues at the b, c and f positions are replaced with Ala. This weakens 
interactions between fibres and designs towards the formation of a fibrous network, rather than the thick 
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crystalline fibres of the SAFs. This new system is termed hydrogelating self-assembling fibres (hSAFs) 
and the new peptides are named hSAF-p1 and hSAF-p2.  
These peptides give rise to narrower (~13±5 nm diameter) fibrils and the formation of a hydrogel with 
an elastic modulus of ~1 kPa, around the upper reported limit for brain tissue (Figure 1.2.2) (12, 140). 
Gel formation occurs in minutes under ambient conditions in MOPS buffer (pH 7.4). hSAFs support 
the growth of PC12 cells (a neuron-like neuroblastoma cell line) (12) and NSCs (141). 
Dexter et al. have also formed hydrogels from 3-heptad designed coiled-coil peptides that form fibrils 
(142). These gels have an elastic modulus of ~200 Pa and support the growth of NIH-3T3 fibroblast 
cells. The group hypothesise that these sequences form pentameric assemblies, however, they are unable 
to confirm this (142). This system remains considerably less developed than hSAFs. 
 
1.4 Tuning scaffold properties for specific applications  
In recent years, further complexity has been introduced into synthetic (and some natural polymer) 
cytoscaffolds. These modifications are generally made with the aim of promoting cell attachment and 
growth on the scaffold, tailoring the gel to a specific cell type, or directing cell behaviour in a way that 
models a particular system or process. The ability to make such user-defined modifications is arguably 
the principle advantage of working with these minimal systems. 
Our ability to modify cytoscaffolds with increasing ease is due, in part, to the development of click 
chemistry. This refers to a number of chemical reactions that proceed under ambient conditions – 
without the need for excessive changes in temperature and pH – in aqueous solution (143). Key 
examples include Cu2+-catalysed azide-alkyne cycloaddition (CuAAC) (144), strain-promoted azide-
alkyne cyloaddition (SPAAC) (145), thiol-ene (146) and maleimide-thiol reaction (147) (Figure 1.4.1). 
Owing to their versatility and compatibility with biological systems (143), many of the examples 
outlined in this section utilise click chemistries to tune cytoscaffold properties. 




Figure 1.4.1: Common click chemistries used for modifying biomaterials. A: Cu2+-catalysed azide-alkyne 
cycloaddition (CuAAC). B: Strain-promoted azide-alkyne cycloaddition (SPAAC). C: The photo-activated thiol-
ene reaction. D: Maleimide-thiol reaction. 
Chemical modification with cell adhesion peptides 
The most common scaffold modification is the introduction of adhesive ligands that promote cell 
attachment. Several bioactive amino-acid sequences have been identified in ECM-resident adhesion 
proteins that are typically incorporated into cytoscaffolds (148). These shorter peptides are easier to 
synthesise compared to their full-length protein counterparts. The most common of these, RGDS, is an 
abundant motif found in both fibronectin and laminin that binds various cell surface integrins (148). 
This results in the activation of downstream integrin-related signalling pathways that are linked to cell 
migration, differentiation, proliferation and spreading (149). Other sequences include IKVAV and 
YIGSR, both derived from laminin (150). These peptides have been incorporated into synthetic 
scaffolds to promote cell attachment, proliferation, differentiation and direct cell growth (107, 125, 132, 
140, 151-158). 
Adhesion peptides are introduced via a range of chemical modification strategies, including: Click 
chemistries (97, 140, 159), affinity peptide interaction (160), and direct incorporation into the 
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scaffolding molecule (125, 132, 157). The level of peptide incorporation into the scaffold is often under 
the user’s control, allowing cell responses to differing adhesion peptide concentrations to be 
investigated (97, 140, 161). 
By replacing the N-terminal Lys of hSAF-p1 with the unnatural amino acid azidonorleucine, Mehrban 
et al. have incorporated an alkyne-modified RGDS into hSAFs via CuAAC (140). This peptide 
promoted PC12 cell and neural stem cell (NSC) adhesion and proliferation on hSAFs (140, 141). 
Furthermore, when exposed to an interface between undecorated and RGDS-decorated gel, NSCs 
migrated towards areas of RGDS (141). 
Tuning gel elastic modulus 
Modifications to hydrogel elastic modulus allow materials to be formed that mimic different tissue types 
and, thus, allow specific cell niches to be modelled. The elastic moduli of both peptide and polymer 
gels have been modified extensively. The most common strategy is to alter the concentration of peptide, 
polymer or crosslinking agent during gelation (102, 108, 154, 162). Gels with a lower concentration of 
these components are generally softer – owing to fewer interactions between neighbouring fibres – than 
those with a higher concentration (102, 108, 154, 162). 
As self-assembling peptide hydrogels are normally held together through non-covalent interactions 
between side chains, their elastic modulus can also be altered through changes to the peptide sequence. 
For example, by mutating a single Lys residue to Glu in MAX1, Haines-Butterick et al. have increased 
the elastic modulus of the gel from ~40 Pa to >100 Pa (133). Anderson et al. have altered the peptidic 
head group of peptide amphiphiles to generate gels between 1 – 150 Pa (163). Similarly, the Hartgerink 
group have investigated how changing the sequences of their amphiphilic peptides alters the elastic 
modulus of the resulting hydrogel (135). By varying both the peptide sequence and constituents of the 
buffer (Salt and Mg2+), the group formed hydrogels ranging from 10 – 6100 kPa (135). 
There are also studies where scaffold stiffness and adhesion peptide content are varied independently 
of one another (97, 154, 159). DeForest et al. have varied the elastic modulus of PEG hydrogels between 
1 – 6 kPa by altering the concentration of azide crosslinker included in the scaffold (159). The group 
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can then vary the exposure of the gel to UV light, which is required for introduction of RGDS via the 
thiol-ene reaction. Hogrebe et al. have independently varied the stiffness (0.5 – 3 kPa) and adhesive 
capacity of KFE-repeat peptides through altering the peptide concentration and percentage inclusion of 
RGDS in the sequence, respectively (154). 
Incorporating growth factors 
Growth factors are extracellular signalling proteins that perform diverse functions, including 
influencing cell growth, differentiation, proliferation and migration (164-171). In addition, growth 
factors direct tissue maintenance and protect cells from damage and disease (168, 172, 173). Common 
growth factors that carry out these functions in the nervous system (collectively known as neurotrophic 
factors) include: the neurotrophins (brain derived neurotrophic factor (BDNF) (164, 174), nerve growth 
factor (NGF) and neurotrophin 1-4) (175), insulin-like growth factors (IGFs) (176-180), fibroblast 
growth factors (FGFs) (181), vascular endothelial growth factor (VEGF) (171), ciliary neurotrophic 
factor (CNTF) (165) and sonic hedgehog (shh) (170) (Figure 1.4.2). 
 
Figure 1.4.2: Examples of common extracellular growth factors that have been incorporated into ECM mimics: 
BDNF (PDB code: 1B8M) (A), IGF1 (PDB code: 1IMX) (B), bFGF (PDB code: 1BFB) (C) and VEGF PDB 
code: 2VPF) (D). 
Hydrogels have been either covalently modified with, or used to passively encapsulate, full-length 
neurotrophic factors to promote the growth of neurons and other cell types (182, 183). For example, 
Yamaguchi et al. have passively incorporated VEGF into PEG hydrogels to promote the proliferation 
of porcine aortic endothelial cells (184). Wylie et al. reported two different affinity tag-based methods 
to independently covalently modify agarose gels with CNTF and shh (185). The group use a photolabile 
chemical group to allow spatiotemporal patterning of the gel with the two growth factors. Parker et al. 
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use Src-homology 3 (SH3) domain binding peptides, covalently attached to a HA-methylcellulose 
composite gel, to incorporate an SH3-IGF1 fusion protein into the scaffold (186). In this system, IGF1 
is shown to promote retinal pigment epithelium cell viability. 
Passive encapsulation of growth factors is another common strategy. This enables slow release of the 
growth factor into the cell culture medium over time, thus, lengthening the exposure time of 
encapsulated cells (183). However, this strategy does not allow spatial patterning of the gel with the 
protein. Bruggeman et al. have modified BDNF and GDNF with the polysaccharide chitosan to promote 
electrostatic interactions between the growth factors and an Fmoc-DDIKVAV peptide hydrogel (187). 
This allowed the growth factors to be released from the gel over longer periods. Similarly, Galler et al. 
have non-covalently incorporated heparin into an amphiphilic peptide gel, allowing FGF-2 and 
transforming growth factor β (TGF-β) to be incorporated via heparin binding (188). Dental pulp cell 
proliferation was promoted by slow release of these growth factors from the gel. 
Spatially patterning hydrogels to direct cell behaviour 
In vivo, precise arrangements of extracellular growth cues and structural ECM components lead to 
chemical and physical patterns that shape cell growth and result in correct tissue formation (189-191). 
In the context of neural tissue, these patterns direct axonal outgrowth, cell migration, neurogenesis and 
differentiation during nervous system development and in adult tissues (192-194). Therefore, cellular 
patterning in this way is essential for correct formation of the nervous system.  
Soft lithography, microcontact printing and microfluidics have been used to recreate these patterns in 
synthetic and natural polymer hydrogels (97, 185, 195-199). In addition, through 3D bioprinting, 
researchers have had success in building tissue-like architectures of defined shape and size (200-202). 
These techniques allow tissue mimics to be formed with increased complexity. For example, Armstrong 
et al. have printed 3D organ-like shapes using an alginate-F127 hybrid gel loaded with mesenchymal 
stem cells (MSCs). A number of groups utilise light-activatable chemical reactions to pattern hydrogels 
by photolithography (97, 161, 185, 203, 204). In this way, DeForest and Anseth have formed physical 
channels modified with RGDS in a PEG hydrogel (205). NIH-3T3 cell migration to, and preferential 
growth in, these channels is observed. Finally, Liu et al. have designed a microfluidic gradient 
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generating device that they use to pattern a PEG hydrogel with a concentration gradient of RGDS (197). 
When MSCs are seeded onto the patterned gel, cell density increases with RGDS concentration.
 
1.5 Biomaterials for neuronal cell culture 
Brain and peripheral nerve tissue are some of the softest and most plastic in the mammalian body (67). 
Therefore, the neuronal niche is arguably the most disparate from traditional 2D cell culture 
environments on rigid surfaces (67). Consequently, there are now many examples of self-assembling 
peptide (206-209), synthetic polymer (109, 210) and naturally derived (96, 101, 103, 211, 212) 
hydrogels that are used for neuronal cell culture and tissue engineering. As this thesis is primarily 
concerned with the in vitro modelling of brain tissue, the following section does not outline materials 
used for neuronal tissue engineering. These are reviewed extensively elsewhere (213). 
 
Figure 1.5.1: Schematic diagram of a typical neuron showing the key structural features. The cell receives 
electrical input from other cells through the dendrites, propagates this signal down the axon and to other cells via 
the synaptic terminals. Neuronal processes or neurites refer to both dendrites and axons that extend out from the 
cell body. These terms are used interchangeably throughout this thesis. 
Self-assembling peptide gels for neuronal cell culture 
Much of the published literature regarding self-assembling peptide neuronal scaffolds focuses on 
neuron-like cells and stem cells. As already stated, hSAFs promote the proliferation and differentiation 
of PC12 cells and NSCs that both send out processes in an RGDS-facilitated manner (140, 141). 
Similarly, RADA16 gels promote NSC differentiation into neurons and process (see Figure 1.5.1) 
formation after the addition of RGDS, IKVAV or other neuroprotective peptides (208, 214). In all these 
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studies, it should be noted that neurites appear relatively underdeveloped. In contrast, the group of Stupp 
have cultured NSCs on amphiphilic peptide gels, incorporating IKVAV into the polar head group (215). 
The group demonstrate that NSC differentiation to neurons (confirmed by staining with the neuron-
specific marker β-III-tubulin or MAP2 in all these studies) is accompanied by the formation of long 
neurites. 
Studies showing that self-assembling peptide gels support the growth of primary neuronal cultures, i.e., 
mature nerve cells isolated from primary tissue, are less common. This is largely due to the difficulty 
in culturing primary neurons (PNs) relative to neural progenitors and neuron-like cell lines (216). The 
first demonstrations of PN culture on a self-assembling peptide gel have been made by Zhang’s group, 
where extensive neurite and synapse formation are observed on unmodified RADA16-II (a variant of 
the original RADA16 peptide) gels (206). More recently, Martin et al. have demonstrated that primary 
hippocampal neurons (PHNs) can be cultured on short tetrapeptide gels (Fmoc-FFKK and Fmoc-FKFK) 
(136). In addition, Sur et al. have shown that PHNs can be cultured on peptide amphiphile hydrogels 
(209). In both of these examples, fluorescence imaging using synaptic markers demonstrate that cells 
produce extensive neurite networks and synapses, indicators of neuronal maturation (136, 209). 
Modifying cytoscaffolds to direct neuronal growth  
Just as cell culture materials have been modified to tune the growth of other cell types, neuronal 
cytoscaffolds have been modified to promote and direct neuronal growth. For example, neurons behave 
differently on hydrogels of differing stiffness. The Stupp group have shown that neuronal maturation, 
neurite length and cell density increase on softer (7.3 kPa) compared to stiffer (22.9 kPa) gels (209). 
This study also demonstrates that, while neural tissue is typically reported to range from 0.1-1 kPa (69-
71), neurons are robust to stiffer environments and their growth likely depends on other factors. 
Similarly, groups have demonstrated that NSCs preferentially differentiate to neurons on softer gels 
(217). Neurotrophic factors have been incorporated into cytoscaffolds to promote neuronal growth. For 
example, the Schneider group have passively encapsulated NGF and BDNF into their MAX8 peptide 
gel (218). These proteins are released gradually into the culture medium over a period of days, in a 
tuneable manner. MAX8 gels incorporating growth factors promote PC12 cell differentiation (218). 
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Directing neurite outgrowth by hydrogel micropatterning is one of the principle areas of interest for 
neuronal biomaterials. In this way, researchers aim to model the process of axonal guidance in vitro 
(219), and direct axonal regrowth in vivo (220-222). Hynd et al. have microcontact printed tracks of 
biotinylated laminin and fibronectin onto streptavidin-modified polyacrylamide gels, along which PHN 
processes preferentially grow (223) (Figure 1.5.2). Similarly, Luo and Shoichet have directed neurite 
outgrowth through RGDS-modified channels in a photopatterned agarose gel (224). The Anseth group 
take a different approach. By photopatterning a PEG gel crosslinked with a photolabile linker, patterns 
of varying elastic modulus are formed, and neurites preferentially grow along channels of softer gel 
(210). In addition, the Shoichet group have patterned synthetic polymer gels with immobilised gradients 
of NGF and NT-3, along which dorsal root ganglion neurons (DRGs) grow (225). Others have shown 
that neurites can be directed on scaffolds containing aligned fibres (226, 227). Taken together, these 
studies demonstrate that neurite outgrowth can be directed through changes in gel elastic modulus, 
adhesive ligand and growth factor concentration, and fibre morphology. Some of these methods have 
been applied to synthetic polymer gels and used to direct axonal regrowth in animal models of spinal 
cord injury (221, 222, 228). 
 
Figure 1.5.2: Schematic diagram of the patterned polyacrylamide gels and axonal responses reported by Hynd et 
al. Neuronal processes (black) grow preferentially along tracks of fibronectin and laminin (green) (223).
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1.6 The scope of this thesis 
While there are now many examples of self-assembling peptide hydrogels – some of which are of de 
novo design – synthetic and natural polymer gels are still more commonly used by the wider cell biology 
and tissue engineering communities. Consequently, de novo designed peptide gels remain considerably 
less developed than these other gel types. Aside from a few notable exceptions (218, 226), these systems 
are typically shown to support cell growth, allow the introduction of adhesive peptides, and form soft 
gels with a narrow range of accessible elastic moduli. Efforts to covalently incorporate growth factors, 
drastically alter the elastic modulus, or spatially pattern gels with growth cues, have almost entirely 
been performed with synthetic and natural polymer gels.  
Introducing these changes into self-assembling peptide systems would likely promote the growth of 
cells on the scaffold, allow scaffolds to be tailored to support specific cell types, and allow complex 
cellular behaviours (e.g. axonal guidance) to be modelled in vitro. In addition, it should be noted that 
the more developed de novo designed hydrogel systems use peptides that form β structure – the α helix 
remains relatively underutilised for cytoscaffold generation. Therefore, the huge potential of designed 
peptide hydrogels as modular platforms upon which to build bespoke environments for cell culture, has 
only been partly realised. 
In the subsequent four chapters, I seek to address this through the development of the de novo designed 
peptide hydrogel, hSAFs, as a modular and tuneable scaffold for PN culture. Chapter 6 of this thesis is 
concerned with using higher-order coiled-coil oligomers (known as α-helical barrels) for the 
development of a novel biosensor for small-molecule detection. This work is distinct from the rest of 
this thesis and, therefore, the relevant literature is reviewed at the start of Chapter 6. Both studies go 
some way to realising the potential of protein design to create tools for real-world applications in cell 









Materials and Methods 
Unless otherwise stated, all materials were obtained from Sigma Aldrich (UK). 
2.1 Peptide synthesis and characterisation 
Solid Phase Peptide synthesis (SPPS) 
All peptides were synthesised on a 0.1 mmol scale by solid phase peptide synthesis (SPPS) on a CEM 
“Liberty Blue” microwave-assisted peptide synthesiser (CEM, USA) using 
fluorenylmethyloxycarbonyl (Fmoc) chemistry. Each amino acid coupling cycle consisted of the 
following steps: removal of the Fmoc protecting group (on the resin or amino acid) by addition of 
20% morpholine in dimethylformamide (DMF); washes with DMF; addition of 5 equivalents Fmoc-
amino acid, 1 M DIC and 0.5 M 6-chloro-2-hydroxybenzotriazole (Cl-HOBt) in DMF; and further DMF 
washes. Peptides containing an Asp residue were deprotected using 20% morpholine with 5% formic 
acid in DMF. The resins used are listed in Table 2.1.1. 
Resin Peptide 
H-Ala-HMBP-ChemMatrix (PCAS BioMatrix, Canada) hSAF peptides 
Fmoc-Glu(ODmab)-Wang resin (Merck Millipore, Germany) shSAFW1,4 peptides 
Rink Amide-ChemMatrix (Merck Millipore, Germany) All other peptides 
Table 2.1.1: Resins used for SPPS of peptides described in this thesis. 
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After any manual coupling steps or N-terminal acetylation were performed (see below), all peptides 
were washed three times with DMF, then dichloromethane (DCM). Peptides were cleaved from the 
resin by addition of 90% trifluoroacetic acid (TFA), 5% triiosopropylsilane (TIPS) and 5% H2O and 
mixing for 3 hours at room temperature. Peptides were filtered, the TFA removed by evaporation, and 
the peptide precipitated by addition of chilled diethyl ether. Peptides were centrifuged at 1620 x g for 
10 minutes and the resulting pellet was dissolved in 50% (v/v) acetonitrile (in H2O), frozen in liquid 
nitrogen and lyophilised overnight. The dry peptides were stored at -20oC until required. 
Manual peptide couplings 
Where required, unnatural amino acids and other functional groups were coupled to the N-terminal 
amine of peptides synthesised by SPPS. 
Azidonorleucine coupling 
2 equivalents N-Fmoc-L-azidonorleucine (Figure 2.1.1, Chiralix, Netherlands), 1.9 equivalents 
hexafluorophosphate azabenzotriazole tetramethyl uranium (HATU) and 4.5 equivalents 
diisopropylethylamine (DIPEA) were added to hSAF-p1 peptide (synthesised without the N-terminal 
Lys), on-resin, and mixed at room temperature for 3 hours. The Fmoc group was removed by addition 
of 20% (v/v) morpholine in DMF and mixing for 1 hour at room temperature. 
 
Figure 2.1.1: Azidonorleucine. 
Propargylglycine coupling 
2 equivalents N-Fmoc-L-propargylglycine (Figure 2.1.2, Merck Millipore, Germany), 1.9 equivalents 
HATU and 4.5 equivalents DIPEA were added to the peptide (either RGDS, IKVAV or SpyTag, all 
synthesised without the N-terminal Gly), on-resin, and mixed at room temperature for 3 hours. The 
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Fmoc group was removed by addition of 20% (v/v) morpholine in DMF and mixing for 1 hour at room 
temperature. 
 
Figure 2.1.2: Propargylglycine. 
Alloc-lysine coupling 
2 equivalents N-Fmoc-L-Lys(Alloc)-OH (Figure 2.1.3, AGTC Bioproducts, UK), 1.9 equivalents 
HATU and 4.5 equivalents DIPEA were added to hSAF-p1 (synthesised without the N-terminal Lys), 
on-resin, and mixed at room temperature for 3 hours. The Fmoc group was removed by addition of 20% 
(v/v) morpholine in DMF and mixing for 1 hour at room temperature. 
 
Figure 2.1.3: Alloc-lysine. 
Maleimidopropionic acid coupling 
2 equivalents N-maleimidopropionic acid (Figure 2.1.4, Alfa Aeser, USA), 1,9 equivalents HATU and 
4.5 equivalents DIPEA were added to the peptide (either RGDS or SpyTag), on-resin, and mixed for 
3 hours at room temperature. 
 
Figure 2.1.4: Maleimidopropionic acid. 




5 equivalents 5(6)-Carboxytetramethylrhodamine (TAMRA, Figure 2.1.5, Merck Millipore, Germany), 
4.5 equivalents HATU and 7.5 equivalents DIPEA were added to CC-Hept, on resin, and mixed for 
3 hours at room temperature. To prevent the further coupling of additional TAMRA molecules, 20% 
(v/v) morpholine in DMF was added and the reaction mixed for a further 1 hour at room temperature. 
 
Figure 2.1.5: 5(6)-Carboxytetramethylrhodamine. 
Peptide N-terminal acetylation 
α-helical barrel peptides were N-terminally acetylated, following SPPS. 30 μl acetic anhydride and 
100 μl DIPEA, in 10 ml DMF, were added to the peptide, on resin, and mixed for 30 minutes at room 
temperature. 
High-performance liquid chromatography (HPLC) 
Peptide HPLC gradient (% acetonitrile) 
hSAF peptides 30-50 
shSAFW1,4 peptides 30-50 
SpyTag peptides 10-60 
RGDS peptides 5-40 




Table 2.1.2: HPLC gradients used for purification of peptides described in this thesis. 
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10 mg crude peptide was dissolved in water-acetonitrile and purified by reverse-phase HPLC (Jasco 
UK) on a Luna C18 column (5µm, 100 Å, 4.6 mm x 150 mm ID), using an appropriate water-acetonitrile 
gradient (Table 2.1.3) and 0.1% TFA over 40 minutes. 
Purified peptides were determined to be >95% pure by analytical HPLC (Jasco, UK) using a 
Phenomenex Prodigy ODS-3 column (5 µm, 4.6 x 100 mm) and an appropriate gradient (Table 2.1.2), 
over 25 minutes. 
Matrix-assisted laser desorption/ionisation-time of flight mass spectroscopy 
(MALDI-TOF MS) 
Peptide sample solution was added to α-cyano-4-hydroxycinnamic acid matrix solution (10 mg α-
cyano-4-hydroxycinnamic acid dissolved in 1 ml 50% (v/v) acetonitrile) at a 1:1 ratio, on a mass 
spectrometry sample plate, mixed and left to dry. Mass spectra were recorded using Applied Biosystems 
4700 Proteomics MALDI-TOF Analyzer and positive ion spectra were obtained at 25 kV accelerating 
voltage.
 
2.2 hSAF scaffold formation and characterisation 
Peptide concentration determination 
Peptide concentrations were determined by UV absorbance using a NanoDrop 2000 spectrophotometer 
(Thermo Fisher Scientific, Loughborough, UK). All peptides contained either a single Trp or Tyr 
residue (except for CC-Tri, which contained one of each) and, therefore, concentrations were 
determined using the reported extinction coefficients of these amino acids: ε280(Trp) = 5690 mol-1cm-
1 and ε280(Tyr) = 1280 mol-1cm-1. 





c = concentration, A = absorbance at 280 nm, ε = extinction coefficient, l = pathlength 
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hSAF scaffold formation 
2 mM hSAF-p1, -p1KAz, -p1KAlloc or p1Cys was mixed with 2 mM hSAF-p2 at 4 oC in 20 mM 
MOPS buffer (3-N-morpholino-propanesulfonic acid, 5 mM sodium acetate, 1 mM EDTA), pH 7.4. 
Typically, for cell studies, 15 μl each peptide was mixed in wells of a 96-well plate to give gels with a 
final volume of 30 μl. The peptides were briefly mixed and incubated on ice for 30 minutes. Gels were 
then incubated at 4 oC overnight and subsequently stored under dH2O until required. 
 
Figure 2.2.1: Schematic showing the protocol for hSAF gel formation. 
For investigations of gel stiffness, 6 different gels were formed by mixing the pairs of peptides outlined 
in Table 2.2.1, following the protocol outlined above. hSAFs required for cell studies were prepared 
under sterile conditions. 
Gel type p1 peptide and concentration p2 peptide and concentration 
0.5 mM hSAF 1 mM hSAF-p1 1 mM hSAF-p2 
1.0 mM hSAF 2 mM hSAF-p1 2 mM hSAF-p2 
1.5 mM hSAF 3 mM hSAF-p1 3 mM hSAF-p2 
0.5 mM shSAFW1,4 1 mM shSAFW1,4-p1 1 mM shSAFW1,4-p2 
1.0 mM shSAFW1,4 2 mM shSAFW1,4-p1 2 mM shSAFW1,4-p2 
1.5 mM shSAFW1,4 3 mM shSAFW1,4-p1 3 mM shSAFW1,4-p2 
Table 2.2.1: hSAF and shSAFW1,4 concentrations used for the formation of gels of varying stiffness. 
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Circular dichroism (CD) spectroscopy 
For analysis of individual peptides, 100 µM peptide samples were prepared in 20 mM MOPS buffer at 
pH 7.4. For fibre analysis, p1 and p2 peptides were similarly prepared and mixed in equal volumes 
before incubating for 1 hour at room temperature to form fibres. For analysis of Cu2+-catalysed azide-
alkyne cycloaddition (CuAAC)-decorated hSAFs, p1KAz:p2 fibres were incubated with 100 μM alk-
RGDS, alk-IKVAV or alk-SpyTag, 400 μM CuSO4 and 400 μM sodium ascorbate (NaAsc) for a further 
1 hour at room temperature. For analysis of thiol-ene-decorated hSAFs, p1KAlloc:p2 fibres were 
incubated with 500 μM 2,2-(ethylenedioxy)diethanethiol (PEG2SH) and irradiated with UVB light (9W, 
Philips Fluo Compact bulb, 10 mm above gel) for between 0 – 3 minutes. For analysis of maleimide 
attachment, PEG-decorated fibres were then subsequently incubated with mal-SpyTag for 1 hour at 
room temperature.  
CD measurements were taken in a 1 mm Hellma quartz cuvette at 20 oC or 37 oC, using a JASCO J-810 
or J-815 spectropolarimeter fitted with a Peltier temperature controller (Jasco, UK). Spectra were 
recorded from 190 nm to 260 nm, with a 50 nm/min-1 scan rate, 1 nm interval, 1 nm bandwidth and 1 
second response times over 8 accumulations. Baseline readings were subtracted from the recorded 
ellipticities in millidegrees. These were then converted to molar residual ellipticities (MRE, 
millidegrees cm-2 dmol-1 res-1). Thermal denaturation curves were acquired by measuring the 222 nm 
signal at 5 – 95 oC. The temperature was increased at a rate of 40 oC/hour.  
Transmission electron microscopy (TEM) 
For analysis of individual peptides, 100 µM peptide samples were prepared in 20 mM MOPS buffer at 
pH 7.4. For analysing mixtures, peptides were similarly prepared, combined in equal volumes and 
mixed briefly, before incubating at room temperature for 1 hour. For studying peptide attachment by 
CuAAC, 100 µM alk-peptide, 400 µM CuSO4 and 400 µM NaAsc were added to 100 µM p1Kaz:p2 
hSAFs and incubated for 1 hour at room temperature. For analysis of thiol-ene-modified hSAFs, 
100 μM p1KAlloc:p2 hSAFs were incubated with 500 μM PEG2SH and irradiated with UVB light (9W, 
Philips Fluo Compact bulb, 10 mm above gel) for 3 minutes. For analysis of mal-peptide attachment, 
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200 μM mal-peptide was incubated with these PEG-decorated p1KAlloc:p2 hSAFs for 1 hour at room 
temperature. 
6 µl each sample was then pipetted onto a 400-mesh carbon-coated copper grid and stained with 6 µl 
1% (w/v) uranyl acetate solution. Samples were left to dry overnight and imaged on a JEM 1200 EX 
MKI (JEOL, UK) microscope at 120 kV on a MegaViewII digital camera (Olympus Soft Imaging 
Systems GmbH, Germany). 
Scanning electron microscopy (SEM) 
hSAF and shSAFW1,4 gel samples were prepared as outlined above in MOPS, pH 7.4. Samples were 
fixed in 2.5% (v/v) glutaraldehyde for 1 hour at 4 oC. They were then incubated for 10 minutes each in 
20%, 30%, 50%, 70%, 90% and 100% (v/v) ethanol. The dehydrated gels were then dried by exchange 
of ethanol with liquid CO2 and subsequent evaporation of the CO2 at 1070 psi, 31oC (Galaxy S+, RS 
Biotech, Eppendorf Limited, UK). 
Samples were gold-coated using a K575X sputter coater (Emitech, Quorum Technologies, UK). Images 
were collected using a Quanta 400 scanning electron microscope (FEI, Netherlands) and analysed using 
ImageJ. 
Rheology 
Owing to the availability of equipment, the rheological studies outlined in this thesis were performed 
using two different instruments. Studies performed by Alex Wasmuth outlined in Chapter 1.3 were 
performed using a Bohlin CVO rheometer (Malvern Panalytical, Malvern, UK). All other studies were 
performed by me using a Kinexus DSR rheometer (Malvern Panalytical, UK). 
In both cases, viscoelasticity of scaffolds was determined by oscillatory frequency sweep measurements 
using a conical plate (CP 4o/20 mm) with 0.5% strain and frequencies from 0.01 – 10 rad/sec. Peptides 
were mixed in situ at 4 oC, the geometry lowered into position, and samples incubated for 30 minutes. 
The temperature of the bed was then increased to 20 or 37 oC and samples were incubated for a further 
1 hour. Measurements were then taken to determine storage (G’) and loss (G’’) moduli. 
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For analysis of protein- and thiol-ene-decorated scaffolds, gels were first formed in situ and incubated 
at 4 oC for 30 minutes. After increasing the plate temperature to 37 oC, a reaction mix was dispensed 
onto the gel and incubated for 1 hour. This mix was wicked off using filter paper before the geometry 
was lowered and measurements taken.
 
2.3 hSAF scaffold modification 
Decorating scaffolds via Cu2+-catalysed azide-alkyne cycloaddition (CuAAC) 
hSAFs required for cell studies were modified under sterile conditions. 
alk-peptide concentrations were determined by UV absorbance (ε280(Tyr) = 1280 mol-1cm-1) using a 
NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, UK). Peptides were prepared at 2 mM 
in 20 mM MOPS buffer, pH 7.4. One gel volume (typically 30 μl) of alk-peptide was added to each 
hSAF gel, followed by 4 mM CuSO4 and 4 mM NaAsc. The reaction was mixed gently before 
incubating at room temperature for 6 hours. 
The reaction mix was removed from the gel and excess Cu2+ removed by incubating six times with two 
gel volumes 10 mM EDTA, for 30 minutes each. Gels were then similarly incubated a further six times 
with PBS and either analysed or incubated under cell culture media overnight.  
Decorating scaffolds via thiol-ene and thiol-maleimide click chemistry 
hSAFs required for cell studies were modified under sterile conditions. The below is the method used 
for the GFP photopatterning studies outlined in Chapter 5.3. All experiments outlined in Chapter 5.2 
used different light sources, irradiation times and conditions that are detailed in the text. 
p1KAlloc:p2 hSAFs were incubated under one gel volume of a reaction mix containing 5 mM PEG2SH, 
0.1% (w/v) Irgacure 2959 in 20 mM MOPS, pH 7.4, for 30 minutes. Gels were then irradiated with 
UVB light (9W, Philips Fluo Compact bulb), placed <1 mm above the plate, for 2 minutes, unless 
otherwise stated. Gels were incubated three times with two gel volumes PBS for 30 minutes. 
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2 mM maleimide-peptide was prepared in 20 mM MOPS, pH 7.4. Two gel volumes of peptide was 
added to p1KAlloc:p2-PEGSH hSAF and incubated for 15 hours at room temperature. Gels were then 
washed three times with PBS for 30 minutes each, and either analysed or incubated under cell culture 
media until required. Typically, this was the next day. 
Determining protein concentration 
SpyCatcher-GFP (SC-GFP) and SpyCatcher-GFP-insulin-like growth factor 1 (SC-GFP-IGF1) protein 
concentrations were determined by UV absorbance using a NanoDrop 2000 spectrophotometer 
(Thermo Fisher Scientific, UK). Molar extinction coefficients at 280 nm for each protein were 
determined using ExPASy (Swiss Institute of Bioinformatics, Lausanne, Switzerland). 





c = concentration, A = absorbance at 280 nm, ε = molar extinction coefficient, l = pathlength 
Decorating scaffolds with SpyCatcher-proteins 
hSAFs required for cell studies were decorated under sterile conditions and proteins were sterile filtered 
prior to immobilisation. 
After SpyTag attachment by CuAAC or maleimide-thiol reaction, SC-GFP or SC-GFP-IGF1 was 
immobilised by incubating hSAFs with two gel volumes (typically 60 μl) of 1 μM protein in Tris-HCl 
(25 mM Tris, 150 mM NaCl, pH 7.4) for 15 hours at 4 oC. Protein was then removed and gels washed 
eight times with two gel volumes of PBS. Protein-decorated hSAFs were then stored under PBS or cell 
culture media, at 4 oC until required. 
SpyCatcher immobilisation assay 
30 μl hSAFs were incubated with 30 μl SC-GFP or SC-GFP-IGF1 of known concentrations between 0 
and 1 μM to create a calibration curve of known protein concentrations. 
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30 μl SC-GFP or SC-GFP-IGF1 was incubated with 30 μl SpyTag-decorated or undecorated hSAFs for 
15 hours at 4 oC. Protein was then removed and gels washed eight times with 60 μl PBS, pH 7.4, at 4 oC 
for 30 minutes each. GFP fluorescence was quantified using a ClarioStar plate reader (BMG LabTech, 
Ortenberg, Germany). 
SpyCatcher detachment assay 
1 μM SC-GFP or SC-GFP-IGF1 were incubated with SpyTag-decorated or undecorated hSAFs for 
15 hours at 4 oC, as above. Any non-specifically bound protein was removed by incubating eight times 
with two gel volumes PBS. Fluorescence at day 0 was then quantified using a ClarioStar plate reader 
(BMG LabTech, Germany).  
Gels were incubated under 100 μl PBS for 1 week at 37 oC in a cell culture incubator. Supernatant was 
collected on day 7 and its fluorescence quantified to calculate the percentage of protein detached over 
the time period. Gels were then incubated for a further 3 weeks under fresh PBS. The supernatant was 
collected and its fluorescence quantified every 7 days, before replacing with fresh PBS.  
Percentage protein detachment per week was calculated using the following equation: 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑑𝑒𝑡𝑎𝑐ℎ𝑒𝑑 𝑝𝑒𝑟 𝑤𝑒𝑒𝑘 = (𝐺𝐹𝑃 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑛𝑒𝑐𝑒 𝑑𝑎𝑦 0 − 𝐺𝐹𝑃 𝑖𝑛 𝑠𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡)  × 100
 
2.4 Cell studies 
Puramatrix and Matrigel formation 
30 μl 0.15% (w/v) Puramatrix (Corning, Tewksbury, USA) was prepared in sterile dH2O in wells of a 
96-well plate. Gelation was triggered by gently adding 100 μl PBS and incubating at 37 oC for 1 hour. 
Gels were then incubated under cell culture media until required. 
30 μl Matrigel (Corning, Tewksbury, USA) was prepared in wells of a 96-well plate and gelation 
triggered by incubation at 37 oC for 1 hour. Gels were then washed three times with PBS and incubated 
under cell culture media until required. 
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Primary neuronal cell culture 
The cortex and hippocampus were dissected from E18 (18 days from mating) Wistar rat embryos, 
trypsin treated, mechanically dissociated and resuspended in plating media (Neurobasal medium 
(Gibco, UK) containing 10% horse serum, B27 (Gibco, UK), penicillin-streptomycin and 5 mM 
GlutaMAX (Thermo Fisher, UK)). Cells were then seeded onto hSAFs, Puramatrix or Matrigel, 
typically at a density of 20,000 cells per well of a 96-well plate, in plating media. After incubation at 
37oC in humidified air with 5% CO2 for 2 hours the medium was changed for unsupplemented 
Neurobasal medium (Gibco, UK), containing only B27 (Gibco, UK) and 2 mM GlutaMAX (Thermo 
Fisher, UK). For IGF1 activity studies, Neurobasal medium lacking B27 was added at this point. 
Neurons were cultured at 37 oC until required, typically after 14 days in vitro (DIV). 
MCF-7 cell proliferation assay and crystal violet staining  
5000 MCF-7 cells were seeded into wells of a 96-well plate and cultured in MEM (10% fetal bovine 
serum, 1 x antibiotic-antimycotic) for 24 hours at 37 oC in humidified air with 5% CO2. The medium 
was then removed, replaced with MEM without serum and cells were cultured for a further 24 hours. 
Cells were then treated with 0 – 30 pmoles either recombinant insulin-like growth factor 1 (rIGF1, 
Abcam, UK), SC-GFP-IGF1, SC-GFP, or no protein, all in serum-free MEM. Cells were cultured for a 
further 48 hours. 
Cells were washed three times with PBS and fixed in 4% paraformaldehyde (PFA) in PBS for 
20 minutes. Cells were washed a further three times in PBS before staining with crystal violet solution 
(0.05% (w/v) crystal violet, 20% (v/v) ethanol in dH2O) for 30 minutes at room temperature. After a 
further three washes with PBS, 1% (w/v) SDS in PBS was added and cells mixed gently for 1 hour.  
The absorbance of each cell suspension at 595 nm was measured using a ClarioStar plate reader (BMG 
LabTech, Germany). For each protein, absorbance readings were normalised to those for untreated cells 
(i.e. 0 pmoles protein). 
 
 




Cells were washed three times with warm PBS buffer and fixed in 4% paraformaldehyde solution in 
PBS for 15 minutes. Cells were washed a further three times and membranes permeabilised by adding 
0.1% (v/v) Triton-X-100 in PBS for 20 minutes. After washing another three times with PBS, 5% BSA 
in PBS was added to prevent non-specific antibody binding and cells were incubated for a further 
20 minutes. Primary antibodies (anti-MAP2 polyclonal antibody, Synaptic Systems; anti-GFAP mouse 
monoclonal antibody, Synaptic Systems) were then added in 2.5% BSA in PBS and cells incubated for 
2 hours at room temperature. Cells were then washed a further three times with PBS. Secondary 
antibodies (Cy3 anti-rabbit IgG, Goat, Invitrogen; Cy5 anti-mouse IgG, donkey, Jackson Immuno 
Research, Stratech) were added and cells incubated for a further 45 minutes at room temperature. Cells 
were then washed a further two times in PBS and once with H2O before being incubated with 
fluoromount-G solution containing DAPI (Thermo Fisher, UK). Cells were stored at 4 oC until imaging. 
Widefield microscopy 
Images of neurons and hSAF gels were collected using a Leica DMI6000 widefield microscope fitted 
with a Leica DFC365FX monochrome digital camera and Leica DFC420C colour camera. Depending 
on the experiment, either a 5x HC PL Fluotar, 10x HC PL Fluotar, 20x N PLAN L CORR or 40x PL 
Fluotar L CORR objective was used. The following excitation filters were used: 360/340 nm (DAPI), 
470/440 nm (Cy2), 545/526 nm (Cy3), 620/660 nm (Cy5). Typically, Z-stacks were acquired by taking 
10 images through an appropriately sized sample depth. Images presented in this thesis are typically 
composites of these Z-stacks. Images were analysed using ImageJ. 
AlamarBlue cell viability assay 
AlamarBlue cell viability assay solution (Thermo Fisher Scientific, UK) was diluted 1:10 into 
Neurobasal medium (containing B27 and glutamax) without phenol red (Gibco, UK). The media on the 
cells was removed and replaced with 100 μl AlamarBlue mix. Cells were incubated for 6 hours at 37 oC. 
The medium was then transferred to a 96-well plate and fluorescence quantified using a ClarioStar plate 
reader (BMG LabTech, Germany)
2.5 Molecular biology 
40 
 
2.5 Molecular biology 
DNA transformation 
All plasmids used during this project contained kanamycin-resistance genes for selecting transformed 
clones.  
Typically, 1 μl plasmid DNA was incubated with 50 μl competent cells (either XL-10, BL21 or SHuffle 
E. coli strains) for 10 minutes on ice. Cells were heat shocked at 42 oC for 45 seconds and incubated on 
ice for a further 2 minutes. 1 ml LB medium (1% (w/v) NaCl, 1% (w/v) Tryptone and 0.5% (w/v) Yeast 
extract) was added and the cells incubated at 37 oC while shaking for 1 hour. Cells were then pelleted 
by centrifugation at 7500 x g for 1 minute and resuspended in 100 μl LB medium. Cells were then 
spread onto kanamycin-containing agar plates and incubated at 37 oC overnight. Colonies were then 
picked and used for downstream applications. 
Polymerase chain reaction (PCR) 
Temperature (oC) Time (seconds) 
<1000 bp inserts 
98 10 
Primer Tm 30 
72 30 
>1000 bp vectors 
98 30 
Primer Tm 30 
72 360 
Table 2.5.1: PCR conditions for amplifying insert and vector DNA. Primer Tm values were calculated using the 
online tool from NEB. 
PCR was performed using a Phusion high-fidelity PCR kit (Thermo Fisher Scientific, UK). 2 μl DNA 
was added to 1 μl dNTP mix, 10 μl 5x Phusion HF buffer, 2.5 μl each primer, 1 μl DMSO and 0.5 μl 
Phusion DNA Polymerase (2 U/μl) in dH2O. DNA fragments and vectors were then amplified using a 
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thermocycler (Eppendorf Limited, Stevenage, UK) and 30 cycles of the temperatures outlined in 
Table 2.5.1. Amplified DNA was then cleaned using a GeneJet gel extraction kit (Thermo Fisher 
Scientific, UK) and analysed by agarose gel electrophoresis. 
Agarose gel electrophoresis  
Samples of DNA for analysis were added to 6x gel loading dye (Thermo Fisher Scientific, UK) and 
loaded onto well of a 1% (w/v) agarose gel containing SybrSafe (Thermo Fisher Scientific, UK) for 
DNA visualisation. A current of 150 V was passed through the gel for 30 mins. The agarose gel was 
then removed and DNA visualised using a UV transilluminator. 
Restriction digest and ligation 
1 μl of each restriction enzyme (NEB, USA) was added to 1 μl DNA in Cutsmart buffer. The reaction 
was incubated for 1 hour at 37 oC, before the addition of DpnI (NEB, USA) and a further 1 hour 
incubation at 37 oC. 
The digested DNA was ligated by mixing 37.5 ng insert DNA with 50 ng similarly digested vector 
DNA in T4 DNA ligase buffer and T4 DNA Ligase (NEB, USA). The reaction was incubated at room 
temperature for 30 minutes before transformation into XL10 E. coli cells. 
Golden Gate digest and ligation 
The concentration of DNA fragments to be digested and ligated by Golden Gate assembly were 
determined using a NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, UK). 75 ng vector 
DNA was added to 75 ng insert DNA in 2 μl NEB Golden Gate buffer (NEB, USA) and 1 μl Golden 
Gate Assembly mix (NEB, USA) in dH2O. The reaction was incubated at 37 oC for 1 hour and 55 oC 
for 5 minutes before transforming into XL10 E. coli cells. 
Cloning the pET28a-SC-GFP plasmid construct 
A pDEST14 plasmid containing the SpyCatcher gene with an N-terminal His-tag was kindly gifted by 
Mark Howarth from Oxford University. A pET28a vector containing GFP with a 5’ flexible linker 
(pET28a-GFP) was gifted by James Ross, a member of the Woolfson group. 
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Name Sequence Restriction enzyme site 
A AATCCCCTGCAGGCATGTCGTACTACCATCACC KpnI 
B GCAACTAAAGGTGACGCTCATATTGGTACC PstI 
C GGATCTCCATGGTTGATACCTTATCAGGTTTATCAAGTGAGC NcoI 
D CATAAGGAATTCTTAGTGGTGATGATGATGGTGGCTAGC EcoRI 
Table 2.5.2: Primers used to clone the SC-GFP construct. 
The SpyCatcher gene, including the N-terminal His-tag, was amplified by PCR using forward and 
reverse primers containing 5’ KpnI and PstI restriction enzyme sites, respectively (Table 2.5.2, A+B). 
This SpyCatcher PCR product and pET28a-GFP were digested with KpnI and PstI (NEB, USA) and 
the resulting products ligated using T4 DNA ligase (Takara, ClonTech, France). This product was 
transformed into XL-10 competent E. coli cells and grown on Kanamycin-containing plates overnight 
at 37 oC. Bacterial colonies were picked and grown in LB medium overnight at 37 oC. Plasmid DNA 
was then extracted from these cultures using a GeneJet plasmid mini-prep kit (Thermo Fisher Scientific, 
UK). The ligated clones were identified by PCR analysis and gel electrophoresis, and the successful 
ligations were sequenced (Eurofins, Bristol, UK). 
The gene encoding the His-tag of SC-GFP was later moved to the protein C terminus using primers C 
and D in Table 2.5.2. The coding sequence was transferred to an empty pET28a vector through NcoI 
and EcoRI (NEB, USA) digestion and ligation following the above protocol. 
Cloning the pET28a-SC-GFP-IGF1 plasmid construct 
A gene containing the coding sequence for insulin-like growth factor-1 (IGF1) with an N-terminal (GS)6 
linker ((GS)6-IGF1) – codon optimised for E. coli expression – was synthesised by GeneArt (Thermo 
Fisher, UK). 
A periplasm targeting sequence was inserted into SC-GFP 5’ of the coding sequence for the N-terminal 
His-tag. SC-GFP was amplified by PCR using primers C and D (Table 2.5.3). A pET28a vector was 
amplified using primers A and B (Table 2.5.3), which contained complementary sticky ends to D and 
C, respectively. These fragments were assembled by Golden Gate assembly and transformed into XL10 
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E. coli. Colonies were picked and inoculated in 10 ml LB medium overnight at 37 oC while shaking 
(180 rpm). Plasmid DNA was extracted from these cultures using a GeneJet plasmid mini-prep kit 
(Thermo Fisher Scientific, UK) and the ligated clones were identified by PCR and gel electrophoresis. 
The successful ligations were sequenced (Eurofins, Bristol, UK). 
Name Sequence Restriction enzyme site 








D CCGAATGGTCTCTCTACCCGACCCCGATCCGCTC BsaI 
E GTGACCGGTCTCTTTGCCACCACCACCACCACCAC BsaI 
F GAATTGGGTCTCTAACCGCTAGCCTTGTACAGCTCGTCC BsaI 
G CTAAAGGGTCTCTGGTTCTGGCTCTGGCAGC BsaI 




J TTCATTAAGCTTTTATGCGCTTTTTGCCGGTTTCAGC HindIII 
Table 2.5.3: Primers used to clone the SC-GFP-IGF1 construct. 
The (GS)6-IGF1 gene was amplified by PCR using primers G and H (Table 2.5.3). The pET28a-SC-
GFP vector containing the N-terminal periplasmic tag was also amplified using primers with 
complementary sticky ends to those used to amplify (GS)6-IGF1 (Table 2.5.3, E + F). These fragments 
were assembled by Golden Gate assembly and transformed, grown up, analysed and successful ligations 
selected as described above. These clones were then sequenced (Eurofins, Bristol, UK). This periplasm 
targeting sequence-containing construct is referred to as p-SC-GFP-IGF1. 
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The periplasmic targeting sequence was later removed and the SC-GFP-IGF1 coding sequence moved 
to a pET28a vector using primers I and J (Table 2.5.3). Both vector and insert were digested with BamHI 
and HindIII (NEB, USA) and ligated as described above. This construct is referred to as SC-GFP-IGF1. 
Protein expression 
pET28a-SC-GFP and pET28a-p-SC-GFP-IGF1 were transformed into BL21 competent E. coli cells, 
while pET28a-SC-GFP-IGF1 was transformed into SHuffle competent E. coli cells (NEB, US). The 
transformed E. coli were grown overnight on kanamycin-containing agar plates. Individual colonies 
were picked and used to inoculate a starter culture of 10 ml LB media containing 50 ng/ml kanamycin. 
This culture was grown at 37 oC for 15 hours while shaking at 180 rpm. This starter culture was then 
used to inoculate a larger culture (typically 400 ml LB medium containing 50 ng/ml kanamycin). This 
was shaken (180 rpm) at 37 oC and 30 oC for SC-GFP and SC-GFP-IGF1, respectively, until the cell 
density reached A600 0.6. Expression of SC-GFP and SC-GFP-IGF1 was then induced by addition of 
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and the cultures were grown for 15 hours at 
18 oC. 
Protein purification by Ni2+-NTA and size exclusion chromatography (SEC) 
Bacterial cultures were harvested by centrifugation at 10,000 x g for 10 minutes in a Lynx 4000 
centrifuge using an F12-6x500 LEX rota (Thermo Fisher Scientific, UK) at 4 oC. The bacterial pellets 
were then resuspended in 20 ml lysis buffer (25 mM Tris (pH 7.4), 150 mM NaCl, 5% glycerol, 10 mM 
imidazole, 1% (v/v) Triton-X-100, 1 mM phenylmethane sulfonyl fluoride (PMSF)), incubated for 
10 minutes at 4 oC, and sonicated for 5 minutes on ice. The cells were then centrifuged at 13,000 x g 
for 30 minutes at 4 oC in a Lynx 4000 centrifuge using an F14-14x50cy rota (Thermo Fisher Scientific, 
UK). 
If contained in the soluble fraction, SC-GFP and SC-GFP-IGF1 were purified without further 
processing. If in the insoluble fraction, the protein was refolded in vitro (see method below). A Ni2+-
NTA column was equilibrated with wash buffer (25 mM Tris (pH 7.4), 150 mM NaCl, 5% glycerol, 
1% Triton-X-100 and 10 mM imidazole) before adding the soluble protein. The column was washed a 
further two times with wash buffer and the protein eluted by addition of elution buffer (25 mM Tris 
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(pH7.4), 150 mM NaCl, 400 mM imidazole). The resulting elute was collected and concentrated using 
an Amicon Stirred Cell concentrator (Merck Millipore, Germany). 
Both proteins were further purified by size exclusion chromatography (SEC) using a SuperDex 75 size 
exclusion column and AKTA protein purification system (AKTAprime plus, GE Healthcare Life 
Sciences) using 25 mM Tris-HCl, 150 mM NaCl buffer, pH 7.4. Protein-containing fractions were 
analysed by SDS-PAGE and fractions deemed pure pooled, before being concentrated using an Amicon 
Stirred Cell concentrator (Merck Millipore, Germany). Proteins were stored at 4 oC and typically used 
within two days of purification. 
SDS-PAGE 
Proteins were resolved on a 10% (v/v) acrylamide resolving gel (4 ml H2O, 3.3 ml 30% (v/v) 
acrylamide, 2.5 ml 1.5 M Tris pH 8.8, 0.1 ml 10% (w/v) SDS, 0.1 ml 10% (w/v) ammonium persulfate 
(APS) and 0.004 ml tetramethylethylenediamine (TEMED)), using a buffer containing 25 mM Tris, 
192 mM Gly and 0.1% (w/v) SDS. Protein samples were mixed with sample buffer (50 mM Tris 
pH 6.8), 2% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v) β-mercaptoethanol, 12.5 mM EDTA, 0.02% (w/v) 
bromophenol blue), boiled at 95 oC for 5 mins and loaded onto the gel. A current of 150 V was passed 
through the gel for 80 minutes. 
The gel was removed from the tank and stained with Coomassie brilliant blue stain (0.1% (w/v) 
Coomassie Brilliant Blue stain, 10% (v/v) glacial acetic acid, 40% (v/v) methanol in dH2O) for 1 hour 
at room temperature. The gel was then washed with dH2O and incubated overnight in destaining 
solution (10% (v/v) glacial acetic acid, 40% (v/v) methanol in dH2O). Proteins were visualised using a 
transilluminator. 
In vitro refolding 
p-SC-GFP-IGF1 was refolded in vitro by dialysis. The pellet was solubilised overnight by mixing at 
room temperature in lysis buffer containing 6 M guanidinium hydrochloride (GuHCl) (25 mM Tris, 
150 mM NaCl, 5% (v/v) glycerol, 10 mM imidazole, 1% (v/v) Triton-X-100, 1 mM PMSF, 
6 M GuHCl). The protein was purified by Ni2+-NTA chromatography as described above, using buffers 
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containing 6 M GuHCl. The protein was then refolded by dialysis against 2 L refolding buffer (25 mM 
Tris, 150 mM NaCl, 50 mM L-Arg, 1 mM reduced glutathione and 0.3 mM oxidised glutathione) for 
48 hours at room temperature. Protein was then purified by SEC as previously described.
 
2.6 hSAF patterning 
3D printing 
Moulds for microfluidic gradient generator devices and hSAFs were designed using computer aided 
design (CAD) software package Autodesk Inventor Professional 2014. These designs were printed 
using a Form 2 desktop stereolithography (SLA) 3D printer and clear photopolymer resin (FormLabs, 
USA). Prints were washed multiple times with isopropanol to remove any excess resin and dried 
overnight at room temperature. 
Microfluidic device fabrication 
50 g polydimethylsiloxane (PDMS) was mixed with 5 g silicon elastomer curing agent (Sigma Aldrich, 
UK) and mixed thoroughly. The mixture was degassed using a desiccator, poured over the 3D printed 
mould, and incubated at 70 oC for 4 hours. Devices were cut from the moulds using a scalpel and 50 μm 
inlets and outlets punched at the desired locations. The PDMS device and a glass microscope slide were 
cleaned using a plasma asher (Zepto, Diener electronic, Germany). The PDMS was immediately pressed 
feature-side down onto the slide, affixing the PDMS to the glass. 
Microfluidic device testing 
Two plastic syringes containing either dH2O, rhodamine dye or food colouring were attached to the 
inlets of the device by 0.8 mm diameter polytetrafluoroethylene (PTFE) tubing (Cole-Parmer, USA). 
Syringes were affixed to two syringe pumps (NE-1000, New Era Syringe Pump Systems, USA) and 
solutions pumped through the device at flow rates between 0 – 200 μl/min. 
Gradient patterning hSAFs by microfluidics  
hSAFs were patterned by microfluidics using two methods, A and B. 
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A: A 30 μl p1KAz:p2 hSAF gel was formed in the patterning chamber of the microfluidic device. The 
gel was decorated with alk-SpyTag as previously described and washed 6 times with EDTA and 6 times 
with PBS. A ~10 mm x 10 mm cube of PDMS was inserted into the top of the patterning chamber and 
pushed down to <1 mm above the gel. The two inlets were connected to solutions of 1 μM SCGFP (in 
Tris-HCl, pH 7.4) and Tris-HCl buffer, pH 7.4, via PTFE tubing. Solutions were pumped through the 
device at 50 μl/min for 10 mins using two syringe pumps (New Era Syringe Pump Systems, USA). 
After patterning, the PDMS plug was removed and the gel washed 6 times with PBS before imaging by 
widefield microscopy. 
B: 30 μl hSAF-p2 was dispensed into the patterning chamber and the PDMS plug inserted as above. 
The two inlets were connected to solutions of hSAF-p1 and hSAF-p2 in 20 mM MOPS via PTFE tubing. 
Solutions were pumped through the device at 50 μl/min for 10 mins using two syringe pumps (New Era 
Syringe Pump Systems, USA). After patterning, the PDMS plug was removed and gels were patterned 
with alk-SpyTag and SC-GFP as previously described. 
Photolithographic patterning of hSAFs 
Photomasks were designed in Inkscape and printed onto transparencies (JD photodata, UK). 
For patterning experiments, p1KAlloc:p2 hSAFs were formed in 1 mm or 2 mm deep 3D printed plastic 
moulds, glued to coverslips. For cell culture experiments, these moulds were autoclaved prior to use. 
hSAFs were incubated under one gel volume 5 mM PEG2SH, 0.1% (w/v) Irgacure 2959 in 20 mM 
MOPS, pH 7.4 for 30 minutes. The gel was placed into a Karl Suss MJB3 mask aligner (Suss Microtech, 
Germany) fitted with a 200 W mercury lamp (350-500 nm). The photomask was affixed into the mask 
aligner and the gel raised as close as possible to the mask without making contact. Gels were exposed 
to UV light (350-500 nm) through the mask for 3 minutes. Samples were then removed from the mask 









Tuning hSAFs for optimal growth 
of primary neurons 
Introduction 
As outlined in Chapter 1, hSAFs are peptide-based hydrogels developed by the Woolfson lab (12). They 
are formed via the self-assembly of two de novo designed α-helical peptides, hSAF-p1 and hSAF-p2 
(12) which, when mixed, form a heterodimeric coiled coil with an offset interface, exposing sticky ends 
for longitudinal assembly into fibres (34). These fibres associate via weak hydrophobic interactions to 
form a soft (~1 kPa) hydrogel (Figure 1.3.2), which has previously been utilised for the culture of PC12 
cells and neural stem cells (NSCs) (140, 141). As one of a small number of cytoscaffolds formed from 
designed peptides (56, 158, 229), the further development of hSAFs is of interest for the development 
of novel tools for cell culture and tissue engineering. In addition, such research demonstrates our 
relatively recently acquired ability to design peptides from first principles, which might be used to form 
materials with tuneable properties. 
While much can be learned from the neuronal-like cell types cultured previously on hSAFs, primary 
neurons (PNs) are arguably a better in vitro model of neuronal processes in vivo (216). Specifically, PN 
cultures are heterogeneous and, thus, contain multiple neuronal cell types and, depending on the culture 
conditions, glia (cells that provide support to neuronal growth in vivo) (216, 230). In addition, owing to 
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their isolation from primary tissue, these cells are extremely similar to those found in vivo. Finally, PNs 
produce extensive neurite networks with mature synapses, the formation of which are essential for 
studying neuronal processes (231-235). 
Here, I assess PN responses to the parent hSAF system in order to identify whether this material can be 
utilised for PN culture. I then optimise these gels as a culture substrate for neurons, by assessing PN 
responses to adhesion peptide modification and variations in gel stiffness.
 
3.1 Assessing hSAFs as a platform for primary neuronal 
culture 
Biophysical characterisation of parent hSAFs  
Initially, I wanted to assess whether hSAFs, without any additional functionality or chemical adducts, 
could support the growth of PN cultures. hSAF peptides (Figure 3.1.1A) were synthesised by solid 
phase peptide synthesis (SPPS), purified by high performance liquid chromatography (HPLC) and 
masses confirmed by matrix-assisted laser desorption/ionisation time of flight mass spectrometry 
(MALDI-TOF-MS). HPLC and MALDI-TOF-MS data for all peptides described in this thesis can be 
found in the Appendix (Chapter 8.1). Secondary structure and fibre formation were confirmed by 
circular dichroism (CD) spectroscopy and transmission electron microscopy (TEM), respectively 
(Figure 3.1.1 B-C). These unmodified, previously reported peptide designs (12) are hereafter referred 
to as the ‘parent’ hSAF system, or p1:p2 hSAFs. 
hSAF peptides are designed to be helical in structure and, upon mixing, to form dimeric assemblies and 
fibres (12). CD analysis of the individual peptides confirmed that they were indeed helical and well 
folded, producing the classical α-helical signal with minima at 208 and 222 nm (Figure 3.1.1B). When 
the peptides were mixed, they remained helical, however the minima at 222 nm was red-shifted to 
~225 nm and was more pronounced relative to that at 208 nm. This is indicative, though not 
confirmatory, of higher-order structure formation (12, 34, 236). Critically, the spectrum of the mixed 
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peptides did not overlay the theoretical average of the two individual peptides, suggesting they were 
interacting in some way. The mixtures were helical at 20 oC and 37 oC, confirming stability at the 
relevant temperatures for gel preparation and cell culture. 
 
Figure 3.1.1: Solution phase characterisation of hSAF peptides and fibres. A: Sequences of hSAF-p1 and -p2. B: 
CD spectra of hSAF-p1 (red), hSAF-p2 (blue) and p1:p2 fibres (black). Dotted lines indicate the theoretical 
average spectra upon combining that of hSAF-p1 and hSAF-p2. Readings were taken at 20 oC (left panel) and 
37 oC (right panel). C-E: TEM images of hSAF-p1 (C), hSAF-p2 (D) and the p1:p2 mixture (E). F: Box plot 
showing fibre diameters, n=10 fibres chosen at random across multiple images. Fibres were measured manually 
using ImageJ. 
To identify whether the parent hSAF peptides formed fibres, mixed peptides were analysed by TEM 
(Figure 3.1.1C-E). The role of the Asn residues in hSAF-p1 and -p2 (Figure 3.1.1A) is to direct the 
formation of offset heterodimers rather than parallel homodimers, the former of which promotes 
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longitudinal assembly. TEM confirmed the individual peptides did not form fibres. When mixed, the 
peptides formed fibres that covered most of the EM grid. Fibres had an average diameter of 5±1 nm 
(Figure 3.1.1F), roughly half that previously reported (13±5 nm) (140), and extended over hundreds of 
nm. Fibres were prepared under identical conditions to those previously reported and, therefore, the 
reason for the formation of narrower fibres is unclear. Fibre diameter was consistent across all 
preparations and therefore this was not investigated further. 
 
Figure 3.1.2: Biophysical analysis of the hSAF scaffold. A: Photograph of the resultant self-supporting gel 
formed upon mixing hSAF-p1 and hSAF-p2. B: SEM images of the p1:p2 hSAF scaffold. C: Frequency sweep 
bulk rheological analysis of p1:p2 hSAFs at 20 oC (left panel) and 37 oC (right panel) and 0.5% strain. G’ (circles) 
and G’’ (crosses) values are shown. 
When 2 mM hSAF-p1 and 2 mM hSAF-p2 were mixed, the peptides formed a self-supporting hydrogel 
(Figure 3.1.2A). This gel was analysed by SEM, revealing a porous network (Figure 3.1.2B). This 
interconnected network resembled that reported previously (12, 140). 
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As outlined in Chapter 1, the viscoelastic properties of a hydrogel (i.e. the gel stiffness) is an important 
consideration when designing a scaffold for cell culture. Different tissue types have different stiffnesses 
that make them suitable for a given cell type, and not another (63, 237) (Figure 1.2.2). Thus, a 
cytoscaffold of a given stiffness might support the growth of one cell type, while preventing that of 
another (68). 
Hydrogel viscoelastic properties are typically measured by bulk rheology (238). Here, a hydrogel is 
exposed to small deformation forces, typically in the form of small amplitude oscillatory shear 
measurements, which yield values for the storage (elastic, G’) and loss (viscous, G’’) modulus of a 
material, based on its deformation upon exposure to a force (238, 239). A G’ > G’’ indicates the material 
behaves as an elastic solid, whereas a G’’ > G’ is indicative of viscous liquid-like behaviour. Thus, a 
G’ > G’’ for a hydrogel-forming material can be used to confirm gelation, and the elastic modulus (G’) 
is typically stated as a measure of stiffness for such a material (239). 
Bulk rheological analysis using small amplitude (0.01 – 10 Hz) oscillatory shear measurements was 
used to assay the elastic modulus of the parent hSAFs, previously reported to be ~1 kPa at room 
temperature (Figure 3.1.2C). When the peptides were mixed, a G’ greater than G’’ confirmed gel 
formation, and this remained true for all oscillation frequencies studied. Elastic moduli of 1.05 and 
2.11 kPa were recorded at 20 and 37 oC, respectively, indicating that the gel stiffened slightly in 
response to an increase in temperature. This temperature-dependent increase in elastic modulus has 
been reported previously (12). 
In summary, hSAF peptides prepared in this work are well folded and helical in solution, self-assemble 
into helical fibrous structures upon mixing, and form a soft hydrogel at room temperature, which stiffens 
slightly upon increasing the temperature to those relevant for cell culture. These observations are 
consistent with those previously reported and, thus, the parent hSAFs used herein are comparable to 
those used in previous studies (12, 140, 141). 
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hSAFs support the growth of primary neurons  
hSAFs were assayed for their ability to support the growth of primary cortical neurons (PCNs), isolated 
from rat embryos, compared to other commercially available cell-culture materials. Two gels were 
chosen for comparison: Matrigel, a naturally derived gel commonly used as a cytoscaffold for many 
different cell types (81-83, 240); and Puramatrix, which, like hSAFs, comprises self-assembling 
peptides (56). These were chosen to cover the range of commercially available alternatives: Matrigel 
contains growth factors and other ECM components that should promote cell growth, while Puramatrix 
contains only the underlying structural peptides. Therefore, Matrigel is rather different to hSAFs and 
PCN growth was expected to be higher on Matrigel. On the other hand, Puramatrix is similar in make-
up to hSAFs, and it was hoped our gel would compare favourably to it. Both have been reported to 
support PN growth (82-84, 86, 241, 242). 
hSAFs, Puramatrix and Matrigel were compared for their ability to support the growth of PCNs by 
AlamarBlue assay and analysis of neurite length via widefield microscopy. AlamarBlue is a commonly 
used cell viability assay where a non-fluorescent, cell-permeable compound, resazurin, enters cells and 
is reduced to resorufin, a red-fluorescent compound (243). This reduction to the fluorescent form only 
occurs in viable cells and is, therefore, a measure of cell viability (Figure 3.1.3).  
 
Figure 3.1.3: Chemical mechanism showing the reaction underpinning the AlamarBlue assay. The weakly 
fluorescent resazurin enters living cells and is reduced to resorufin, which is strongly fluorescent at 585 nm. 
Like many such assays, disentangling cell viability from cell activity and number is difficult. However, 
as PNs are postmitotic and, therefore, do not divide, no increase in neuronal cell number should occur 
after seeding onto the scaffolds. Additionally, cells were co-stained for microtubule-associated protein 
2 (MAP2) and glial fibrilliary associated protein (GFAP), which are specific for neuronal and glial cells, 
respectively. Thus, any increases in overall cell number contributed by glial cells – which do divide – 
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are accounted for. Neurite length was measured using the ImageJ tool NeuronJ and used as an additional 
indirect measure of neuronal health and growth (Figure 3.1.4). 
 
Figure 3.1.4: PCN viability and morphology on hSAFs, Puramatrix and Matrigel. A: Cell viability on the three 
gel types, determined by AlamarBlue assay, relative to Puramatrix. n = 3 measurements taken from 3 independent 
PCN cultures derived from 3 different rats. B: Length of the longest neurite for each analysed neuron on the three 
growth substrates. n=30 individual cells chosen randomly across the 3 different cultures. C-E: Representative 
widefield images of PN cultures on hSAFs (C), Puramatrix (D) and Matrigel (E). Scale bars are 50 μm. Cells 
were stained with DAPI (blue, nuclear), MAP2 (green, neuron-specific) and GFAP (magenta, glial cell-specific). 
Statistical analysis is by one-way ANOVA with Tukey’s post-analysis. ** = P<0.01, *** = P<0.001. 
PN viability and neurite outgrowth on hSAFs was comparable to that on Puramatrix: cell viability on 
the two gel types was very similar and median neurite length was 20 μm greater on hSAFs than on 
Puramatrix (Figure 3.1.4A-B). In contrast, cell viability and neurite length on Matrigel were 
significantly greater, with a 50% increase in median neurite length compared to hSAFs. As previously 
stated, the additional ECM components and growth factors in Matrigel are likely to promote neuronal 
growth and, therefore, these differences are to be expected. Very little glial growth was detected on any 
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of the scaffolds. This suggested, perhaps, that the GFAP antibody used did not bind to the target protein. 
However, binding was confirmed in PCN cultures grown under high-serum conditions that promote 
glial growth (Appendix, Figure 8.4.1). Due to the removal of serum from the medium shortly after 
initial cell seeding, the lack of glia in the PCN cultures (Figure 3.1.4) was unsurprising, and I was 
satisfied that glia were unlikely to contribute to the reduction of resazurin in the AlamarBlue assay. 
These data suggest that hSAFs are a suitable culture substrate for PNs and are comparable to a 
commercially available peptide hydrogel (Puramatrix). However, the fact that Matrigel promotes 
neuronal growth to a greater extent suggests that the parent hSAFs are a suboptimal growth substrate 
for PNs. As outlined in Chapter 1.4, one of the major advantages of using a synthetic scaffold, such as 
hSAFs, is the ability to manipulate gel properties, either by introducing chemical adducts or by altering 
the underlying sequences of the peptides. By exploring both these avenues, I sought to optimise hSAFs 
for PN growth.
 
3.2: Assessing PCN responses to adhesion peptide-modified 
hSAFs 
Peptides can be incorporated via Cu2+-catalysed azide-alkyne cycloaddition 
(CuAAC) 
The attachment, proliferation and growth of many cell types on synthetic scaffolds is improved by 
incorporating adhesion proteins and peptides into the gels (244). In particular, the fibronectin-derived 
peptide, RGDS, has been introduced into a range of cytoscaffolds and shown to have positive effects 
on cell growth (107, 151, 152, 157, 245). Previously, members of the Woolfson group have 
demonstrated increased attachment and proliferation of PC12 cells and NSCs on hSAFs when RGDS 
is incorporated into the scaffold via Cu2+-catalysed azide-alkyne cycloaddition (CuAAC) (140, 141). 
Therefore, it was hypothesised that introducing RGDS or the laminin-derived adhesion peptide, 
IKVAV, into hSAFs might promote PN growth. Both of these ligands have previously been shown to 
do so in other systems (155, 226, 246). 
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CuAAC involves the reaction of an azide with a terminal alkyne, catalysed by the addition of Cu2+ ions, 
forming a covalent complex (Figure 1.4.1A). Cu2+ is typically provided via the reduction of CuSO4 by 
a reducing agent such as sodium ascorbate (NaAsc) (144). This reaction occurs relatively quickly under 
ambient conditions, making it suitable for modification of hSAFs, where excessive heating or changes 
in pH might disassemble the gel. Cu2+ is cytotoxic. However previous work demonstrated effective 
removal of Cu2+ by stringent washes with EDTA, followed by PBS (140) prior to cell seeding. 
Therefore, CuAAC was adopted for hSAF decoration in this work. 
 
Figure 3.2.1: CuAAC-mediated decoration of hSAFs with adhesion peptides. A: Table showing sequences for 
hSAF-p1KAz and hSAF-p2, with the azidonorleucine residue highlighted in green. B: Schematic diagram 
showing CuAAC-mediated decoration of hSAFs with RGDS peptide. N3 = azide group. C: Sequence of alk-
RGDS, along with HPLC chromatograms for p1KAz:p2 hSAF (black) and p1KAz:p2 hSAF reacted with alk-
RGDS by CuAAC (green). The mass spectrum is for the product peak labelled * (Expected mass = 3841.0 Da, 
recorded mass = 3840.2 Da). D: Sequence of alk-IKVAV along with HPLC chromatograms for p1KAz:p2 hSAF 
(black) and p1KAz:p2 hSAF reacted with alk-IKVAV (green). The mass spectrum is for the product peak labelled 
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An azide-modified variant of hSAF-p1 was synthesised with an azidonorleucine (Kz) in-place of the N-
terminal Lys residue (Figure 3.2.1A). This peptide was named hSAF-p1KAz. RGDS and IKVAV 
sequences were synthesised, both preceded by a flexible linker (GSGYG) to provide space between the 
hSAF fibres and the cell-adhesion sequence (140). These peptides contained an N-terminal 
propargylglycine (pG) residue, which possesses a side-chain alkyne (Figure 3.2.1C-D). All structures 
of unnatural amino acids and functional groups used in this work are listed in Chapter 2.1. 
 
Figure 3.2.2: Biophysical characterisation of CuAAC-modified hSAFs. A-B: CD spectra of p1KAz:p2 hSAFs 
(black), alk-RGDS (A, yellow) or alk-IKVAV (B, yellow), the theoretical average of combining p1KAz:p2 hSAFs 
with either adhesion peptide (grey, dotted) and the recorded spectra when p1KAz:p2 hSAFs were mixed with 
either adhesion peptide, CuSO4 and NaAsc. C-E: TEM images of unreacted p1KAz:p2 fibres (C) and those after 
reaction with alk-RGDS (D) or alk-IKVAV (E). Scale bar is 100 nm. F: Box plot showing fibre diameters, n=10 
fibres chosen at random across multiple images. Fibres were measured manually in ImageJ. 
The reaction between p1KAz:p2 hSAFs and these adhesion peptides (Figure 3.2.1B) was probed by 
HPLC and MALDI-TOF-MS (Figure 3.2.1C-D). For both reactions, a product peak was detected by 
HPLC only when CuSO4 and NaAsc were added to the reaction. These peaks were analysed and 
corresponded to the masses of the covalent complexes p1KAz-RGDS (Figure 3.2.1C) and p1KAz-
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IKVAV (Figure 3.2.1D). The percentage of hSAF-p1KAz converted to these products was calculated 
to be ~45% based on the relative peak sizes for the reacted versus unreacted gels. 
To confirm that the adhesion peptides were incorporated into hSAFs without impacting fibre stability, 
CD spectra and TEM images of RGDS- and IKVAV-decorated fibres were recorded. CD spectroscopy 
showed little change in α-helical character upon reaction of either peptide, both of which were 
unstructured in isolation (Figure 3.2.2A-B). In addition, TEM revealed no significant alteration in fibre 
morphology (Figure 3.2.2C-E). The average fibre diameter remained around 5 nm (Figure 3.2.2F), as 
observed in Chapter 3.1.1. These analyses confirm that CuAAC-mediated introduction of adhesive 
ligands does not destabilise hSAFs. 
PCN growth is not promoted by the addition of  adhesion peptides 
PCN responses to adhesion peptide-decorated hSAFs were assessed in the same way as outlined in 
Chapter 3.1.1. PCNs were seeded onto undecorated, RGDS- or IKVAV-decorated hSAFs. Despite 
stringent washing with EDTA and PBS, I wanted to be sure that the non-peptide components of CuAAC 
were not influencing PCN growth. Therefore, PCNs were also seeded onto gels, treated in the same way 
as those decorated with RGDS or IKVAV (i.e. incubated with CuSO4 and NaAsc), but without addition 
of the adhesion peptide. Puramatrix and Matrigel were used as positive controls (Figure 3.2.3). 
No significant difference in cell viability or neurite length was observed on gels decorated with either 
RGDS or IKVAV. In fact, there was a small, though not significant, decrease in viability and neurite 
length when hSAFs were decorated with either adhesion peptide or incubated with CuSO4 and NaAsc 
alone (Figure 3.2.3A-B). While this might suggest a detrimental effect of the CuAAC reaction 
components on PN growth, it should be noted that this reduction in viability in response to CuAAC, 
was not seen in similar assays described in Chapter 4. Nonetheless, I investigated an alternative, Cu2+-
free, mechanism for immobilising peptides on hSAFs, the details of which are outlined in Chapter 5. 
Irrespective of this, the adhesion peptides assayed here had no growth-promoting effects on PNs. The 
comparisons with Puramatrix (Figure 3.1.4) suggest that neurons can associate with the amino acids 
presented by the hSAF peptides to a great enough extent that these additional adhesive ligands are not 
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required for cell growth. Therefore, I reasoned that their incorporation was unnecessary for downstream 
experiments with PNs. 
 
Figure 3.2.3: PCN responses to hSAFs decorated with RGDS and IKVAV peptides. A: Box plot showing 
AlamarBlue cell viability assay results for cells seeded onto the different hSAFs, Puramatrix and Matrigel. 
Readings were normalised to those for Puramatrix, n=3 measurements taken from 3 independent PCN cultures 
derived from 3 different rats. B: Box and volcano plots showing the length of the longest neurite measured for 
each analysed neuron on the different gels. Analysis was performed manually using NeuronJ, n=30 individual 
cells, chosen randomly across the 3 dissections. C-H: Representative widefield fluorescence images of neurons 
on the different gels. Blue = DAPI, green = MAP2 and magenta = GFAP. Scale bars are 50 μm. Statistical analysis 
was by one-way ANOVA with Tukey’s post analysis. n.s. = not significant.
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3.3: Modulating gel stiffness 
Much of the work in the following section – namely the redesign of hSAFs to form stiffer gels, all 
rheological and SEM analyses – was conducted by Dr Alex Wasmuth, a previous member of the 
Woolfson group. All other biophysical characterisation and cell studies were performed by me. I am 
grateful for Alex’s contribution to this work and thank her for beginning this project prior to my arrival 
in the Woolfson lab. 
The stiffness of hSAFs can be altered by peptide concentration 
As stated in Section 3.1.1, the elastic modulus of parent hSAFs is ~1 kPa at room temperature. This 
characterises hSAFs as a soft gel with viscoelastic properties analogous to brain tissue, which is widely 
reported to range from 0.1-1 kPa in stiffness (68-71). This value varies with age and brain region and 
depends upon the measurement technique used, with values as high as 16 kPa reported in particular 
contexts (67, 247). Many neuronal behaviours such as neurite extension, differentiation and axonal 
direction are reported to vary with substrate stiffness and subtle local changes thereof (102, 154, 248-
250). Producing gels of varying elastic modulus would not only allow the study of neuronal responses 
to such changes, but also the generation of scaffolds that are best suited to different cell types, such as 
muscle (3-15 kPa) or bone (20 kPa – 2 GPa) (66). These stiffer scaffolds would have applications in 
tissue engineering and in vitro cell culture, similarly to the 1 kPa system. Therefore, we sought to form 
hSAF gels with altered elastic modulus. 
It was hypothesised that varying the peptide concentration would be one way in which this might be 
achieved. It was reasoned that increasing hSAF peptide concentration could result in a higher density 
of fibres upon mixing, resulting in a greater number of interactions between adjacent fibres, and 
increased strength of the assembled scaffold. This method has been exploited extensively for other gel 
types (102, 154, 162, 249). 
Parent hSAF gels contain 1 mM of each peptide. Therefore, to explore the possibility of forming softer 
and stiffer gels, hSAFs were formed with 0.5 and 1.5 mM each peptide. 0.5 mM appeared to be the 
minimum concentration required for visible gelation, while the peptides precipitated upon increasing 
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concentration above 1.5 mM. We compared the elastic moduli of these gels with parent hSAFs (1 mM) 
via bulk rheological analysis (Figure 3.3.1). 
 
Figure 3.3.1: Frequency sweep rheological analysis showing elastic modulus (G’) values for parent hSAFs at 0.5 
(turquoise), 1 (light blue) and 1.5 (navy) mM. All readings were taken at 20 oC and using 0.5% strain. This data 
was collected by Alex Wasmuth. 
Reducing the concentration of peptide to 0.5 mM gave a gel with an elastic modulus of 0.17 kPa, while 
increasing the concentration to 1.5 mM yielded a 2.01 kPa gel. Relatively speaking, these gels are all 
soft; roughly equivalent to brain – endothelial tissue (66). hSAF-p1 and -p2 are rationally designed 
based on our firm understanding of coiled-coil assembly. One of the primary benefits of working with 
such a well-defined system is the ability to tune gel properties by further design of the underlying 
peptides. Therefore, it was reasoned that stiffer hSAF gels might be accessible by redesigning the α-
helical peptide components. 
Redesigning hSAFs for the formation of stiffer gels  
As outlined in Chapter 1, the dimeric coiled-coil heptad repeat has an hpphppp pattern of hydrophobic 
(h) and polar (p) residues, often denoted abcdefg (Figure 3.3.2). In hSAFs, a and d residues provide the 
hydrophobic interface for dimer assembly, while e and g residues form complementary salt bridges to 
help specify offset dimer formation (34). Therefore, these residues are essential for coiled coil and fibre 
self-assembly and were left unmodified. On the other hand, the b, c and f residues are positioned away 
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from the coiled-coil interface allowing modification without impacting dimeric assembly 
(Figure 3.3.2). 
 
Figure 3.3.2: Helical wheel diagrams showing coiled-coil assembly. A: Residues are denoted abcdefg according 
to their position around the helix. Hydrophobic and polar residues are coloured green and black respectively. B: 
Position of polar and hydrophobic residues in hSAFs. The hydrophobic dimer interface is indicated by the dot-
dashed line, with salt bridging residues indicated by a dashed line between Glu and Lys residues. Dotted lines 
indicate the b, c and f position residues, away from the dimer interface, which might be altered. 
SAF peptides contain charged and polar residues at b, c and f positions that promote electrostatic 
interactions between fibres, leading to extensive lateral assembly and thick, crystalline fibres (34, 41). 
In contrast, hSAF peptides contain Ala residues at the b, c and f positions, with a single Trp in the third 
heptad f position. The design rationale is that these Ala/Trp surfaces promote non-specific and relatively 
weak hydrophobic interactions between adjacent fibres (12). This leads to little lateral assembly, narrow 
fibres (Figure 3.1.1) and hydrogel formation. It was reasoned that by incorporating additional Trp 
residues into further heptads of the hSAF peptides, hydrophobic interactions between fibres would be 
increased, possibly leading to stiffer gels (Figure 3.3.3). 




Figure 3.3.3: Lateral assembly of individual coiled-coil fibrils into fibres in SAFs, hSAFs and the newly proposed 
shSAFW1,4s. Upper panels show helical wheels for the first heptad of SAFs, hSAFs and shSAFW1,4s. Middle and 
lower panels depict the proposed methods of lateral assembly in each system, as described in the text. b, c and f 
position residues are shown in green and dotted lines indicate proposed electrostatic (SAFs) and hydrophobic 
(hSAFs and shSAFW1,4s) interactions between residues on adjacent fibres. Models of SAF, hSAF and shSAFW1,4 
peptides were created using the web-based coiled coil modelling software CCBuilder 2.0 (251).  
Previous work in the group indicated that incorporating an additional Trp residue into any of the 
remaining three f positions leads to precipitation of the peptides in solution. However, by shifting the 
peptide register to start at an f position, an additional Trp could be tolerated in the first heptad to yield 
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relatively water-soluble peptides. These are called shifted hydrogelating self-assembling fibres 
(shSAFW1,4s) (Table 3.3.1). 
 
Table 3.3.1: hSAF and shSAFW1,4 peptide sequences. f position Trp residues are highlighted in green.  
Biophysical characterisation of shSAFW1,4 peptides and fibres 
These newly designed peptides showed α-helical character by CD spectroscopy and were both well-
folded (Figure 3.3.4), and shSAFW1,4-p1 was more folded than the parent hSAF-p1 peptide 
(Figure 3.1.1B). However, unlike the parent system, the 222 nm minima were pronounced in both 
shSAFW1,4 peptides, and red-shifted in the case of shSAFW1,4-p2, which suggested the peptides self-
assembled into higher order structure prior to their mixing. Despite this potential homomeric self-
assembly, the CD spectra of the mixed peptides did not overlay closely with the theoretical average of 
the two individuals, indicating that the peptides interacted at 20 oC, similarly to the parent system. 
Thermal denaturation of the peptides confirmed this observation, with the peptide mixture appearing 
marginally more stable than the individual peptides (Figure 3.3.4B). Both peptides and their mixture 
adopted β structure upon heating above ~60 oC and, therefore, accurate melting temperatures could not 
be extracted (Figure 3.3.4C). 
TEM analysis of the mixed peptides revealed fibre formation (Figure 3.3.4F). These were similar in 
diameter to hSAFs (Figure 3.3.4G). However, the new fibres appeared to bundle into larger ribbon-like 
structures. This is consistent with our design principle: fibres associate more readily upon insertion of 
the additional Trp residue. TEM analysis of the individual peptides revealed that shSAFW1,4-p1 also 
formed similar fibres, though no such structures were observed in preparations of hSAFW1,4-p2 
Both CD and TEM analyses indicate that shSAFW1,4 peptides have propensity to self-assemble into 
higher order structure in isolation. However, these analyses also indicate that the peptides do interact, 
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suggesting that complementary salt-bridges between e and g residues and hydrogen bonds between Asn 
residues in the core of each peptide promote heterodimeric coiled-coil assembly as designed in the 
parent system. It should be noted that, in preparation of samples for TEM, deposition onto a TEM grid 
results in a rapid increase in the effective peptide concentration on the surface, which might push the 
peptides towards self-assembly. 
 
Figure 3.3.4: Solution phase characterisation of shSAFW1,4s. A-C: CD spectra at 20 oC (A), thermal melt curve 
(B) and CD spectra at 5 oC post-melt (C) for the individual shSAFW1,4 peptides (p1 = red and p2 = blue) and 
mixture (black). Theoretical averages of combing the shSAFW1,4-p1 and -p2 spectra are shown (grey, dotted). D-
F: TEM images of shSAFW1,4-p1 (D), shSAFW1,4-p2 (E) and the mixture (F). Scale bar is 100 nm. G: Box plot 
showing diameter of hSAF and shSAFW1,4 fibres, n=10 fibres chosen at random across multiple images.  
While satisfying that the peptides appear to self-assemble as designed, our primary concern was the 
generation of hydrogels with increased elastic modulus. Therefore, I assayed the individual peptides, 
and the mixture, for their propensity to form a self-supporting hydrogel, via an inversion experiment 
(Figure 3.3.5). The individual peptides did not gel, whereas the mixture formed a self-supporting 
hydrogel when incubated overnight at 4 oC, according to the preparation protocol for parent hSAFs. 
Taken together, the above experiments indicate that shSAFW1,4 peptides are helical and well-folded in 
solution, similarly to the parent hSAFs. The peptides self-assemble upon mixing to form fibrous 
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structures (Figure 3.1.1E). These data also suggest that the individual peptides self-assemble in isolation 
but are nonetheless able to interact upon mixing (Figure 3.3.4). Given that these homomeric assemblies 
do not form a self-supporting hydrogel, I propose that fibre formation in these preparations is 
sufficiently rare, or the fibres formed are sufficiently unstable, to prevent gel formation. Upon mixing, 
heterodimer assembly should be more favoured and therefore the equilibrium will be pushed towards 
the fibrous state and gel formation can occur. As the aim of this work was to design hydrogels with 
increased elastic modulus, the mechanism of homofibre assembly was not probed further. Instead, we 
proceeded to characterise the elastic modulus of shSAFW1,4 gels. 
 
Figure 3.3.5: Photograph showing a gel-inversion assay for the individual shSAFW1,4 peptides and the mixture. 
shSAFW1,4s can be used to form hydrogels with increased elastic modulus 
Bulk rheological analysis was performed on shSAFW1,4 samples made with 0.5, 1 and 1.5 mM each 
peptide (Figure 3.3.6). This demonstrated that these peptides formed gels with elastic moduli of 1.99, 
3.73 and 18.32 kPa, respectively. Therefore, shSAFW1,4s form hydrogels with increased elastic moduli 
compared to hSAFs, which are comparable to endothelial (1.99 kPa), fat (3.73 kPa) and muscle 
(18.32 kPa) tissues (63, 66). 
























      




Figure 3.3.6: Bulk rheology comparing elastic moduli (G’) of 0.5 mM (turquoise), 1 mM (blue) and 1.5 mM 
(navy) shSAFW1,4s. All readings were taken at 20 oC and 0.5% strain. Data was collected by Alex Wasmuth. 
Taking rheology data for both hSAFs and shSAFW1,4s together, we can produce a suite of gels ranging 
from 0.17 – 18.32 kPa, analogous to brain – muscle tissue (Figure 3.3.7). Complete data for each gel 
type, showing G’ and G’’ values, are listed in Appendix Figure 8.4.2. 
 
Figure 3.3.7: Bulk rheology data for hSAF and shSAFW1,4 gels. A: Examples of frequency sweep data showing 
G’ values for hSAFs (light blue) and shSAFW1,4s (navy) with 0.5 (small dots), 1 (crosses) and 1.5 (large dots) mM 
peptide at 0.01-10 Hz. B: Replicate elastic moduli data recorded at 0.01 Hz, n=3, error bars show one standard 
deviation. Light blue = hSAFs; navy = shSAFW1,4s. C: Table listing mean recorded elastic moduli at 0.01 Hz for 
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The macrostructure of these gels was examined by SEM, which revealed the formation of porous, 
interconnected networks for each gel (Figure 3.3.8). Gross scaffold morphology did not appear to vary 
between hSAFs and shSAFW1,4s. However, the obvious fibrous structures visible in 0.5 and 1 mM 
preparations were less distinct in both 1.5 mM gels. As previously mentioned, 1.5 mM is at the limit of 
solubility for both these peptide systems and it seems likely that a reduction of distinct fibrous structure 
by SEM might be a result of some aggregation of the peptides prior to or during scaffold assembly. 
 
Figure 3.3.8: SEM images of 0.5 mM (A), 1 mM (B) and 1.5 mM (C) hSAF and 0.5 mM (D), 1.0 mM (E) and 
1.5 mM (F) shSAFW1,4 scaffolds. These data were collected by Alex Wasmuth. 
Assessing primary neuronal responses to hSAF and shSAF W1,4 gels of varying 
stiffness 
Brain tissue typically ranges from 0.1 – 1 kPa, and neuronal development is largely reported to be 
promoted on growth substrates of stiffness within this range (252-254); though exceptions to this have 
been reported (153). Neurite outgrowth also depends on tissue elastic modulus, and it has been 
suggested that soft substrates (<1 kPa) promote neurite extension (102, 255). However, some reports 
suggest slightly stiffer growth substrates (≥1 kPa) promote neurite extension (153, 250). It seems likely 
then that neuronal development depends upon tissue stiffness, but the exact cellular responses observed 
are likely context and cell-type dependent. 
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With the suite of hSAF and shSAFW1,4 gels in hand, PCN responses to changes in growth substrate 
stiffness were analysed. As such PCNs were seeded onto 0.5 and 1.0 mM hSAF and 1.0 and 1.5 mM 
shSAFW1,4 gels. These concentrations were selected to cover the range of possible elastic moduli 
accessible with these two gel systems; i.e. 0.17, 1.13, 3.73 and 18.32 kPa, respectively. Puramatrix was 
included as an additional control. Cell viability and neurite length after 14 days in culture were assessed 
by AlamarBlue assay and widefield microscopy, respectively, as outlined in Chapter 3.1 (Figure 3.3.9). 
PCN viability was significantly greater on both 0.17 kPa and 1.13 kPa hSAFs compared to either 
shSAFW1,4 gel, where an ~50% reduction in viability was observed. This supports literature suggesting 
neurons are most viable on soft gels with elastic moduli analogous to that of neuronal tissue (252-254). 
Neurite length was significantly increased on 1.13 kPa hSAFs when compared with 0.17 kPa hSAFs or 
3.73 kPa shSAFW1,4s (Figure 3.3.9B). This indicates that slightly stiffer gels, which possess a G’ value 
close to the upper bound of bulk brain tissue (1 kPa), promote neurite extension, and similar findings 
have been reported previously (153, 250, 256).  
Neurite length was also significantly greater on 18.32 kPa shSAFW1,4s than 0.17 kPa hSAFs 
(Figure 3.3.9B). Promotion of neurite growth on gels that possess an elastic modulus so far from the 
normal range for brain tissue was unexpected, particularly as overall cell viability appeared low. 
However, similar small increases in neurite extension of cortical progenitors have been observed on 
similarly stiff growth substrates, though this was also accompanied by an increase in cell viability (153). 
PCN cultures are heterogeneous and will contain subpopulations of neurons that may respond 
differently to changes in environment. It is possible that, while most cells are unable to develop on these 
stiffer substrates (leading to reduced cell viability (Figure 3.3.9A)), the growth of certain neuronal 
subtypes is promoted. This is an interesting observation that warrants further study. 
It is entirely possible that the reduction in viability on shSAFW1,4s is simply a result of using a different 
peptide or gel type, rather than a result of a difference in stiffness per se. To investigate this, PCNs were 
seeded onto 1.5 mM hSAF and 0.5 mM shSAFW1,4 gels. These possess very similar elastic moduli (2.01 
and 1.99 kPa, respectively), but utilise the two different peptide systems: hSAFs and shSAFW1,4s 
(Figure 3.3.9G). 




Figure 3.3.9: PCN responses to gels of varying stiffness. A: Box plot showing PCN viability on the four different 
gel types, relative to that on Puramatrix. n=6 measurements taken from 6 independent PCN cultures derived from 
6 different rats. B: Box plot showing neurite length analysis for the longest neurite of each analysed cell. n=35 
individual cells chosen at random across the 6 different dissections. C-F: Widefield images of PCNs on 0.17 kPa 
hSAFs (C), 1.13 kPa hSAFs (D), 3.73 kPa shSAFW1,4s (E) and 18.32 kPa shSAFW1,4s (F). Scale bar = 50 μm. Blue 
= DAPI, green = MAP2 and magenta = GFAP. G: Box plot showing PCN viability on hSAF and shSAFW1,4 gels 
of ~2 kPa stiffness. n=3 independent measurements. H: Plot of PCN viability against gel elastic modulus. All 
statistical analyses were by one-way ANOVA with Tukey’s post analysis. * = P<0.05, ** = P<0.01, *** = 
P<0.001. n.s. = not significant. 
There was no significant difference in PCN viability on these two gel types, with both values between 
those for 1.13 and 3.73 kPa gels. This suggested the changes in viability observed were responses to 
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gel stiffness, rather than to shSAFW1,4s. Plotting cell viability against elastic modulus indicates that PCN 
viability decreases with increasing elastic modulus in a sigmoidal fashion (Figure 3.3.9H). Taken 
together, these data demonstrate that PCNs are most viable on growth substrates with elastic moduli 
that lie close to the typical range of brain tissue (0.1-1 kPa). Neurite extension by these cells is greatest 
on gels that are at the upper end of this stiffness range.
 
3.4: Conclusions 
Unmodified hSAFs support the growth of PCNs to a comparable degree to Puramatrix, a commercially 
available and established hydrogel for neuronal culture (241, 242). The addition of adhesion peptides 
does not further promote cell growth, indicating that PCNs are able to adhere to hSAFs without 
additional ligands. These studies demonstrate the applicability of hSAFs as a culture substrate for PNs 
– which presents a considerable challenge – and are a step forward from previous studies with neuronal-
like cell types (140, 141). It is worth reiterating that hSAFs are one of a small number of de novo-
designed peptide cytoscaffolds (44, 48, 54, 56, 158) and one of even fewer that utilise α-helical 
structured peptides (142). While PNs have been cultured on other designed peptide scaffolds (136, 257, 
258), to my knowledge, this is the first example of PN growth on a de novo-designed α-helical peptide 
hydrogel. As such, this work demonstrates the power of de novo peptide design as a method for novel 
cytoscaffold generation. 
While these comparisons with another designed peptide gel (Puramatrix) are promising, Matrigel 
promotes neuronal development to a greater extent, indicating that hSAFs are a suboptimal growth 
substrate for PNs. Matrigel contains extracellular growth factors that promote neuronal development, 
and I propose that neuronal growth might be further stimulated by incorporating these growth factors 
into hSAFs. I investigate this possibility in Chapter 4. 
Through the redesign of hSAFs to form shSAFW1,4s, we have produced gels ranging from 0.17-
18.32 kPa. Other examples of gel stiffness variation by rational redesign of peptide sequences, rather 




exist (133, 135, 163). However, these modifications normally result in small changes to gel elastic 
modulus (133, 135, 163). In contrast, here we have generated peptide scaffolds that cover a large range 
of stiffnesses without additional non-peptide modifications or formation of a composite (260, 262, 263). 
Therefore, this study demonstrates that hSAFs are amenable to redesign of the underlying peptide 
architecture and, consequently, can be used to form gels that cover a large range of elastic moduli. By 
culturing PCNs on these scaffolds, I have contributed to the growing hypothesis that neurite outgrowth 
is promoted by relative increases in brain tissue stiffness (153, 250, 256). However, the stiffness of 
shSAFW1,4 gels aligns with that of fat and muscle tissue (Figure 1.2.2) (66) and, therefore, these 
scaffolds are likely to be better suited to the culture of these cell types. I would like to assess muscle 
cell responses to scaffolds of varying stiffness. I hypothesise that growth of these cells should be 
stimulated on the stiffer shSAFW1,4 gels compared with the parent hSAFs (66). 
However, for further studies with neurons, I concluded that the parent 1 kPa hSAFs, without adhesion 
peptide modification, were best suited for PCN culture. Therefore, these gels were taken forward for 








Chapter 4.  
Incorporating full-length proteins 
into hSAFs 
Introduction 
Incorporating mimetic peptides, such as RGDS and IKVAV, into scaffolds has distinct advantages over 
the introduction of the whole adhesion protein, namely increased stability and ease of production (264). 
However, as demonstrated in Chapter 3, introducing these peptides into hSAFs has little discernible 
effect on PN growth. In addition, many mimetic peptides of extracellular growth factors have been 
developed, though with mixed results (265-268). In these cases, the introduction of whole proteins (i.e. 
adhesion proteins or neurotrophic factors) is advantageous. 
Naturally derived cytoscaffolds, such as Matrigel, have the benefit of containing a cocktail of 
endogenous, full-length growth factors native to tissues in vivo, which promote cell health and growth 
(85). In addition, the natural ECM contains growth factor-binding molecules (such as heparin and 
vitronectin) that cluster these proteins at particular locations. This increases growth factor local 
concentration to promote their effect on cells (60-62, 269). I hypothesised that introducing whole 
neurotrophic factors into hSAFs might further promote PN growth. Furthermore, by having tighter 
control over the presence of these factors, our scaffold would have a significant advantage over Matrigel 
where the exact molecular make-up of constituents is not known (85). Here, I outline the development 
4. Incorporating full-length proteins into hSAFs 
76 
 
of methods for the incorporation of whole proteins into hSAFs, the utilisation of these methods to 
introduce the neurotrophic factor insulin-like growth factor 1 (IGF1) into the scaffold, and assessment 
of PN responses to these IGF1-modified scaffolds.
 
4.1 Incorporating a fluorescent protein into hSAFs 
Selecting an approach for protein incorporation  
 
Figure 4.1.1: Common protein-based modification mechanisms. A: The biotin-streptavidin complex (navy = 
streptavidin, cyan = biotin) (270). B: CuAAC using proteins modified with unnatural amino acids (271), orange 
= dihydrofolate reductase (DHFR), green = GFP, * indicates the point at which the proteins are linked via CuAAC. 
C: SpyTag-SpyCatcher (cyan = SpyTag, navy = SpyCatcher) (127). D: The Fc-region of an IgG molecule (pink) 
bound to the Z-domain of protein A (yellow) (272). PDB reference codes: 3RY2 (A), 1DRF and 1GFL (B), 4MLI 
(C), 4WWI (D). 
I postulated that modification of hSAFs with a whole protein could be achieved using one of several 
established methods for protein-protein or protein-peptide conjugation. These include, though are by 




4.1 Incorporating a fluorescent protein into hSAFs 
77 
 
click chemistries using unnatural amino acids (274); and antibody-mediated binding (275). Examples 
of these are depicted in Figure 4.1.1. When selecting one of these methods, I considered the following 
criteria: immobilised proteins should remain bound to the scaffold over a period of weeks, a relevant 
amount of time for PN culture; there should be a straightforward method for quantifying protein 
attachment to the scaffold; and finally, the attachment method should be modular, such that any protein 
could be incorporated via a similar mechanism. 
 
Figure 4.1.2: SpyTag-SpyCatcher. A: Crystal structures of SpyCatcher (navy) SpyTag (cyan) and the complex 
formed when the two are mixed. Asp 7 (D7) of SpyTag and Lys 31 (K31) of SpyCatcher are highlighted in yellow 
and Glu 77 (E77) is highlighted in wheat. B: Magnified image of the isopeptide bond formed between SpyTag 
(D7) and SpyCatcher (K31) (yellow). C: Chemical mechanism showing the formation of the isopeptide bond 
between K31 and D7. Figure and structures adapted from (127, 276). PDB code = 4MLI. 
With these criteria in mind, I reasoned that proteins should be covalently linked to hSAFs. This would 
not only increase the stability of the protein on the scaffold – thus, maximising the length of exposure 
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to cells – but also allow me to control the spatial location of the protein within the gel. Therefore, affinity 
tag-mediated methods of immobilisation were deemed unsuitable. 
 
Figure 4.1.3: Schematic diagram showing SpyTag-SpyCatcher-mediated immobilisation of GFP on hSAFs. 1: 
alk-SpyTag is attached to p1KAz:p2 hSAFs via CuAAC. 2: fibres are then decorated with SpyCatcher-GFP (SC-
GFP) via the formation of an isopeptide bond between SpyTag and SpyCatcher. 
The Howarth group at Oxford have developed a two-component peptide-protein binding system that 
involves the spontaneous formation of a covalent complex, namely SpyTag-SpyCatcher (Figure 4.1.2). 
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The group split the CnaB2 protein from Streptococcus pyogenes into two binding partners: a 14 amino 
acid peptide (SpyTag), and a 12.4 kDa protein (SpyCatcher) (127). When mixed, Glu 77 of SpyCatcher 
catalyses the spontaneous formation of an isopeptide bond between Asp 7 of SpyTag and Lys 31 of 
SpyCatcher (Figure 4.1.2C). 
This SpyTag-SpyCatcher complex is extremely thermostable and forms under ambient conditions, at 
neutral pH, and in minutes (127). This system has now been utilised for hydrogel formation (125), 
vaccine development (277) and as a research tool (278). Therefore, SpyTag-SpyCatcher was used to 
incorporate proteins into hSAFs via the method outlined in Figure 4.1.3. SpyTag peptide would first be 
immobilised via CuAAC, following the method outlined in Chapter 3. A protein-of-interest would then 
be fused to SpyCatcher and immobilised onto hSAFs via the SpyTag-SpyCatcher interaction. Initially, 
as a proof-of-concept, I chose to immobilise GFP on hSAFs, owing to its ease of synthesis and 
detectable fluorescence upon incorporation. 
SpyTag can be incorporated into hSAFs via CuAAC 
 
Figure 4.1.4: CuAAC-mediated immobilisation of SpyTag. A: alk-SpyTag peptide sequence with the N-terminal 
propargylglycine (pG) residue highlighted. B: HPLC chromatograms (left panel) showing p1KAz:p2 hSAFs 
either unreacted (black) or reacted with alk-SpyTag (green). MALDI-TOF-MS spectrum (right panel) is for the 
product peak labelled * (Expected mass = 4817.6 Da, recorded mass = 4816.0 Da). C: CD spectra of p1KAz:p2 
fibres (black), alk-SpyTag (yellow), the theoretical average of mixing the two (grey, dotted) and the recorded 
spectra of p1KAz:p2-SpyTag fibres (green). 
SpyTag peptide was synthesised with an N-terminal propargylglycine (pG) to allow conjugation to 
p1KAz:p2 hSAFs by CuAAC. This peptide was named alk-SpyTag. Its incorporation was followed by 
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HPLC and MALDI-TOF-MS (Figure 4.1.4) and secondary structure of SpyTag-hSAFs assessed by CD 
spectroscopy.  
alk-SpyTag was successfully appended to hSAFs via CuAAC (Figure 4.1.4B). ~35% hSAF-p1KAz was 
converted to the reaction product, p1KAz-SpyTag (peak labelled *) (Figure 4.1.4B). Like RGDS and 
IKVAV, SpyTag was unstructured in isolation and interacted with p1KAz:p2 hSAFs upon mixing 
(Figure 4.1.4C). Fibres remained well-folded and helical upon attachment of alk-SpyTag. 
Expression and purification of SpyCatcher-GFP 
An expression construct encoding the SpyCatcher-GFP (SC-GFP) fusion protein, with an intervening 
flexible (GS)6 linker and N-terminal His-Tag (Figure 4.1.5A-B), was produced using Golden Gate 
cloning methods. Briefly, the SpyCatcher sequence (kindly gifted to me by Mark Howarth), with an N-
terminal His-Tag, was ligated into a vector containing GFP with an N-terminal (GS)6 linker (kindly 
gifted by James Ross of the Woolfson group). SC-GFP was expressed in competent E. coli cells and 
subsequently purified by Ni2+-affinity and size exclusion chromatography (SEC). Full experimental 
details are listed in Chapter 2.5. Protein purity was assessed by SDS-PAGE (Figure 4.1.5). 
 
Figure 4.1.5: Expression and purification of SC-GFP with an N-terminal His-tag. A: Domain structure of SC-
GFP. Full amino acid sequences for all SpyCatcher fusion proteins can be found in the Appendix (Chapter 8.3). 
B: SDS-PAGE showing Ni2+-NTA- and SEC-purified SC-GFP. From left to right, lanes correspond to: Material 
that did not bind to the Ni2+-NTA column; material removed by the wash buffer; material eluted upon addition of 
imidazole; and fractions resulting from SEC purification of the elute. C: SEC fractions 1 – 4 from B were pooled 
and further purified by Ni2+-affinity chromatography using a gradient of imidazole. The resulting fractions were 
analysed by SDS-PAGE. Expected mass: 44 kDa, indicated by green arrows in B and C. 
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The protein obtained was roughly the expected mass for SC-GFP (44 kDa), however, multiple products 
were detected by SDS-PAGE (Figure 4.1.5B). Three prominent bands were present between 35 – 
50 kDa, one of which was likely the 44 kDa, full length SC-GFP protein. These same three products 
were observed in all SC-GFP expressions. The distinct nature of the observed bands suggested these 
were likely not degradation products. 
To separate these products, SEC fractions 1 – 4 from the initial purification (Figure 4.1.5C) were pooled 
and further purified using Ni2+-NTA chromatography coupled with an imidazole gradient 
(Figure 4.1.4C). I hypothesised that the three products might have slightly different affinities for the 
Ni2+-NTA column and, therefore, would elute at different imidazole concentrations. However, though 
the largest product was separated from the other two, the two smaller products could not be separated 
from one another using this method. Furthermore, repeated purification steps resulted in a significant 
reduction in protein yield. 
 
Figure 4.1.6: Expression and purification of C-terminal His-tagged SC-GFP. A: Diagram showing the domain 
structure of the new SC-GFP fusion protein, with a C-terminal His-Tag. B: SE chromatogram of Ni2+-NTA-
purified SC-GFP. C: SDS-PAGE gel showing the resulting fractions after SEC. Expected mass: 41 kDa, indicated 
by green arrows. 
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It was hypothesised that, if partial expression products were produced, moving the His-Tag to the 
C terminus would prevent these from co-eluting with the full-length protein. Therefore, I redesigned 
the expression vector by moving the His-tag to the protein C terminus (Figure 4.1.6A). This new 
construct was again expressed in E. coli, purified by Ni2+-NTA chromatography and SEC and analysed 
by SDS-PAGE (Figure 4.1.6B-C). A distinct product peak was observed by SEC (Figure 4.1.6B) that 
corresponded to a single product by SDS-PAGE (Figure 4.1.6C), with a mass roughly that expected for 
the new SC-GFP protein (41 kDa – a Tobacco Etch Virus (TEV) protease site contained in the N-
terminal His-Tag construct was also removed, resulting in the decrease in mass). The protein was 
obtained at high yield. This C-terminal His-tagged construct was used for all subsequent experiments 
and, henceforth, SC-GFP refers to this fusion protein. 
GFP can be incorporated into hSAFs via SpyTag-SpyCatcher 
With this SC-GFP fusion in hand, I sought to determine whether GFP could be incorporated into hSAFs 
via SpyTag-SpyCatcher. 1 μM SC-GFP was incubated with alk-SpyTag-decorated and, to determine 
the specificity of the SpyTag-SpyCatcher interaction, undecorated hSAFs (Figure 4.1.7). Typically, 
studies of neurotrophic factors in vitro use nM concentrations of protein (180, 279-282), and I reasoned 
that incubation with 1 μM protein would likely result in protein immobilisation in the nM range. 
However, I acknowledge that SpyTag is in a significant excess in this reaction (roughly 350 μM is 
immobilised on the gel (Figure 4.1.4B)) and, therefore, the concentration of SC-GFP immobilised 
would likely vary significantly depending on its starting concentration. Nonetheless, after extensive 
washes to remove non-specifically bound protein, the approximate GFP concentration on each gel was 
quantified via comparison with known concentrations of SC-GFP. Fluorescence was quantified using a 
ClarioStar plate reader (BMG LabTech, Germany) and widefield microscopy (Figure 4.1.7). 
Very little SC-GFP bound to undecorated hSAFs, while around 5-fold more protein bound to SpyTag-
decorated gels (Figure 4.1.7A-C). This indicated that SC-GFP bound with relative specificity to 
SpyTag-decorated hSAFs. When incubated with 1 μM SC-GFP, approximately 0.47 μM protein bound 
to the gel. For future studies, it is likely that individual growth factors would need to be assayed for 
optimum activity in order to choose a suitable starting concentration for immobilisation. 




Figure 4.1.7: SC-GFP immobilisation on hSAFs. A-B: Widefield images showing GFP fluorescence on 
undecorated and SpyTag-decorated p1KAz:p2 hSAFs after incubation with SC-GFP. Scale bars = 200 μM. C: 
Quantification of protein immobilisation (left panel). Approximate bound SC-GFP concentration was calculated 
using a calibration curve of known SC-GFP concentrations (right panel). Calibration data was fitted to a 
polynomial curve. D: SC-GFP detachment from SpyTag-decorated hSAFs over a 4-week period. n=3 different 
gels. Statistical analysis was via t-test. *** = P<0.001. Error bars show one standard deviation from the mean. 
One of the advantages of covalent immobilisation is that cells might be exposed to bioactive proteins 
for longer and, thus, the effect of these proteins on encapsulated cells might be maximised. Therefore, 
the level of SC-GFP detachment from SpyTag-decorated hSAFs over a 4-week period was assessed 
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(Figure 4.1.7D). Around 15% of the total SC-GFP immobilised initially was detected in the supernatant 
by the end of the study, leaving 85% still attached. Some detachment is expected over time, due partly 
to the non-specific association of some SC-GFP with the gel at the beginning of the 4-week period, 
despite stringent wash steps after immobilisation. In addition, as individual peptides are associated with 
the gel through relatively weak non-covalent interactions, some peptide, possibly that linked to GFP, is 
expected to dissociate from the gel over time. I was satisfied that the majority of protein remained 
associated with the gel over the timescale analysed. I did not perform further analysis to determine the 
nature of this detached component. 
Protein inclusion can be tuned via p1KAz content 
 
Figure 4.1.8: Controlling SC-GFP attachment by hSAF-p1KAz content. Graph showing GFP fluorescence on 
p1KAz:p2-SpyTag hSAFs with different hSAF-p1KAz contents, incubated with SC-GFP and washed copiously 
with PBS. Values are relative to 0% hSAF-p1KAz gels. n=3 different gels for each azide percentage. Error bars 
show one standard deviation from the mean. Inset: representative widefield images for each gel type, scale bars 
= 200 μm. 
One of the main advantages of our synthetic peptide-based system is the modular way in which 
components can be incorporated. For example, by varying the number of azides available in the gel, it 
should be possible to vary the amount of SpyTag peptide and, therefore, SC-GFP protein attached to 
the gel. I tested this by making hSAF gels with differing hSAF-p1KAz percentages, relative to the non-
4.1 Incorporating a fluorescent protein into hSAFs 
85 
 
reactive hSAF-p1. These gels were decorated with alk-SpyTag and SC-GFP, and protein immobilisation 
quantified by widefield microscopy (Figure 4.1.8). 
Little SC-GFP bound to 0% hSAF-p1KAz gels, which are unmodified with SpyTag, as no azide was 
present for CuAAC-mediated alk-SpyTag attachment. Inclusion of 20%, 40% and 60% hSAF-p1KAz 
led to roughly 2.2-, 2.75- and 3-fold increases in GFP immobilisation, respectively. This demonstrates 
that protein content can be tuned by varying the concentration of azide in the gel. Despite the 
concentration of SC-GFP (1 μM) being much lower than that of SpyTag (theoretically between 70-350 
μM in 20-100% gels), protein immobilisation did not vary linearly with increasing azide content. Little 
further increase in protein immobilisation occurred when hSAF-p1KAz content was increased past 
60%. Presumably, the low concentration of SC-GFP relative to SpyTag meant that, at high hSAF-
p1KAz concentrations, azide concentration was no longer limiting to the reaction. Further incorporation 
would likely result from incubating with increasing SC-GFP concentrations. However, these 
investigations were beyond the scope of this thesis.
 
4.2 Incorporating insulin-like growth factor 1 (IGF1) into 
hSAFs via SpyTag-SpyCatcher 
 
Figure 4.2.1: Crystal structure of IGF1 with its three disulphide bonds highlighted (yellow). PDB code = 1IMX. 
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Insulin-like growth factor 1 (IGF1, Figure 4.2.1) is a neurotrophic factor expressed throughout the brain 
during development. It has a range of effects on diverse neuronal cell types, including promoting 
neuronal survival (177, 283), neurite extension and polarity (178, 179), progenitor cell proliferation and 
neurogenesis (176, 180). Furthermore, it has been incorporated into similar hydrogel systems previously 
(186, 284) and bioactive fusions between IGF1 and additional proteins have been successfully produced 
in E. coli (186). Therefore, IGF1 was selected for immobilisation on hSAFs via SpyTag-SpyCatcher. 
SC-GFP-IGF1 expression and purification 
I chose to N-terminally modify IGF1 with SC-GFP as similar modifications – while maintaining IGF1 
activity – had been previously reported (186, 285). The inclusion of GFP would once again allow me 
to easily monitor protein incorporation. The gene encoding IGF1, with an N-terminal (GS)6 linker, 
optimised for expression in E. coli, was synthesised by GeneArt from Thermo Fisher Scientific and 
amplified by PCR. This was ligated into a vector containing N-terminal His-tagged SC-GFP 
(Figure 4.1.5), C terminal to the SC-GFP coding sequence. IGF1 contains three disulphide bonds that, 
in E. coli, need to be formed in the periplasmic space. Therefore, a periplasm-targeting sequence was 
introduced via PCR at the extreme N terminus. Both the His-tag and periplasm-targeting sequence were 
introduced away from IGF1 to reduce the likelihood of them interfering with protein folding or activity. 
This construct was named p-SC-GFP-IGF1 (periplasm-targeted-SpyCatcher-GFP-insulin-like growth 
factor, Figure 4.2.2). Full experimental details are listed in Chapter 2.5. 
IGF1 expression in E. coli has been previously reported, but is non-trivial. The resulting protein is 
typically insoluble and requires in vitro refolding to attain the active, soluble protein (186, 286-288). 
As expected, upon expression in BL21 cells, p-SC-GFP-IGF1 was in the insoluble fraction. It seemed 
likely that this protein formed inclusion bodies before it could be transported to the periplasm for 
disulphide-bond formation and proper folding into its native state. p-SC-GFP-IGF1 was refolded in 
vitro by dialysis and purified by Ni2+-NTA chromatography and SEC. However, SDS-PAGE analysis 
indicated the formation of multiple, coeluted products (Figure 4.2.2B). 




Figure 4.2.2: p-SC-GFP-IGF1. A: Domain structure of p-SC-GFP-IGF1. PTS = periplasm targeting sequence. B: 
SDS-PAGE analysis of Ni-NTA- and SEC-purified p-SC-GFP-IGF1 after solubilisation of the insoluble protein 
fraction extracted from E. coli. Expected mass is 51.4 kDa, assuming periplasm-tag cleavage upon exportation to 
the E. coli periplasm. 
While in vitro refolding is an established technique for refolding aggregated protein from E. coli, it is 
also time consuming. Alternative E. coli strains exist that, I hypothesised, might aid expression of SC-
GFP-IGF1 in its soluble form. SHuffle® T7 competent E. coli (SHuffle cells) are an engineered strain 
that allow disulphide bond formation in the E. coli cytoplasm (289). The periplasmic tag was removed 
from the p-SC-GFP-IGF1 gene by PCR, producing a new fusion, SC-GFP-IGF1, which was expressed 
in SHuffle cells (Figure 4.2.3). This protein was contained primarily in the soluble fraction. SEC 
indicated that the protein formed a discrete species and did not form large aggregates (Figure 4.2.3B). 
SDS-PAGE confirmed the expected mass of 52.6 kDa (Figure 4.2.3D). Therefore, this protein was used 










   
   
                 
 
 




Figure 4.2.3: Expression and purification of SC-GFP-IGF1. A: Domain structure of SC-GFP-IGF1. B: SE 
chromatogram of SC-GFP-IGF1. C: SDS-PAGE gel showing SC-GFP-IGF1 after Ni2+-NTA and SEC 
purification. Expected mass: 52.6 kDa, indicated by green arrow. 
SC-GFP-IGF-1 can be incorporated into hSAFs via SpyTag-SpyCatcher 
Immobilisation of SC-GFP-IGF1 on hSAFs was assessed as described for SC-GFP, by analysing GFP 
fluorescence on hSAFs compared to known SC-GFP-IGF1 concentrations (Figure 4.2.4A). SC-GFP-
IGF1 immobilised on SpyTag-decorated hSAFs was around 7-fold greater than on undecorated gels. 
This indicated that SC-GFP-IGF1 bound specifically to SpyTag-decorated hSAFs. 
In contrast to SC-GFP, SC-GFP-IGF1 detached significantly from the gel over 4 weeks, with around 
60% of the total starting protein detected in the supernatant (Figure 4.2.4B). The amount of protein 
bound to the gel without SpyTag was similar to that observed for SC-GFP, indicating that non-specific 
protein binding was similar in both. However, the concentration of SC-GFP-IGF1 initially immobilised 
to SpyTag-decorated gels was greater for SC-GFP-IGF1 than for SC-GFP. Therefore, despite 
significant SC-GFP-IGF1 detachment from the gel, the concentration of immobilised protein after 4 
weeks was similar in both experiments (approximately 0.36 and 0.32 μM for SC-GFP and SC-GFP-
IGF1, respectively). It seems likely that – despite following an identical method for both proteins – 
more SC-GFP was initially removed during the wash procedure prior to measuring the immobilised 









   
                            








Figure 4.2.4: SC-GFP-IGF1 immobilisation on hSAFs. A: Quantification of protein immobilisation (left panel). 
Approximate bound SC-GFP-IGF1 concentration was calculated using a calibration curve of known SC-GFP-
IGF1 concentrations (right panel). Calibration data was fitted to a polynomial curve. B: SC-GFP-IGF1 detachment 
from SpyTag-decorated hSAFs over a 4-week period. n=3 different gels. Statistical analysis is via t-test. ** = 
P<0.01. Error bars show one standard deviation from the mean. 
Protein incorporation does not impact fibre morphology or gel viscoelastic 
properties 
The attachment of these rather large fusion proteins to hSAFs might impact fibre stability, which might 
in turn impact upon the viscoelastic properties of the gel. This might inadvertently influence cell 
behaviour in unintended ways. Therefore, I investigated whether changes in fibre morphology or gel 
stiffness occurred when gels were decorated with SC-GFP or SC-GFP-IGF1. TEM images and 








Figure 4.2.5: Biophysical characterisation of SC-GFP- and SC-GFP-IGF1-decorated hSAFs. A-C: TEM images 
of undecorated p1KAz:p2 fibres (A), SC-GFP-decorated (B) and SC-GFP-IGF1-decorated (C) fibres. Scale bars 
= 100 nm. D: quantification of fibre diameter for each fibre type. n=10 fibres chosen at random across multiple 
images. E: Bulk rheological analysis of undecorated (black), SC-GFP-decorated (turquoise) and SC-GFP-IGF1-
decorated (blue) hSAF gels. G’ (circles) and G’’ (crosses) are shown. Rheological measurements were performed 
at 37 oC. 
Neither incorporation of SC-GFP or SC-GFP-IGF1 impacted upon the presence or morphology of fibres 
(Figure 4.2.5A-D). Similarly, all gels possessed similar G’ and G’’ values (Figure 4.2.5E). These 
measurements are analogous to those recorded for the parent hSAFs at 37 oC. Taken together, these 
observations suggest that introduction of proteins into hSAFs via SpyTag-SpyCatcher does not impact 
upon fibre or gel properties. 
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SC-GFP-IGF1 has comparable bioactivity to wildtype IGF1 
Next, I determined whether SC-GFP-IGF1 retained the bioactivity of wildtype IGF1. MCF-7 cell 
proliferation is promoted by IGF1 and is a common read-out for IGF1 activity (186, 290). Crystal Violet 
is a dye that binds non-specifically to DNA and proteins and is widely used to assay cell number (291). 
To examine the bioactivity of my fusion proteins, MCF-7 cells, incubated with SC-GFP, SC-GFP-IGF1 
or recombinant IGF1 (rIGF1, Abcam, UK), were stained with Crystal Violet (Figure 4.2.6). 
When SC-GFP-IGF1 was expressed in SHuffle E. coli cells, most of the protein produced was contained 
in the soluble protein fraction. Though this suggested it had not formed large aggregates upon 
expression, it did not guarantee the protein had folded correctly. Therefore, this protein was refolded in 
vitro by denaturation in guanidinium hydrochloride (GuHCl) and dialysis against refolding buffer. I 
included this refolded protein (SC-GFP-IGF1 IVR), along with one that had not undergone refolding 
(SC-GFP-IGF1), in the bioactivity assay, to determine whether this was a necessary step to procure 
active protein (Figure 4.2.6). 
 
Figure 4.2.6: Assessing SC-GFP-IGF1 bioactivity. A-D: MCF-7 cell proliferation in response to rIGF1 (A), SC-
GFP-IGF1 (B), SC-GFP-IGF1 IVR (C) and SC-GFP (D), relative to untreated cells, quantified by crystal violet 
(CV) stain. E: MCF-7 cell number after treatment with 30 pmoles each protein, shown as a percentage of untreated 
control cells (labelled C, black). n=3. Statistical analysis was by one-way ANOVA with Tukey’s post-hoc test. ** 
= P<0.01. Error bars show one standard deviation from the mean. 
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rIGF1 and the two SC-GFP-IGF1 fusions promoted MCF-7 cell proliferation in a dose-dependent 
manner (Figure 4.2.6A-D). All did so to a comparable level, with mean percentage increases in cell 
number varying from 30 – 50% compared to untreated cells (Figure 4.2.6E). SC-GFP did not induce 
any such increase in proliferation, indicating that the IGF1 component of the fusion was responsible for 
bioactivity. Thus, SC-GFP-IGF1 was determined to be active in solution regardless of whether the 
protein was refolded in vitro. Therefore, I did not refold the protein in vitro for downstream experiments. 
IGF1-decorated hSAFs promote primary neuronal growth  
With SC-GFP-IGF1 in-hand, and its bioactivity confirmed, I sought to determine PN responses to IGF1-
decorated hSAFs. Given the heterogeneity of cortical cultures, and the fact that IGF1 has been widely 
reported to promote cell growth in the hippocampus (176-178, 292), primary hippocampal neurons 
(PHNs) were used for these studies. I cultured PHNs on undecorated p1KAz:p2 hSAFs, SC-GFP-hSAFs 
or SC-GFP-IGF1-hSAFs. PHNs were also cultured on two further unmodified p1KAz:p2 gels with 
rIGF1 or SC-GFP-IGF1 included in solution. Thus, I reasoned that any differences in the effect of 
immobilised IGF1, compared with that in solution, would be uncovered. Matrigel was included as a 
further control. As described in Chapter 3, AlamarBlue assay and widefield microscopy were used to 
measure neuronal viability and neurite length, respectively (Figure 4.2.7). 
PHN viability and neurite length were significantly increased on SC-GFP-IGF1-hSAFs compared to 
undecorated hSAFs (Figure 4.2.7A-B). In addition, there was no significant difference in either 
measurement between SC-GFP-IGF1-hSAFs and Matrigel. These observations indicated that the 
incorporation IGF1 had the desired effect of promoting neuronal growth and survival on hSAFs to a 
level comparable with Matrigel. 




Figure 4.2.7: PHN responses to IGF1-modified hSAFs. A: PHN viability on the different growth substrates, 
relative to that on undecorated, untreated hSAFs. n=4 measurements taken from 4 independent PCN cultures 
derived from 4 different rats. B: Length of longest neurite of each analysed cell on the different growth substrates. 
n=40 individual cells chosen at random across the 4 dissections. C-G: Representative widefield images of neurons 
on p1KAz:p2 hSAFs (C), SC-GFP (D) and SC-GFP-IGF1 (E) decorated hSAFs, p1KAz:p2 hSAFs treated with 
SC-GFP-IGF1 (F) and rIGF1 in solution (G), and Matrigel (H). DAPI = blue, MAP2 = green, GFAP = magenta. 
Scale bar = 50 μm. Images are all maximum projections of z-stacks. Statistical analysis was by one-way ANOVA 
with Tukey’s post-hoc test. * = P<0.05, ** = P<0.01, *** = P<0.001. n.s. = not significant. 
  
                                           
                                                  
 
   
   
  
 
   
   
 
  
4.2 Incorporating IGF1 into hSAFs via SpyTag-SpyCatcher 
94 
 
However, though not significant, a trend towards increases in viability and neurite length were also 
observed when gels were decorated with SC-GFP (Figure 4.2.7A-B). Critically, there was no significant 
difference in either parameter between SC-GFP- and SC-GFP-IGF1-hSAFs. This suggests that neuronal 
growth might be promoted by the addition of SpyCatcher or GFP, two supposedly non-neurotrophic 
proteins. A possible explanation for this might be the addition of positive charge to the gel surface, 
which would promote neuronal association (293, 294). However, both SC-GFP and SC-GFP-IGF1 are 
negatively charged at neutral pH and, therefore, would be expected to repel negatively charged neuronal 
membranes. Alternatively, SpyCatcher and GFP may contain motifs that promote neuronal adherence. 
SpyCatcher is derived from a bacterial adhesin (127), suggesting it may contain such cell adherence 
ligands, though one would assume these would have little effect on neuronal cells. I did not investigate 
the mechanism of neuronal growth promotion by SC-GFP further. 
Addition of both SC-GFP-IGF1 and rIGF1 in solution had a significant detrimental effect on overall 
cell viability, without impacting neurite length (Figure 4.2.7A-B). Indeed, upon imaging, fewer cells 
remained after 14 days in vitro than in any of the other groups, suggesting significant cell death over 
the time studied. When delivered in solution, more IGF1 is expected to be available to cells than when 
the protein is immobilised. Most in vitro studies of IGF1 activity in neurons are performed using 
relatively acute IGF1 exposure times, no more than 24 hours (180, 279, 280). Some studies indicate 
that, with chronic exposure, IGF1 has a negative impact upon cell viability in vitro (295), though no 
such studies have been performed with PNs. IGF1 levels have also been shown to inversely correlate 
with lifespan and accelerate ageing in a number of animal models (296, 297). I speculate that the 
observed negative effect on PN viability is a potentially previously unreported effect of chronic 
exposure to IGF1. However, further investigation would be required to support this hypothesis.
 
4.3 Conclusions 
I have demonstrated the incorporation of two proteins, GFP and IGF1 into hSAFs via the SpyTag-




IGF1-modified gels promote PHN viability and neurite outgrowth in culture. These findings further 
demonstrate the utility of hSAFs as a culture scaffold for PNs. Furthermore, they support my hypothesis 
that introducing a neurotrophic factor into the scaffold further promotes neuronal growth. 
Modification of cytoscaffolds with proteins has been previously demonstrated (185, 187, 298, 299), as 
has protein decoration of self-assembling peptides (300-302), though these examples are generally 
limited to modifications with fluorescent proteins. Growth factors have also been passively 
encapsulated into designed peptide gels (187, 188). However, I believe this to be the first example of 
covalent modification of a de novo designed peptide hydrogel with a full-length protein. Thus, this work 
demonstrates that designed peptide cytoscaffolds can be modified with whole proteins, in a similar 
manner to synthetic or natural polymer derived gels. 
IGF1 has previously been shown to promote neuronal growth both in vitro and in vivo (176, 177, 279), 
this being the primary reason for its selection in the current study . In addition, IGF1 incorporation into 
hydrogels has been shown to promote the growth and survival of non-neuronal cell types (186, 303-
305). Therefore, my findings further demonstrate that IGF1 incorporation into biomaterials promotes 
the growth of a range of cell types. IGF1-decorated hSAFs promoted neurite outgrowth and neuronal 
viability to a similar extent to Matrigel. This confirmed my hypothesis that neuronal growth on hSAFs 
could be promoted to a similar extent to Matrigel upon introduction of a neurotrophic growth factor. 
The protein modification strategy was chosen in such a way that it would be modular and, thus, allow 
the introduction of other proteins, simply by appending a different protein to the SpyCatcher module. I 
would have liked to explore the introduction of other growth factors, such as brain derived neurotrophic 
factor (BDNF) or vascular endothelial growth factor (VEGF), which might have similar growth-
promoting effects on PNs. Neurotrophic factors often have synergistic effects on cell growth, and cells 
in vivo are likely to be exposed to multiple growth factors at once (306-308). Therefore, I would like to 
explore PN responses to tightly controlled cocktails of different growth factors. Ideally, this would 
involve the development of another, orthogonal, method of protein introduction, such that growth factor 




Another reason for adopting the chosen strategy (i.e. covalent modification) was that the concentration 
of growth factor could be temporally controlled across the gel. This might allow the direction of PN 
behaviour in a spatiotemporal manner. This possibility is explored in Chapter 5.




Chapter 5  
Spatially patterning hSAFs 
Introduction 
In vivo, certain cellular behaviours are dictated by the presence of a particular bioactive molecule and 
its spatial and temporal presentation. Many neuronal cell behaviours rely explicitly on the spatial 
patterning of growth cues within the extracellular matrix (ECM). For example, developing axonal 
growth cones – i.e. structures at the tips of developing axons – respond to chemorepulsive and 
chemoattractive cues within the ECM (189, 309). These bind to transmembrane receptors, triggering 
the cytoskeletal remodelling required to turn the growth cone in a particular direction (189, 193) 
(Figure 5.1). This follows the chemoaffinity hypothesis outlined by Sperry in 1963 (310). Many of these 
growth cues have now been identified, including netrins, semaphorins, ephrins and the neurotrophins 
(169, 311-315). The spatial patterning of these cues within the ECM underpins this process, and the 
maintenance of these patterns is essential for correct patterning of the nervous system during 
development (193).  
Directing axonal growth using biomaterials is of interest for promoting axonal regrowth and repair in 
vivo (220-222), modelling neuronal systems (e.g. polarised synaptic networks), and for studying the 
cellular mechanisms underlying axonal guidance in vitro (219). In addition, while spatiotemporal 
patterning of synthetic polymer or naturally derived gels is relatively common (97, 185, 195-197, 199, 
205), there is little precedent for similarly patterning self-assembling peptide hydrogels. Therefore, the 
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spatiotemporal patterning of hSAFs is of interest, both due to its novelty for materials science and 
potential for modelling neuronal processes in vitro. Here, I describe the development of methods for 
spatially patterning hSAFs with peptides and proteins. 
 
Figure 5.1: Schematic diagram showing the chemoaffinity hypothesis of axonal guidance. A developing axonal 
growth cone senses particular chemorepellent and chemoattractive extracellular growth cues via transmembrane 
receptors. Activation of these receptors causes cytoskeletal remodelling and turning of the growth cone either 
towards or away from the cue (189). 
Selecting a method for spatially patterning hSAFs  
Reported methods for spatially patterning hydrogels include: 3D bioprinting (201, 202, 316), 
photolithography (97, 185, 195, 205), microfluidics (197, 198, 317) and microcontact printing (199, 
318) (Figure 5.2). Bioprinting is arguably the best explored of these and has been applied to various 
synthetic polymer and protein gel systems (319). However, for a gel to be suitable as a bioink for 
printing, it must possess the property of shear-thinning. That is, upon exposure to extrusion forces, the 
gel transitions to a liquid, and then back to a gel when deposited onto a print platform (319). To test 
whether hSAFs shear thinned, I extruded a gel through a needle. The hydrogel transitioned to a liquid 
state with little structural definition (data not shown), presumably due to the disruption of fibre-fibre or 
peptide heterodimer interactions. This rendered bioprinting unsuitable for patterning hSAFs. 
Microcontact printing was also disregarded, since hSAFs are relatively soft and would likely be 
damaged upon contact. Therefore, I tested microfluidics and photolithography as potentially suitable 
techniques for patterning hSAFs with growth cues. 




Figure 5.2: Common methods used for hydrogel micropatterning: 3D biprinting (A), photolithography (B), 
microfluidics (C) and microcontact printing (D).
 
5.1: Microfluidic patterning of hSAFs 
Designing a gradient-generating microfluidic device for patterning hSAFs  
Developing axonal growth cones are not directed to particular locations within tissues by distinct 
patches of a particular neurotrophic factor, but by concentration gradients of that factor (166, 191, 320, 
321). These gradients allow neuronal growth to be patterned over large distances (millimetres – 
centimetres) (189, 321). Therefore, I reasoned that patterning hSAFs with gradients would best model 
chemotaxis in vitro.  
Microfluidics is the study and manipulation of fluid flow on the microscale, typically using devices 
with channels 10s or 100s of microns in diameter (322). Fluids in these channels travel by laminar flow, 
where minimal mixing occurs between fluids that flow parallel to one another (322). Therefore, the 
mixing of fluids can be manipulated using a carefully engineered series of channels. Microfluidic 
devices have been reported for patterning surfaces and hydrogels with gradients (323-326), of which 
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the diffusion mixer (327), Y-junction (317, 328) and serial dilutor (323, 329) are some of the most 
common (Figure 5.1.1). 
 
Figure 5.1.1: Common microfluidic gradient generator device designs: Diffusion mixer (A), Y-junction (B) and 
serial dilutor (C). Dotted arrows indicate the direction of fluid flow from the inlets to the outlets (circles). 
I chose to pattern hSAFs using a serial dilutor microfluidic gradient generator (Figure 5.1.1C), largely 
due to the frequency with which it is reported (197, 323, 329-331). Here, two or more fluids enter the 
device through separate inlets. These fluids are mixed by passage through a network of channels, further 
mixing the solutions at every level (323). Snake channels are often included to aid further mixing (323). 
These channels recombine into a central chamber, forming a gradient perpendicular to the fluid flow. 
The solution then flows out of the device via an outlet. I hypothesised that a SpyTag-decorated hSAF 
gel, formed in the chamber, could be patterned with a gradient of SpyCatcher-GFP (SC-GFP), by 
flowing protein and buffer through the two inlets (Figure 5.1.2). 
Typically, microfluidic device manufacture uses a master mould – usually made of silicon or 3D printed 
plastic – that is used to cast polydimethylsiloxane (PDMS). The moulded PDMS is then bonded to glass, 
forming the device. I designed master moulds using computer aided design (CAD) software, which 
were printed using a Form2 stereolithography (SLA) 3D printer (FormLabs, USA). These moulds were 
used to cast PDMS that was then bonded to a glass microscope slide. This method allows the rapid 
prototyping of devices at relatively low cost. 




Figure 5.1.2: Schematic of the proposed design for a microfluidic gradient-generating device for patterning 
hSAFs. Two fluids (green and white) enter the device at inlets 1 and 2. An hSAF gel is formed in the patterning 
chamber and fluid exits the device via the outlet. The dotted arrow indicates the direction of fluid flow. 
First, I chose to focus on the gradient-generating part of the device. My initial design (microfluidic 
gradient generator device 1 Figure 5.1.3) had 100 μm diameter channels, 5 serial dilutor levels and 
snake-shaped channels. Similar designs have been previously reported (197, 323) and, therefore, I 
proposed that this design would be suitable for gradient formation. To test whether this device could 
generate concentration gradients, dH2O and rhodamine dye were pumped through inlets 1 and 2 
(Figure 5.1.3B). 
The device was water-tight and produced the desired pattern of rhodamine pumped alongside water, 
with mixing at the interface. However, several issues were evident upon operation of the device. First, 
the channels were not spaced far enough, meaning that the snake-channels merged, likely hampering 
mixing. In addition, certain channels collapsed during bonding of the PDMS to the glass. To rectify 
this, a second device was designed with a longer gradient generator, thus, allowing channels to be 
spaced further apart. This device also incorporated an open chamber for a gel to be introduced 
(Figure 5.1.4). 




Figure 5.1.3: Microfluidic gradient generator device 1. A: CAD design of the device master mould, channel width 
=100 μm. B: Photograph of dH2O and rhodamine dye pumped through inlets 1 and 2, respectively, at equal rates 
(50 μl/min). 
Liquid flowed through the gradient generator and out into the chamber as desired. By altering the flow 
rate through each inlet, the dH2O:rhodamine gradient could be shifted (Figure 5.1.4B-D). However, 
merging of the snake-channels persisted and any generated gradient was lost upon liquid entering the 
patterning chamber. I reasoned that this could be prevented by keeping the liquid under laminar flow 
while travelling through the chamber. However, this would require the patterning chamber to be 
enclosed. 
      
              
 
 
        
         




Figure 5.1.4: Microfluidic gradient generator device 2. A: CAD design of the mould used for the device, channel 
width =100 μm. B-D: Photographs of the device with Rhodamine and dH2O pumped into each inlet at different 
rates as shown.  
This poses a problem for patterning hSAFs. The gel must be formed in a closed chamber with a small 
total volume such that laminar flow of liquid through the chamber and, thus, the gradient, is maintained. 
However, the gel must then be accessible for subsequent cell culture. In addition, thorough mixing of 
hSAF-p1 and -p2 (required for proper gelation) in an enclosed chamber is difficult. Ideally, the gel 
would be formed in the patterning chamber, enclosed temporarily to allow patterning under laminar 
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flow, then uncovered for downstream neuronal cell culture. Approaches analogous to this have been 
reported previously (317), but are uncommon. 
 
Figure 5.1.5: Microfluidic gradient generator device 3. A: CAD design of the mould for the device, channel width 
= 50 μm B: Photographs of the device with solutions of blue and yellow food dye pumped through either inlet at 
50 μl/min. A PDMS plug was used to maintain laminar flow through the chamber while patterning. 
To test this, another device was designed (microfluidic gradient generator device 3, Figure 5.1.5). Once 
again, this device had an open patterning chamber following the gradient generator, in which an hSAF 
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gel could be formed. However, this time, a PDMS plug was inserted into the chamber and positioned 
just above the glass slide. This was proposed to maintain laminar flow though the chamber during 
patterning. The plug could then be removed and the gel accessed following patterning. In addition, to 
prevent channel merging, narrower, further spaced channels were designed. To test this device, yellow 
and blue food dye solutions were flowed through the two inlets (Figure 5.1.5B). 
A visible gradient of blue, through green, to yellow across the patterning chamber was observed when 
the PDMS plug was in place. Channels were sufficiently spaced out that liquid flowed through in the 
desired manner. Therefore, I used this device for initial hSAF patterning studies. 
Microfluidic gradient-generating devices are unsuitable for patterning hSAFs 
 
Figure 5.1.6: Widefield images of hSAFs patterned with SC-GFP using microfluidic gradient generator device 3. 
A: SpyTag-hSAFs were formed in the chamber before SC-GFP and PBS were pumped through the left and right 
inlet of the device, respectively. B: hSAF-p2 was dispensed into the chamber and the device was incubated at 
4 oC while p1KAz and hSAF-p1 were pumped through the left and right inlet, respectively. alk-SpyTag and SC-
GFP were subsequently patterned onto the gel as previously described. Both methods used flow rates of 50 μl/min, 
for each inlet, for 10 mins. The direction of flow was from top to bottom of the image. Scale bar = 1 mm. 
Two methods of hSAF patterning were attempted. First, a p1KAz:p2 gel was formed in the chamber 
and decorated with SpyTag via CuAAC. PBS and SC-GFP were then flowed through the device to 
pattern the gel with SC-GFP. This method will be referred to as method A. In the second method, hSAF-
p2 peptide was dispensed into the chamber. hSAF-p1 and hSAF-p1KAz were then flowed through the 
two inlets. It was hypothesised that this would form a gel in the chamber with a gradient of hSAF-p1 – 
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hSAF-p1KAz. SpyTag and SC-GFP were subsequently patterned onto the gel after removal of the 
PDMS plug. This will be referred to as method B. I patterned hSAFs using both these methods and 
recorded GFP fluorescence on each gel after patterning, using widefield microscopy (Figure 5.1.6). 
Using both methods, very little gel remained in the chamber following patterning. For method B, this 
was likely due to a lack of mixing between the hSAF-p1 and hSAF-p2 peptides in the chamber. For 
method A, this may have resulted from disruption of the gel during patterning. In addition, placement 
and removal of the PDMS plug resulted in some visible damage to the gel. 
These observations made me question whether microfluidics was a suitable method for patterning 
hSAFs. Consider method B: The protocol for hSAF gel formation (i.e. the mixing of two peptides) 
requires thorough mixing of solutions for gelation to occur. Such thorough mixing is not possible when 
patterning by this method without the destruction of any formed gradient. Examples of hydrogel 
patterning using microfluidic gradient generators typically utilise systems where gelation is triggered 
by photocuring (e.g. certain synthetic polymer hydrogels) and, thus, mixing is not required (332, 333). 
Therefore, hSAFs must be pre-formed, as in method A. However, gel formation within the device, and 
manipulation once there, is difficult. Therefore, I decided to pursue other avenues for patterning hSAFs.
 
5.2: Photolithographic patterning of hSAFs using thiol -ene 
click chemistry 
Hydrogels can be patterned via photolithography 
Photolithography is a common method for patterning 2D surfaces (334). Here, a photoreactive surface 
is placed under a mask with opaque and transparent regions in the desired pattern. A visible or UV light 
source is then shone through the mask onto the surface, triggering a light-activated reaction, either 
directly resulting in pattern formation, or allowing further steps to fabricate the desired pattern (334). 
The application of these principles to hydrogels has been pioneered by Kristie Anseth and others, using 
synthetic polymer gels (195, 205, 335). Manipulation of cell behaviour on these patterned scaffolds has 
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been reported (97, 196, 204). However, to the best of my knowledge, photolithography has not been 
attempted with a self-assembling peptide scaffold. 
Given that hSAFs can be modified with chemical handles with relative ease, I reasoned that it should 
be possible to incorporate a chemical group that is sensitive to light. This should allow the photo-
induced incorporation of bioactive ligands and, thus, photolithographic patterning of hSAFs 
(Figure 5.2.1). 
 
Figure 5.2.1: Schematic diagram showing the proposed method for photolithographic patterning of hSAFs. An 
hSAF gel is covered with a photomask, through which columnated UV light is shone. This triggers a photo-
activated chemical reaction only in areas of the gel exposed to UV light.  
Selecting a photo-activated chemical reaction 
There are two primary photo-inducible reaction types applied to surface and hydrogel patterning (336). 
In the first (Figure 5.2.2i), a molecule of interest is caged with a photo-cleavable group, commonly a 
nitrobenzyl or coumarin derivative, which are UV and visible light-labile, respectively (336). Irradiation 
causes this group to be removed, revealing a reactive handle that can react with a second molecule of 
interest. Alternatively, the reaction between the two molecules may itself be photo-activated 
(Figure 5.2.2ii). These methods have both been applied to hydrogels (203, 205, 224, 337) and I initially 
chose to pursue both. 
A common photo-uncaging mechanism for peptides and proteins is the removal of a photo-labile group 
from a side-chain thiol on a Cys residue (224). This can then react with a maleimide or thiol on another 
peptide or protein (97, 338, 339). I synthesised a variant of hSAF-p1 with an N-terminal Cys (named 
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hSAF-p1Cys) and attempted to cage this peptide with a nitrobenzyl group according to (339). However, 
this was unsuccessful (data not shown) and, therefore, this method was abandoned. 
 
Figure 5.2.2: Schematic diagram of two common photochemical mechanisms. i: A photo-labile protecting group 
(black) is removed from molecule A by light irradiation. This allows subsequent reaction of A with B. ii: Molecule 
A reacts with molecule B directly via a photo-activated reaction. 
Thiol-ene click chemistry (TECC) 
 
Figure 5.2.3: The thiol-ene click reaction. 1: A thiyl radical (R1) is generated by UV or visible light exposure in 
the presence of a radical photoinitiator. 2: Propagation; thiyl radical addition to the electrophilic C of an -ene 
group (R2) results in the formation of a carbon-centred radical. 3: The carbon-centred radical species abstracts the 
H· of a sulfhydryl group of another R1 molecule, generating a further thiyl radical (4) and forming the covalently 
linked product R1:R2. Adapted from (146, 340). 
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The second method tested was the free radical-induced thiol-ene reaction (or thiol-ene click chemistry, 
TECC) (146, 341). Here, a thiol-containing molecule is reacted with an -ene group, following the two-
step mechanism outlined in Figure 5.2.3. In the presence of a photoinitiator, irradiation with UV or 
visible light causes reduction of the thiol to a thiyl radical. The radical attacks the electrophilic C of an 
-ene group, forming a carbon-centred radical (146). This is followed by a chain transfer, where a 
hydrogen radical is abstracted from another thiol by the carbon-centred radical. This forms the 
covalently linked product and regenerates the thiyl for further propagation (146). 
This reaction has been extensively utilised for patterning synthetic polymer hydrogels, often with 
peptides and proteins, using a variety of thiol and -ene functionalities (Figure 5.2.4) (161, 205, 337, 
342-345). In addition, TECC has been utilised for the formation of peptide macrocycles via the reaction 
of Cys side chain thiols with -ene containing small molecules (346). However, examples of TECC 
where both the thiol and -ene groups are contained on peptides are rare. That being said, one key 
example is the introduction of Cys-containing peptides into SAFs via an allyl-Gly residue in SAF-p1, 
though the reaction product was attained at a very low yield (347). TECC-mediated modification of a 
synthetic peptide hydrogel has, to my knowledge, not been reported. 
 
Figure 5.2.4: Common reactive -ene (A) and thiol (B) groups reported for TECC (341). 
Peptides cannot be directly incorporated into hSAFs via TECC 
As previously reported (140) and demonstrated in Chapter 3.2, the N-terminal Lys residue of hSAF-p1 
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was chosen for modification with a reactive handle for TECC. Given that this reaction is not commonly 
used to join two peptides, I decided to take two different approaches using two different reactive pairs 
of peptides, termed pair 1 and pair 2 (Figure 5.2.5). Pair 1 consisted of hSAF-p1, modified with an 
allyloxycarbonyl (Alloc)-Lys residue at the N-terminal position (hSAF-p1KAlloc) and a variant of 
RGDS with an N-terminal Cys (Cys-RGDS). I chose to use an Alloc, rather than the allyl previously 
used for modification of the SAFs (347), due to previous reports suggesting increased reactivity of allyl 
ethers compared with alkenes (348). Pair B consisted of hSAF-p1, modified with a Cys residue at the 
N-terminal position (hSAF-p1Cys), and another variant of RGDS containing an N-terminal norbornene 
group (norb-RGDS). A norbornene was chosen due to its reported increased reactivity compared to a 
linear alkene (341, 348). Inclusion of a norbornene in hSAF-p1 via modification of a Lys side chain 
was also intended, but synthesis of this peptide was unsuccessful. 
 
Figure 5.2.5: Peptide pairs 1 and 2 used for TECC. A: Sequences for each peptide. Reactive groups are 
highlighted in green: Alloc-Lys (Kal), Cys (C) and norbornene (norb). B: Structures of the thiol and -ene groups 
for each pair of peptides. Reactions contained 200 μM Cys-peptide, 100 µM ene-peptide and 0.1% (w/v) 
Irgacure 2959 in MOPS, pH 7.4. 
Irgacure 2959 is one of the most commonly reported UV photoinitiators for TECC (161, 343, 347) and 
was chosen for these reactions. To be consistent with all other hSAF studies, all reactions were 
conducted at pH 7.4 in MOPS buffer. A 9W, Philips Fluo Compact UVB lamp (280 – 315 nm), placed 
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~1 cm above the reaction solution, was used to initiate the reaction. The individual reaction components, 
prior to UVB irradiation, were analysed by HPLC (Figure 5.2.6, left panels). The reaction components 
(200 µM Cys-peptide, 100 µM ene-peptide, 0.1% (w/v) Irgacure 2959 in MOPS, pH 7.4) were then 
mixed and exposed to UVB light. Product formation was monitored by HPLC (Figure 5.2.6, right 
panels). I hypothesised that, if the pairs of peptides formed a new conjugated product, I should observe 
both the disappearance of the reactants and formation of product by HPLC. 
Prior to UVB irradiation, Irgacure 2959 eluted as a prominent peak with far greater absorbance at 
220 nm than the peptide reactants (Figure 5.2.6A and C, grey). Furthermore, this peak overlaid exactly 
with that of Cys-RGDS (Figure 5.2.6A, cyan), making any disappearance of this reactant difficult to 
follow. Upon UVB irradiation, numerous peaks were observed, making it difficult to monitor reaction 
progression in either pair 1 (Figure 5.2.6B) or 2 (Figure 5.2.6D). However, all peaks were analysed by 
MALDI-TOF-MS and no conjugated product was observed for either pair of peptides. Due to the 
intensity of these peaks relative to unreacted Irgacure 2959, I suspected that these were not peptide 
products of the reaction, but likely formed by the photoinitiator. This was confirmed by irradiating 
Irgacure 2959 alone with UVB light (Figure 5.2.6E, black). A similar number of high intensity peaks 
were observed that closely matched those in the TECC reaction mixes. These peaks likely masked any 
peptide product formation, or lack thereof. 
Owing to these difficulties in monitoring reactions containing Irgacure 2959, I briefly investigated a 
different photoinitiator, Eosin Y, which is activated by visible light (205). This did not produce any 
noticeable absorbance at 220 nm (Appendix Figure 8.4.3A) prior to irradiation, however, exposure to 
visible light resulted in the formation of multiple product peaks (Appendix Figure 8.4.3B), the masses 
of which did not match that of the formed product. Critically, exposure to visible light did not reduce 
the intensity of either reactant peak, indicating that they were not converted to product. 









                                        
Figure 5.2.6: HPLC chromatograms of solution-
phase TECC. Inset: magnified regions of interest. 
A: Irgacure 2959 (grey), hSAF-p1KAlloc (navy) 
and Cys-RGDS (cyan) prior to UVB exposure. B: 
Chromatograms of reactants from A after mixing 
and irradiating with UVB light for 0 (pink), 5 
(purple) and 30 (indigo) minutes. C: Irgacure 2959 
(grey), hSAF-p1Cys (navy) and norb-RGDS 
(cyan) prior to UVB exposure. D: Chromatograms 
of reactants from C after mixing and irradiating 
with UVB light for 0 (pink), 5 (purple) and 30 
(indigo) minutes. E: Irgacure 2959 (black) or 
MOPS buffer (grey) after UVB exposure for 30 
minutes. All gradients are 0 – 100% acetonitrile. 
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I reasoned that the reaction might be easier to follow if performed on an hSAF gel, rather than peptides 
in solution. This would allow any photoinitiator to be removed prior to analysis by HPLC and, thus, 
only peptide products of the reaction should be observed. For these studies, I returned to using 
Irgacure 2959. Cys inclusion in the hSAF scaffold is not desirable, as disulphide-bond formation 
between adjacent peptides might alter the properties of the gel (as well as render the peptides unreactive 
for TECC). Therefore, for all further studies, p1KAlloc:p2 hSAFs were used. These gels were prepared 
following the same protocol as the parent system. p1KAlloc:p2 hSAFs were incubated with 2 mM Cys-
RGDS, 0.1% (w/v) Irgacure 2959 and irradiated with UVB light (Figure 5.2.7A) for 10 minutes. 
 
Figure 5.2.7: HPLC chromatograms showing p1KAlloc:p2 gels decorated via TECC. A: Chromatogram of 
p1KAlloc:p2 hSAF reacted with Cys-RGDS after 0 (black) and 10 minutes (purple) UVB irradiation. B: 
Chromatogram of p1KAlloc:p2 hSAF reacted with L-Cys via TECC after 0 (black) and 10 minutes (purple) UVB 
irradiation. The two prominent peaks common to all chromatograms correspond to hSAF-p2 (11.75 minute 
elution) and hSAF-p1KAlloc (12.5 minute elution). Gradients were 30 – 40% acetonitrile. 
Though this new approach enabled the reaction to be followed more clearly by HPLC, no product was 
observed (Figure 5.2.7A). I was concerned that this was due to the formation of disulphides between 
adjacent Cys-RGDS peptides prior to mixing with the gel. However, addition of TCEP to the reaction 
mixture, to reduce these bonds, resulted in the formation of a product with a mass matching that of 
p1KAlloc-TCEP (Appendix Figure 8.4.4). This product was formed in a light-dependent manner, 
accompanied by a reduction in intensity of the hSAF-p1KAlloc reactant. As this conjugation was not 
desired, I did not investigate the mechanism further and omitted TCEP from all further reaction 
mixtures. 
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It is possible that, by reacting two large and sterically hindered (relative to a small-molecule or 
monomeric polymer building block) peptides, the thiol and -ene are unable to come into contact for 
long enough for the reaction to occur. Therefore, I reacted p1KAlloc:p2 hSAFs with the free amino acid 
L-Cys (Figure 5.2.7C). This reaction was also unsuccessful – neither formation of product, nor 
disappearance of reactants, was visible by HPLC. This led me to believe that either the thiol or Alloc 
group was unsuitable for the thiol-ene reaction to proceed under these conditions. 
A small molecule PEG can be incorporated into hSAFs by TECC 
TECC is not often reported between two peptides. Either the -ene or thiol is almost always contained 
on a synthetic polymer or small molecule (161, 337, 345). Therefore, I hypothesised that a short polymer 
linker, rather than a peptide, might be incorporated into p1KAlloc:p2 hSAFs by TECC. Polyethylene 
glycol (PEG) is one of the most commonly used synthetic polymers in materials science. As such, PEGs 
are commercially available with various chain lengths and terminated with a range of functional groups, 
including thiols. 
 
Figure 5.2.8: p1KAlloc:p2 hSAFs decorated with PEG2SH by TECC. A: PEG2SH. B, left panel: HPLC 
chromatograms of p1KAlloc:p2 hSAFs, incubated with PEG2SH, and irradiated with UVB light for 0 (black) or 10 
(purple) minutes. The gradient was 30 – 40% acetonitrile. B, right panel: MALDI-TOF-MS spectrum of the 
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Owing to the relative lack of secondary structure of PEG chains – compared to a peptide backbone – I 
postulated that these thiol groups would be less sterically hindered than that of a Cys side chain and, 
thus, might allow TECC to proceed. Therefore, I chose to react p1KAlloc:p2 hSAFs with 2,2’-
(ethylenedioxy)diethanethiol (PEG2SH, Figure 5.2.8A). I reasoned that, after attachment to hSAF-
p1KAlloc by TECC, the second thiol might allow conjugation with a peptide. I accepted here that, as a 
thiol was available at either end of PEG2SH, it would be possible for both to react with two different 
hSAF-p1KAlloc peptides, which was not desired. To prevent this, PEG2SH was provided in a 5-fold 
excess (5 mM). p1KAlloc:p2 hSAFs were reacted with PEG2SH in the same way as for all previous 
studies (Figure 5.2.8B). 
Upon UVB irradiation, a clear product peak was formed (Figure 5.2.8B, *) accompanied by a reduction 
in the intensity of the hSAF-p1KAlloc peak. MALDI-TOF-MS analysis confirmed the mass of the 
product to be that of the desired hSAF-p1KAlloc-PEGSH complex. The approximate percentage of 
hSAF-p1KAlloc converted to p1KAlloc-PEG was 34%, a slightly lower yield than that achieved with 
CuAAC (Figure 3.2.1). No product peak corresponding to the mass of a trimeric p1KAlloc-PEG-
p1KAlloc conjugate was observed. It is possible that this larger complex was undetectable by MALDI-
TOF-MS, however, I was satisfied that an appreciable amount of the desired p1KAlloc-PEGSH product 
was produced and did not probe this further. 
PEG2SH can act as a linker between hSAFs and RGDS via maleimide-thiol 
reaction 
Given the success of TECC using p1KAlloc:p2 hSAFs and PEG2SH, and the apparent lack of the 
p1KAlloc-PEG-p1KAlloc product, I concluded that PEG2SH might act as a linker between the gel and a 
desired peptide. Once bound to hSAF-p1KAlloc, PEG2SH would still have one thiol available for 
subsequent modification. I chose to target this via the well-characterised and commonly used 
maleimide-thiol reaction, which proceeds under ambient conditions without addition of catalyst (224, 
349, 350). A variant of RGDS with an N-terminal maleimide was synthesised (mal-RGDS) and 
p1KAlloc:p2 hSAFs were decorated following the method outlined in Figure 5.2.9. First, PEG2SH was 
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appended to p1KAlloc:p2 hSAFs by TECC via UVB light exposure. The gel was then incubated with 
mal-RGDS. Once again, the reaction was monitored by HPLC and MALDI-TOF-MS (Figure 5.2.10). 
 
Figure 5.2.9: Schematic diagram showing photo-activated incorporation of RGDS peptide via TECC and thiol-
maleimide chemistries. hSAF-p1KAlloc:p2 gels are formed and PEG2SH incorporated via TECC, triggered by 
UVB light (1). mal-RGDS can then be reacted with the second thiol of PEG2SH to form the final product (2), 
covalently modifying the gel with RGDS. The sequence of mal-RGDS is shown inset with the maleimide group 
highlighted in green. 
Upon addition of mal-RGDS to undecorated p1KAlloc:p2 gels, no product was formed (Figure 5.2.10A, 
grey). However, addition of mal-RGDS to PEG2SH-decorated gels (Figure 5.2.10A, navy) resulted in 
the formation of a product (*), which had a mass equal to the expected p1KAlloc-PEG-RGDS conjugate 
(Figure 5.2.10A, right panel). This led me to believe that the method outlined in Figure 5.2.9 was 
suitable for photo-activated attachment of peptides to hSAFs. I refer to this thiol-ene and subsequent 





    
    
   




        










Figure 5.2.10: p1KAlloc:p2 gels reacted with PEG2SH and mal-RGDS. A, left panel: HPLC chromatograms of 
p1KAlloc:p2 hSAFs: incubated with PEG2SH and then mal-RGDS, but without UVB irradiation (grey); incubated 
with PEG2SH and irradiated with UVB light for 3 minutes (pink); or incubated with PEG2SH, irradiated with UVB 
light for 3 minutes and incubated with mal-RGDS (navy). The gradient was 30 – 40% acetonitrile. A, right panel: 
MALDI-TOF-MS spectra of the product peak labelled * in A (expected mass = 4193.8 Da, recorded mass = 
4195.0 Da) that corresponds to p1KAlloc-PEG-RGDS. B: Expanded view of the key reactant and product peaks 
from A, with labels indicating each species identified by MALDI-TOF-MS. 
TECC does not impact fibre stability or scaffold properties  
Before proceeding further, I wanted to test if the TE-MTCC method of peptide attachment impacted 
the biophysical properties of hSAFs. UVB irradiation is potentially damaging to peptides (351) and 
might affect scaffold stability. Therefore, CD spectroscopy and TEM were performed to assess fibre 
stability after TE-MTCC (Figure 5.2.11A-F). 
                   
                








Figure 5.2.11: Biophysical characterisation of TE-MTCC-decorated hSAFs. A: CD spectra of hSAF-p1KAlloc 
(red), hSAF-p2 (blue), the theoretical average of mixing the two (grey, dotted), and the recorded spectra when the 
two are mixed (black). Recordings were taken at 20 (left panel) and 37 oC (right panel). B-E: TEM images of: 
p1KAlloc:p2 fibres (B); fibres after 3 minutes UVB irradiation (C); after incorporation of PEG2SH by UVB 
exposure (D); and after incorporation of mal-RGDS following PEG2SH attachment (E). F: CD spectra of 
p1KAlloc:p2 fibres after 0 (cyan) and 3 (blue) minutes UVB exposure, as well as PEG2SH-decorated fibres after 3 
minutes UVB exposure (navy). G: Frequency sweep rheological analysis of p1KAlloc:p2 hSAFs (cyan), PEG2SH-
decorated (blue) and mal-RGDS-decorated hSAFs (navy). G’ (dots) and G’’ (crosses) values are shown. Data in 
F and G were collected at 37 oC. 
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CD indicated that hSAF-p1KAlloc and hSAF-p2 interacted and spectral red-shifting suggested they 
formed higher-order assemblies, with α-helical character (Figure 5.2.11A). This behaviour was similar 
at 20 and 37 oC and comparable to the parent hSAFs (Figure 3.1.1). TEM revealed that the peptides 
formed fibres analogous to those observed for the parent and p1KAz:p2 hSAFs (Figure 5.2.11B). 
Similar structures were observed after 3 minutes UVB exposure (Figure 5.2.11C) and after 
incorporation of PEG2SH (Figure 5.2.11D) and mal-RGDS (Figure 5.2.11E). In addition, CD 
spectroscopy of UVB-irradiated p1KAlloc:p2 hSAFs indicated that neither UVB exposure or addition 
of PEG2SH, impacted fibre stability (Figure 5.2.11F). Taken together, these data indicate that hSAF-
p1KAlloc and hSAF-p2 interact to form α-helical fibres that are stable to UVB exposure at the 
timescales relevant for TECC. 
It is reasonable to contend that, if p1KAlloc-PEG-p1KAlloc assemblies did occur, the PEG might act 
as a crosslinker between fibres. This might promote fibre-fibre interactions and, therefore, increase the 
elastic modulus of the scaffold upon UVB irradiation. Therefore, I performed bulk rheological analysis 
to investigate whether TECC-mediated PEG2SH introduction resulted in a change in hSAF elastic 
modulus (Figure 5.2.11G).  
p1KAlloc:p2 hSAFs formed a gel with an elastic modulus of 2.6 kPa at 37 oC (Figure 5.2.11G, cyan) – 
on the same order of magnitude as the parent system, which stiffened to 2 kPa upon heating to 37 oC 
(Figure 1.1.2). Upon irradiation with UVB light, either in the absence (Figure 5.2.11G, blue) or 
presence (Figure 5.2.11G, navy) of PEG2SH, the recorded G’ fell to 1.7 kPa. This confirmed that the gel 
did not stiffen following TECC. The reduction in elastic modulus in response to UVB irradiation was 
relatively minimal and remained within the range of hSAF gels described in this thesis. I was satisfied 
from these observations that TE-MTCC did not markedly impact fibre stability or viscoelastic 
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5.3: Patterning hSAFs with GFP via photolithography 
GFP can be introduced into hSAFs in a light-dependent manner 
By combining TE-MTCC with SpyTag-SpyCatcher, I posited that fluorescent proteins could be 
patterned into hSAFs. The proposed method by which this would proceed is outlined in Figure 5.3.1. 
 
Figure 5.3.1: Schematic diagram showing TE-MTCC- and SpyTag-SpyCatcher-mediated patterning of GFP on 
hSAFs by photolithography. 1: p1KAlloc:p2 hSAFs are formed on a glass slide. 2: PEG2SH and Irgacure 2959 are 
then added and a photomask placed over the gel. UVB light is shone through the mask onto hSAFs, creating 
patterns of immobilised PEG2SH. 3: mal-SpyTag is then incorporated via maleimide-thiol reaction. 4: Finally, gels 
are incubated with SC-GFP, creating patterns of GFP immobilised on hSAFs. 
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First, I wanted to confirm that our method of photo-induced peptide incorporation also worked for 
SpyTag-SpyCatcher-mediated protein incorporation. A maleimide-modified SpyTag peptide (mal-
SpyTag) was synthesised (Figure 5.3.2A). p1KAlloc:p2 hSAF gels were incubated with PEG2SH and 
irradiated with UVB light for 0 – 5 minutes. The gels were then incubated with mal-SpyTag, and 
subsequently SC-GFP. GFP fluorescence on each gel was quantified using a ClarioStar plate reader 
(BMG LabTech, Germany) (Figure 5.3.2B). 
 
Figure 5.3.2: Photo-inducible SC-GFP incorporation. GFP fluorescence on p1KAlloc:p2 hSAFs, decorated with 
PEG2SH via TECC, and subsequently mal-SpyTag and SC-GFP. Gels were irradiated with UVB light for varying 
lengths of time. Fluorescence values are normalised to 0 minutes UVB exposure. n=3 different gels for each 
condition. Error bars show one standard deviation from the mean. 
GFP attachment to the scaffold increased with UVB irradiation time up to 2 minutes. This suggested 
that TE-MTCC and subsequent incorporation of SC-GFP proceeded as depicted in Figure 5.3.1. In 
addition, this suggested that 2 minutes UVB exposure was adequate for protein attachment via this 
method and, therefore, I used this time for all further photolithographic studies. 
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Unfortunately, attempts to monitor mal-SpyTag conjugation to p1KAlloc-PEG2SH by HPLC and 
MALDI-TOF-MS were unsuccessful. No obvious product was observed by HPLC, though a small peak 
very close to that of hSAF-p1KAlloc suggested that the p1KAlloc-PEG-SpyTag product coeluted with 
hSAF-p1KAlloc (Appendix Figure 8.4.5). However, I was unable to separate this from the higher 
intensity hSAF-p1KAlloc to obtain a mass. I was satisfied that, given SC-GFP attachment was promoted 
by UVB light exposure (Figure 5.3.2), the reaction proceeded as intended. 
hSAFs can be patterned with GFP by photolithography  
 
Figure 5.3.3: Design of masks and moulds for photolithography. A: Examples of photomask designs printed on 
transparent film by JD Photodata (UK) for photolithographic patterning of hSAFs. Scale bar = 200 μm. B: 
Schematic diagrams of 1 (left) and 2 mm (right) deep hSAF moulds for photolithography. These designs should 
result in <0.1 mm and 1 mm, respectively, between the top of the gel (blue) and the photomask, assuming the 
depth of a 30 μl volume gel is ~1 mm. 
After determining the light exposure time required to incorporate SC-GFP, the method outlined in 
Figure 5.3.1 was followed to spatially pattern hSAFs with GFP. Several photomasks were printed onto 
transparent film (JD Photodata, UK) with feature sizes ranging from <50 – 500 μm (Figure 5.3.3A). 
This allowed the feature resolution achievable with this technique to be tested. The success of 
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photolithography depends on placing the photomask as close to the top of the hydrogel as possible, thus, 
minimising spreading of the light beam before it contacts the gel (352, 353). Therefore, 1 and 2 mm 
deep moulds were 3D printed and glued to coverslips, in which to form hSAFs (Figure 5.3.3B). These 
allowed the mask to be placed close to the gel surface. 
Initially, a photomask with 400 μm diameter transparent spots (among the largest features designed) 
was used to pattern p1KAlloc:p2 hSAFs with PEG2SH. Gels were subsequently incubated with mal-
SpyTag, then SC-GFP, and washed copiously with PBS to remove any non-specifically associated 
protein. Images were collected by widefield microscopy (Figure 5.3.4). 
 
Figure 5.3.4: Photopatterning hSAFs with GFP. A-B: Widefield images showing spot patterns across a whole 
hSAF gel (A) and a subsection of the same gel (B). Scale bars = 1000 (A) and 400 (B) μm. C: Fluorescence 
intensity plot through the dotted line in B, values are normalised to the minimum intensity recorded. D: Widefield 
image of patterned hSAFs in a 2 mm deep mould. Scale bar = 400 μm. 
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Spots of GFP fluorescence were clearly visible across hSAFs contained in 1 mm deep moulds 
(Figure 5.3.4A-B). These had an average diameter of 460 μm, despite the photomask containing 400 μm 
diameter spots. This indicated that some light dissipated either before contacting the gel or while 
travelling through it, causing some blurring at the pattern edges. Fluorescence intensity was plotted 
across one of these spots (Figure 5.3.4C), demonstrating that fluorescence at the spot edge increased 
over a length of ~100 μm. Therefore, these patterns are less sharply defined than some previously 
reported in other gel systems. (196, 204). This indicated that patterning hSAFs with smaller features 
might be challenging. 
 
Figure 5.3.5: Patterning hSAFs with smaller features. A-B: Widefield image (A) and fluorescence intensity plot 
(B) of spiral-patterned hSAFs. Fluorescence intensity is plotted across the dotted line in A. C-D: Widefield image 
(C) and fluorescence intensity plot (D) of straight line-patterned hSAFs. Fluorescence intensity is plotted across 
the dotted line in C. Scale bars = 200 μm. Fluorescence values in B and C are normalised to the minimum recorded 
intensity 
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No patterns were observed when using the 2 mm moulds. As suspected, the photomask must be in very 
close contact with the top of the gel for patterning to be successful. Presumably, the columnated light 
passing through the spots dissipated before contacting the gel in the 2 mm deep moulds. This meant 
that the patterns of light exposure were lost and, thus, no spot patterns were visible (Figure 5.3.4D). 
Therefore, 1 mm deep moulds were used for all other experiments. 
To understand the limitations of this photolithographic patterning method, hSAFs were patterned using 
two photomasks – straight lines and a spiral – both with 100 μm diameter features. Images were 
collected by widefield microscopy after mal-SpyTag and SC-GFP incubation (Figure 5.3.5). While both 
patterns were distinguishable, they were not as well defined as the 400 μm spot in Figure 5.3.4. This 
was demonstrated by the fluorescence intensity profiles across each pattern (Figure 5.3.5B and C). The 
desired pattern of alternating 100 μm-wide fluorescent and non-fluorescent regions was difficult to 
make out in either case, particularly for the 100 μm diameter line pattern (Figure 5.3.5C-D). Lines had 
an average diameter of 160 μm, meaning that the space between them was barely discernible in the 
fluorescence profile. I concluded from these experiments that, using the current method, feature sizes 
on the order of hundreds of microns are possible. However, further development would be required to 
achieve feature sizes of <100 μm. 
 
5.4 Conclusions 
Hydrogel micropatterning through various approaches is an established practice for synthetic and 
natural polymer hydrogels (97, 195, 199, 201, 202, 205, 332, 342, 354). However, while there are now 
many examples of synthetic peptide gels (44, 48, 54, 126, 158, 229), to the best of my knowledge, no 
attempts have been made to micropattern these materials. Here, through the novel application of 
photolithography to a designed peptide gel, I have demonstrated that hSAFs can be micropatterned with 
GFP. Therefore, this work demonstrates a significant step-forward for the field of synthetic peptide 
biomaterials – the approach taken here could be applied to other self-assembling peptide hydrogel 




less reproducible than some previously reported on synthetic polymer gels (196, 205). Further 
development of the patterning method would be required to achieve higher-resolution patterns. 
A logical next step would be to pattern IGF1 into the gel and observe effects on neuronal growth. IGF1 
is a reported axonal guidance factor (178, 179) and, therefore, one might expect to see patterns of 
neuronal growth towards regions of IGF1. However, the ephrin (166, 355), sonic hedgehog (170, 356) 
and semaphorin (313, 357) protein families are archetypal axonal guidance factors. The modular nature 
of our system, means that introduction of these proteins into hSAFs through SpyTag-SpyCatcher, 
should be possible. 
Following the development of TE-MTCC, there are now two different methods for patterning hSAFs 
with peptides and proteins – CuAAC and TE-MTCC. These two reactions should be orthogonal, 
allowing two different peptides (or proteins) to be patterned into the gel and manipulated independently. 
This would allow neuronal cells to be exposed to carefully tailored cocktails of growth factors, or 
mixtures of adhesive ligands. I would have liked to demonstrate that CuAAC and TE-MTCC are 
orthogonal. For this, a second method of fluorescent protein introduction (in addition to SpyTag-
SpyCatcher) would be required. The binding of biotin to streptavidin is commonly used in 
biotechnology (185, 270) and would likely be a suitable method to demonstrate orthogonality of these 
two types of click chemistry. 
Though the microfluidic devices developed in this work proved unsuitable for patterning hSAFs, they 
might be suited to patterning neuronal growth on 2D surfaces. Microfluidic gradient generator device 3 
appeared suitable for the generation of solution-phase gradients. By introducing a neurotrophic factor 
into one of the inlets, and maintaining flow through the device during culture, the effect of these factors 
on neuronal growth could be analysed in high throughput. Similar devices have been reported for such 






α-helical peptides as sensors for 
small molecule detection 
This work is distinct from the preceding results chapters and, therefore, I have chosen to present it as a 
stand-alone chapter with its own introduction (Chapter 6.1) and materials and methods (Chapter 6.2). 
However, certain methods outlined in Chapter 2 are relevant to experiments detailed in this chapter. 
6.1: Introduction 
Olfaction 
Most biological sensing systems function in a specific manner. One ligand molecule binds to a single 
receptor, which triggers a downstream signalling cascade and leads to a specific response to that 
particular ligand (359). For example, when insulin-like growth factor 1 (IGF1) binds to the IGF1 
receptor, subsequent phosphorylation of the receptor leads to a specific intracellular signalling response 
by the cell (168). In contrast, the sense of smell relies on the simultaneous binding of odorant molecules 
to many promiscuous G-protein coupled receptors (GPCRs) (360, 361). These receptors bind a 
multitude of volatile molecules with relatively low affinity and to different extents (359). This creates 
a pattern of receptor binding and stimulation. A specific odorant molecule – or mixture of molecules – 




Sensing in this way means the number of molecules (or sets of molecules) and, thus, scents, that can be 
detected is dramatically increased (359). The human olfactory system contains ~400 olfactory receptor 
genes, and different reports estimate we can differentiate between 10,000 – 1 trillion different odorant 
stimuli (362, 363). Other mammals possess an even greater diversity of receptors: ~800, ~1200 and 
~2000 for dogs, rats and elephants, respectively (364, 365). 
 
Figure 6.1.1: Schematic diagram showing sensing in the olfactory system (B) compared to a typical sensing 
mechanism (A). A: A specific substrate molecule (navy) binds to a single specific receptor and triggers a cellular 
response that is specific to that substrate. B: A mixture of substrate molecules bind to several promiscuous 
receptors. The differential binding of these receptors is interpreted as a pattern of receptor activation. In this case, 
the two left hand receptors are activated while the right hand one is not. Adapted from (359). 
Differential sensing arrays 
Given the benefits of sensing in this fashion, it is unsurprising that fingerprint-based diagnostics – or 
differential sensing – has been widely utilised for the detection of small molecules and complex 
mixtures (e.g. bodily fluids, sewage, beverages and foodstuffs) (366, 367). These sensors generally 
consist of immobilised arrays of synthetic receptor molecules with subtly different properties. These 
are selected to associate rather weakly (with binding constants in the μM – mM range) with a chosen 
analyte or analytes, i.e., the molecule, or mixture of molecules, to be detected (359). Thus, each 
component of the array is expected to bind the analyte to a different extent. Analyte association with 
this array of receptors generates a unique fingerprint for a particular analyte or mixture (Figure 6.1.2). 
Analyte binding is detected via an electrochemical or, more typically, optical output (367). Here, analyte 
  




binding alters the state of a dye molecule – normally either part of the receptor itself or bound to the 
receptor – in a detectable manner. Patterns of receptor binding are interpreted by various computational 
statistical analysis methods, including principle component analysis (PCA), linear discriminant 
analysis, support vector machines (SVMs), and artificial neural networks (367). The analysis method 
chosen depends largely on the type of data and ease with which individual fingerprints can be 
recognised. 
 
Figure 6.1.2: Differential sensor arrays. An array of receptor molecules each contain a colorimetric or fluorescent 
dye. Upon exposure of this array to three different analytes, the dye is either displaced from, or changes 
conformation in, the different receptors. The analytes produce different patterns of association with the array, 
which are interpreted as distinguishable fingerprints for a specific analyte. Adapted from (367). 
The number of reported differential sensing approaches is vast. Receptor molecules include small 
molecule dyes (368-370), metals (371), metalloporphyrins (372), peptides (373) and proteins (374). 
Arrays of these receptors have been applied to the detection of explosives, biomarkers for disease and 
volatiles contained in perfume, wines, whiskeys and oils (370, 371, 373-376). 
There are good reasons for using peptides and proteins for differential sensing applications. Proteins 
are the primary molecules nature uses for substrate binding, owing to their extraordinary range of 
sequence and structural diversity (377). Enzymes, membrane-bound receptors, chaperones, 
transcription factors and cytoskeletal proteins all bind either small molecules, other proteins or larger 
                           




biomolecules with varying degrees of specificity (377). And, of course, olfactory receptors are proteins 
(360, 361). Therefore, proteins and peptides are ideally suited as sensing components for differential 
sensing and have been exploited as such (373-375, 378). 
Anslyn and colleagues have used a 3x3 array of short peptides bound to metal-coordinated dyes to 
detect molecular differences in red wine blends. Binding of red wine tannin molecules to the peptides 
displaces the dyes to different extents, thus, yielding fingerprints for each wine type (373). In addition, 
the same group have used serum albumins to detect volatiles in perfume. Five terpenes are discriminated 
by their relative displacement of the lipophilic dye prodan from three different serum albumins (374). 
The group of Rotello use fluorescent proteins, non-covalently associated with gold nanoparticles or 
polymers, to differentiate between cancerous and healthy cell types, and to identify the mechanisms of 
therapeutic agents on cells (379, 380). Here, dissociation of the fluorescent proteins – resulting from 
interactions with media components or the cells – alters fluorescence energy transfer (FRET) between 
the proteins, creating specific fluorescence fingerprints (379, 380). Olfactory receptors have also been 
expressed in vitro for the detection of volatile compounds by the group of Matsunami (381). 31 mouse 
olfactory receptors are selected based on their activation by common odorant molecules. These 
receptors are then used to differentiate acetophenone analogues (378). In summary, there is a precedent 
for the use of peptides and proteins as differential sensors. 
De novo-designed α-helical peptide barrels 
The aforementioned examples of protein- and peptide-based differential sensors utilise sequences that 
exist in nature (374, 375, 378) or random peptide libraries (373). However, as outlined in Chapter 1.1 
of this thesis, our ability to design non-natural proteins and peptides has improved immensely over 
recent years. These designed peptides might have significant benefits over natural sequences for 
differential sensing. First, they are often relatively easy to synthesise compared to naturally occurring 
alternatives – the GPCRs of the olfactory system, for instance, are extremely challenging to produce in 
the laboratory (382, 383). Second, the properties of the peptides might be tuned to promote, or weaken, 
binding of a particular analyte. Third, many de novo designed proteins are hyperstable (5, 25), allowing 




sequences might also be designed to tailor the array towards detection of analytes with specific 
properties. Of course, for one to exploit these advantages, a substantial understanding of the peptide 
sequence-to-structure relationships in question is required. 
Coiled-coil dimers, trimers and tetramers exist widely in nature and are utilised by many natural proteins 
for myriad purposes (384, 385). Consequently, there are now many examples of de novo designed 
coiled-coil dimers, trimers and tetramers that have been developed for basic and applied research (3, 4, 
386-388). In contrast, higher-order coiled-coil structures, namely pentamers, hexamers and heptamers, 
exist sparingly in nature (384, 389, 390). However, increased understanding of coiled-coil sequence-to-
structure relationships and the development of computational methods, have allowed the design of α-
helical peptides that form these higher order structures, not seen in nature (5). There are now many 
examples of de novo designed pentameric, hexameric and heptameric coiled coils, as well as octameric 
assemblies (5, 6, 10, 11). In 2014, the Woolfson group reported a computationally designed homomeric 
pentamer (CC-Pent), two hexamers (CC-Hex2 and CC-Hex3) and a heptamer (CC-Hept) (Figure 6.1.3) 
(5). 
 
Figure 6.1.3: Crystal structures of CC-Pent (left), CC-Hex2 (middle) and CC-Hept (right). PDB codes = 4PND, 
4PN9 4PNA (5). Bottom images show these barrels viewed down the helical axis, demonstrating the presence of 




These assemblies differ from their lower oligomeric state counterparts in that they have central solvent-
accessible pores (5). Thus, they are named α-helical barrels (αHBs). Molecules can diffuse into and out 
of these pores to a certain extent (391), and such assemblies have been utilised for catalysis and small-
molecule binding (13, 14). In exploring these applications, the Woolfson group have designed a range 
of pentameric, hexameric, heptameric and octameric assemblies with subtly different pore properties, 
such as size, charge and hydrophobicity (5, 10, 11, 13, 14). Some of these variants form drastically 
different assemblies, where the central pore is partially or completely occluded (11). 
Small-molecule binding by αHBs 
The αHBs developed by the Woolfson group bind the small-molecule fluorescent dye 
difluorohexatriene (DPH, Figure 6.1.4) within their hydrophobic pore (14). This dye is environmentally 
sensitive and fluoresces only in hydrophobic environments, i.e., when bound within the barrel pores. 
As such, this dye can be used to probe the presence of these pores in coiled-coil assemblies (14).  
 
Figure 6.1.4: Diphenylhexatriene (DPH). 
Thomas et al. have shown that the dissociation constant (KD) of DPH to pentameric, hexameric and 
heptameric αHBs decreases across the range of accessible oligomeric states (4.5, 1.6 and 1.3 μM, 
respectively), indicating a higher affinity of the dye for assemblies with larger diameter pores (14). In 
addition, upon incubating these DPH-loaded αHBs with increasing concentrations of various lipophilic 
small molecules, DPH fluorescence decreases. The crystal structure of one of these molecules, farnesol, 
bound in the pore of CC-Hex2, confirms this is due to the displacement of DPH from the barrel pore by 
the small molecule (14). Finally, small-molecule binding can be tuned by introducing charged residues 
into the pore of CC-Hept (14). 
To summarise, the Woolfson group has designed a range of αHBs, each with subtly different pore 




can in turn be displaced by various hydrophobic small molecules, each with its own unique binding 
specificity. The affinity of both DPH and lipophilic compounds for the αHBs is on the μM scale. This 
led the group to hypothesise that this array of αHBs might be used as a fingerprint-based sensor for 
small-molecule detection, and the following chapter outlines our efforts to do so. The developed sensor 
is tested for its ability to distinguish between 13 fatty acid molecules. Secondly, in an effort to move 
towards a sensing device, I outline attempts to immobilise αHBs on solid supports, in a way that retains 
the ability of the barrel to bind DPH.
 
6.2 Materials and methods 
Unless otherwise stated, all materials were purchased from Sigma-Aldrich (UK). Peptides synthesis and 
purification were performed as described in Chapter 2, by Drs William Dawson and Jordan Fletcher, 
from the Woolfson group. 
DPH displacement assay with fatty acids 
Component Final concentration 
Peptide 10 μM 
DPH 1 μM 
HBS (pH 7) - 
DMSO 5% (v/v) 
Fatty acid 10 μM 
Table 6.2.1: Final concentrations of reaction components contained in each well of the 384-well assay plate. 
Blank wells marked ‘-’ in Figure 6.2.1 contained dH2O in place of peptide. All reaction components, except for 
the fatty acids, were added prior to storing the plates at -80 oC. Plates were thawed and the fatty acids added 
immediately before quantifying DPH fluorescence. 
After synthesis and purification, each αHB peptide in the array was aliquoted into eppendorf tubes, 
freeze-dried and stored at -20 oC until required. All fatty acid stocks (Sigma, UK) were prepared at 
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2 mM in DMSO and stored at -80 oC until required. 8 separate 2 mM stocks were prepared, 
corresponding to each independent assay repeat. 
All reaction components (Table 6.2.1), apart from the analytes, were dispensed into wells of a black 
384-well plate using a TECAN Freedom EVO 150 liquid handling robot (TECAN Group Ltd, 
Switzerland). Each well contained the components outlined in Table 6.2.1. αHB peptides, labelled a – 
o according to Figure 6.3.1, were dispensed in the layout described in Figure 6.2.1. ‘–’ indicates a well 
where no peptide was added. Plates, without analyte, were covered with an air-tight foil film and stored 
at -80 oC until required. 
 
Figure 6.2.1: 384-well plate layout used for fatty acid displacement experiments. Peptides are labelled a – o 
according to Figure 6.3.1. ‘–’ indicates that no peptide was added. Green, blue, yellow, red and purple colours 
indicate the location of 5 different analytes. Grey wells are those where dH2O, rather than analyte, was added. 
Analytes and 384-well plates containing the reaction components were thawed at room temperature. 
2 mM analyte stocks were diluted to 20 μM in 5% (v/v) DMSO. Analytes were dispensed into wells of 
the 384-well plate containing the other reaction components, according to the layout in Figure 6.2.1, 
using the TECAN Freedom EVO 150 liquid handling robot (TECAN Group Ltd, Switzerland). Five 
analytes were dispensed per 384-well plate, with four arrays per analyte to account for any pipetting 
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errors across the plate. Four blanks, containing dH2O rather than analyte, were included (Figure 6.2.1, 
grey). For repeated experiments, the position of each analyte was varied to prevent any pipetting 
artefacts. After all analytes were dispensed, the plates were briefly centrifuged and DPH fluorescence 
quantified using a ClarioStar plate reader (BMG LabTech, Ortenberg, Germany). 
Fatty acid fingerprint data analysis  
The code and pipeline used for all these analyses was developed by Christopher Wood and Kathryn 
Shelley. 
The displacement assay was repeated across 7 different plates for each analyte, using a separately 
prepared analyte stock each time. As each plate contained 4 arrays for a given fatty acid, a total of 
28 arrays were probed with each analyte. Therefore, the data set consists of 7 independent replicates. 
However, given the small data set, and to better represent the variance in the data, each of the 28 arrays 
was plotted as a single data point in Figures 6.3.4, 6.3.5 and 6.3.6. Therefore, points on these plots are 
not independent replicates. The 7 independent replicates were then used to train the SVM model. A 
separate replicate (4 arrays) was used to test the model. Again, predictions were made on all four of the 
individual arrays within this replicate to show the variance in the data. The predictions presented in 
Figure 6.3.7 do not represent independent replicates. 
DPH fluorescence readings were normalised by minimum-maximum scaling. Minimum (DPH without 
peptide (‘-’ in Figure 6.2.1)) and maximum (DPH with peptide, but in the absence of analyte) 
fluorescence values were calculated for each αHB in the blank array. Data in the analyte-treated arrays 
was then normalised according to these minimum and maximum values. Thus, a value of 1 for a given 
analyte-αHB mixture, indicated no displacement. A value of 0 indicated that the analyte had completely 
displaced DPH from the αHB. Coloured fingerprints were generated based on these normalised raw 
data, where each αHB-analyte combination was given a colour (0 = white, maximum fluorescence 
across all analytes = dark blue). Principal component analysis (PCA) was used to discriminate between 
different fatty acids across the normalised dataset. 
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An SVM model was trained with the minimum-maximum normalised data from the 7 independent assay 
replicates, using K-folds cross validation. Here, the data was partitioned into equal segments and 90% 
of the data used to train the model, while the remaining 10% was used to validate it. This was repeated 
multiple times using different segments of the data as training and testing data each time. This ensures 
that all data in the data set is used for training and testing the model. This is an established method for 
training SVM models. These analyses used standard algorithms within scikit-learn, a machine learning 
package in Python. The model was then used to predict the category of a final, previously unseen, 
analyte preparation. Given the limited size of the dataset, predictions were made on each of the 4 arrays 
within this single replicate. 
Peptide immobilisation on epoxysilane-coated glass 
CC-Hept was synthesised and N-terminally modified with 5(6)-Carboxytetramethylrhodamine 
(TAMRA) as outlined in Chapter 2.1. 1 μl 1, 10 and 100 μM TAMRA-CC-Hept in PBS pH 7 were 
dispensed in triplicate onto Nexterion E Epoxysilane-coated glass slides (Schott, Stafford, UK). The 
slides were incubated for 15 hours, at room temperature, in a hybridisation chamber containing a 
saturated NaCl solution. Slides were washed twice with PBS with Tween 20 pH 7 (PBST), twice with 
methanol, twice with acetone and once with dH2O, each for 10 minutes at room temperature. Slides 
were then imaged by widefield microscopy (see Materials and Methods 2.4). 
For experiments with DPH binding, 10 and 100 μM CC-Tri and CC-Hex2 solutions were prepared in 
dH2O and mixed with 0.1 equivalents DPH. 1 and 10 μM DPH solutions, without peptide, were also 
prepared. Reactions were mixed for 1 hour at room temperature. 1 μl of these reaction mixtures were 
dispensed in triplicate onto Nexterion E Epoxysilane-coated glass slides (Schott, UK) and incubated in 
a hybridisation chamber for 15 hours at room temperature. Slides were imaged using a UV 
transilluminator and widefield microscopy before and after washing with PBS. 
Peptide immobilisation on paper 
0, 10, 100 and 1000 μM CC-Hex2 were prepared in dH2O and mixed with 0.1 equivalents DPH for 
1 hour at room temperature. 30 μl each CC-Hex2-DPH mix was pipetted onto ~5 mm diameter circles 
of either: Whattman qualitative filter paper, grade 1 (Sigma, UK); 80 gsm white inkjet printing paper 
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(Euroffice, UK); nitrocellulose membrane, pore size 0.22 μm (Sigma, UK); or Immobilion PVDF 
chromatography grade blotting paper (Sigma, UK). These circles were placed at the bottom of a black 
96-well plate. CC-Hex2-DPH was incubated with the paper substrates for 1 hour at room temperature. 
Any excess reaction mix was removed and DPH fluorescence quantified using a ClarioStar plate reader 
(BMG LabTech, Ortenberg, Germany). The assay was repeated on filter paper with CC-Tri and a no-
peptide control, using 100 μM each peptide and 0.1 equivalents DPH. 
Peptide immobilisation in hydrogels 
CC-Tri and CC-Hex2 were prepared at 100 μM in dH2O and mixed with 10 μM DPH for 1 hour at room 
temperature. An additional reaction, containing only 10 μM DPH, was also prepared and similarly 
mixed. These three reaction mixtures were dispensed into wells of a 96-well plate and diluted 10-fold 
with either 0.1% agarose, 10% polyacrylamide or 1% Puramatrix before gelation. Therefore, the final 
concentration of DPH and peptide in each gel was 1 and 10 μM, respectively. These mixtures were left 
to gel at room temperature for 1 hour before DPH fluorescence was quantified using a ClarioStar plate 
reader (BMG LabTech, Ortenberg, Germany). 
Studies were also performed where the peptides were first encased within each gel (with a final 
concentration of 10 μM), and 1 μM DPH dispensed after the gel-peptide mixtures had been incubated 
for 1 hour to solidify. Gels were incubated with DPH for 1 hour before quantifying fluorescence.
 
6.3 Sensing lipophilic small-molecules using an array of 
αHBs 
The results described in the following section were collected as part of a highly collaborative project. I 
would like to thank several past and present members of the Woolfson group for their substantial 
contribution to this work. All peptides were previously designed and characterised by several past and 
present members of the Woolfson research group. The αHBs used in the array were selected by Drs 
William Dawson and Guto Rhys. Peptides were synthesised and purified by Drs William Dawson and 
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Jordan Fletcher. Data analysis and machine learning code and protocols were developed by Dr 
Christopher Wood and Kathryn Shelley. I designed and carried out the fatty-acid binding experiments. 
Array design 
 
Figure 6.3.1: The array of αHBs. The top-left position of the array is a peptide-free control. All structures marked 
* are models created in CC Builder2.0 (251). All others are crystal structures experimentally determined by 
various members of the Woolfson group (PDB codes: b = 6G6F, c = 6G67, d = 6G66, e = 6G65, g = unpublished, 
h = 4PN8, i = 3R46, j = 4PN9, k = 4PNA, m = 6EIK, o = unpublished) (5, 10, 11, 14). αHBs are coloured according 
to their oligomeric state: pentamer (greens), hexamer (pinks), heptamer (blues) or octamer (yellow). αHBs are 
labelled a-o according to their position in the array. Peptide names are either previously published nomenclature 
(CC-Pent, CC-Hex, CC-Hex2, CC-Hept and its mutants (5, 10, 14)) or refer to the amino acid sequence of the 
heptad repeat, also using published nomenclature (11). In the case of the CC-Hept mutants, mutated residues 
around the barrel pore have been highlighted. These barrels were selected by Drs William Dawson and Guto Rhys 
of the Woolfson group. 
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It was hypothesised that, by taking a subset of the αHBs designed by the Woolfson group and arraying 
them in a 384-well plate, solutes could be probed for the presence of specific hydrophobic small 
molecules. We envisaged that each small-molecule analyte would displace DPH from each αHB to a 
different extent, generating analyte-specific fingerprints of DPH displacement. 15 αHBs were selected 
that would form the basis for the array (Figure 6.3.1). This selection was based on barrel oligomeric 
state, pore size, chemistry and accessibility, and covered the range of designs available in the group. A 
peptide-free control was also included to control for DPH fluorescence, which should be minimal in the 
absence of αHB. 
The array comprised two pentamers, four hexamers, eight heptamers and an octamer. The original CC-
Pent, CC-Hex, CC-Hex2 and CC-Hept designs (5) were included. CC-Hept is particularly tolerant to 
mutation (13) and five CC-Hept mutants: I17C, I24D, I24E, I24K and I17K (14) were also included. 
These all alter the chemistry inside the central pore and, thus, should change the affinities of DPH and 
analyte. A further pentamer, hexamer and octamer were included, all with hydrophobic residues lining 
a solvent-exposed pore (11). Finally, a collapsed hexameric assembly was included. This does not have 
a solvent-exposed pore and, thus, does not bind DPH (11). It was reasoned that this would form an 
additional control for DPH fluorescence in the presence of peptide, which should be minimal in the 
absence of a hydrophobic pore to bind to. These are all either previously reported sequences, or point 
mutants thereof (5, 11, 14). The group possesses data confirming secondary structure, oligomeric state 
and DPH binding kinetics for all peptides. Aside from CC-Hept-I17C, AVKEIA, CC-Hept-I24D and 
CC-Hept-I24K, all structures shown in Figure 6.2.1 are experimentally determined crystal structures. 
The array of αHBs can be used to generate distinct fingerprints for 13 fatty 
acids 
Given that the binding of lipophilic compounds to αHBs had already been reported (14), we reasoned 
that lipophilic compounds were some of the most likely biomolecules to displace DPH from the pore. 
Therefore, these were deemed most likely to be differentiated by our αHB array. Fatty acids are a large 
family of lipophilic molecules that we posited might be a suitable group with which to probe our array. 
13 fatty acids were chosen as analytes for initial studies (Figure 6.3.2). These were selected to 
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encompass a range of chain lengths, unsaturated and saturated fatty acids, and to include compounds 
that are reported biomarkers for certain diseases (392-395). 
The array of αHBs, loaded with DPH, was dispensed across a 384-well plate, using the layout described 
in Figure 6.2.1. I incubated our array of αHBs (preincubated with DPH) with 10 μM each fatty acid. 
This value was chosen based on the previously determined Ki values for αHBs incubated with palmitic 
acid (0.5 – 0.8 μM), one of the longer-chain fatty acids. Some of the molecules chosen are less lipophilic 
than palmitic acid (e.g. butyric acid and hexanoic acid) and were, therefore, expected to bind with the 
αHBs much more weakly. Therefore, I posited that 10 μM would allow the binding of all fatty acids to 
be detected, without completely displacing DPH from all αHBs for all analytes. After adding each 
analyte, DPH fluorescence was quantified using a ClarioStar plate reader (BMG LabTech, Germany). 
Full details of the plate layout and experimental details are described in Chapter 6.2. 
 
Figure 6.3.2: Fatty-acid analytes: Butyric acid (But, 1), hexanoic acid (Hex, 2), octanoic acid (Oct, 3), 
decanoic acid (Dec, 4), dodecanoic acid (Dod, 5), myristic acid (Myr, 6), palmitic acid (Pal, 7) stearic acid (Ste, 
8), palmitoleic acid (Pol, 9), oleic acid (Ole, 10), nervonic acid (Ner, 11), linoleic acid (Lin, 12) and arachidonic 
acid (Ara, 13). 
Full details of the data analysis pipeline used to process the data are listed in Chapter 6.2. DPH 
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All fluorescence values were normalised by minimum-maximum scaling between DPH fluorescence in 
the absence of peptide or analyte (minimum) and the same αHB incubated with dH2O (maximum). 
Therefore, a value of 1 was expected for DPH, bound to peptide, with no displacement by the analyte. 
A value of 0 was expected if DPH were completely displaced by the analyte. These numbers were 
converted to colours by scaling between the minimum (white) and maximum (navy) readings for all 
analytes bound to all αHBs. 
In general, the analytes followed the expected pattern of DPH displacement. Shorter-chain, less-
lipophilic fatty acids (butyric, hexanoic, octanoic, decanoic and dodecanoic acid) did not displace DPH 
from the αHBs as much as the longer-chain, more-lipophilic molecules (myristic, palmitic, stearic, 
palmitoleic, oleic, linoleic, nervonic and arachidonic acid). While these fingerprints are a good way of 
visualising the data, they do not give any information about reproducibility and are not quantitative. 
Therefore, the minimum-maximum normalised fluorescence data were plotted in boxplots 
(Figure 6.3.4). The assay was repeated using seven separate analyte preparations across seven different 
plates. For each analyte, the 16-bit array was repeated four times across each plate. While these four 
arrays use the same analyte preparation and, therefore, are not independent replicates, given the small 
size of the data set, I plotted each of the individual arrays as data points in Figure 6.3.5. This shows the 
variation in the data across the data set more completely. Therefore, each αHB-analyte combination in 
Figure 6.3.4 has 28 datapoints associated with it, contributed by 7 independent replicate experiments. 
As was evident from the fingerprints (Figure 6.3.3), the shorter-chain fatty acids gave values close to 1 
for most of the αHBs, indicating that relatively little displacement of DPH occurred. In contrast, the 
longer-chain fatty acids gave values close to 0, indicating that DPH was displaced to a large degree. In 
addition, incubation with these long-chain fatty acids increased DPH fluorescence in several cases 
(Figure 6.3.5), particularly in barrel c, but also a and o (AIKEIA, CC-Hept-I17C and CC-Hept-I17K). 
As DPH fluoresces in any hydrophobic environment, it might be that this increase in signal was due to 
DPH interacting with the fatty acids themselves. I speculate that some of these long-chain fatty acid 
molecules may self-assemble into larger micelle or vesicle structures in the presence of αHBs in solution 
(396, 397). These structures would be relatively hydrophobic and would likely have some affinity for 
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DPH, resulting in increased fluorescence. These observations are not problematic as they contribute to 
the overall formation of an analyte-specific fingerprint, and I did not investigate this further. 
 
Figure 6.3.3: Fingerprints for each fatty acid. White = 0, navy = highest recorded measurement for all αHB-
analyte combinations. The arrangement of αHBs is shown using the single letter nomenclature outlined in 











































































































































































































































































































































































































































































































































Figure 6.3.5: Box plots of the data shown in Figure 6.3.4, with expanded y axes for the six fatty acids that 
increased DPH fluorescence above a value of 3 when incubated with certain αHBs. 
Despite DPH not binding to the collapsed αHB (b, AFKEIA), a value of close to 0 was recorded for 
many of the longer-chain fatty acids. I suggest that, while this peptide produces very little DPH 
fluorescence – owing to the lack of a solvent accessible pore – very low-level DPH binding likely 
occurs. Upon addition of analyte, there is a reduction in DPH binding to the peptide and, therefore 
fluorescence, from ~1 to ~0. However, as these values are normalised using the fluorescence values of 
the same αHB without analyte, this reduction in fluorescence (from ~1 to ~0) is rather small. Again, 
these observations contribute to the overall fingerprint and are not problematic. 
Fatty acids can be differentiated based on their DPH fluorescence fingerprints  
While the differences between analytes are often distinguishable by eye, statistical analysis methods 
must be used to identify trends in differential sensing data (367). We used principal component analysis 
(PCA) to attempt to identify each fatty acid molecule based on its fluorescence fingerprint 
(Figure 6.3.6). Again, to show the variation in the data, each of the 28 arrays was platted as a single 
data point. 
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Certain groups of data could be separated. The short-chain fatty acids clustered together and could be 
distinguished from the longer chain molecules. However, aside from these obvious separations, little 
distinction was observed between the analytes. Support-vector machine (SVM) is a machine learning 
approach that separates data across many more dimensions than is possible using PCA. Therefore, we 
used SVM to discriminate between the 13 fatty acids. Details of how this was applied are outlined in 
Chapter 6.2. 
 
Figure 6.3.6: PCA of the fatty acid dataset. Each data point represents a single fingerprint. There are 28 data 
points for each analyte, with 4 data points contributed by a single assay replicate. A: 2D graphs showing the 
separation of the data using two principal components. Right panel: Expanded view of the main cluster of data 
B: 3D graph showing the separation of the data using three principal components. Right panel: Expanded view 
of the main cluster of data. 
The SVM model was trained with the minimum-maximum normalised data from the 7 independent 
assay replicates using K-folds cross validation. Once the model had been trained using these 7 initial 
replicates, the array was probed with a further analyte preparation (for each of the fatty acids) not used 
to train the model. These new data were minimum-maximum scaled in the same way as the training 
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data set. The SVM model was then used to categorise each of these replicates as one of the 13 fatty 
acids. Once again, to show the variance in the data, each of the 4 individual arrays within this replicate 
were predicted. The predictions for each of these arrays are shown in the confusion matrix below 
(Figure 6.3.7). 
 
Figure 6.3.7: Confusion matrix showing the success rate of the SVM model at characterising the 13 fatty acids. 
The y axis represents each fatty acid and the x axis shows the molecule predicted by the model. Here, all 4 
individual arrays of the final fatty acid preparation were predicted. A successful prediction for the final replicate 
was defined as correctly categorising 3 or more of the 4 arrays. Correct predictions run diagonally from top-left 
to bottom-right of the matrix. 
The SVM model correctly predicted nine of the 13 fatty acids. These were the 8 molecules with alkyl 
chains of 14 carbon atoms or longer and decanoic acid. Butyric, hexanoic, octanoic and dodecanoic 
acid were miscategorised by the model. The longer-chain fatty acids resulted in most displacement of 
DPH from the αHBs (Figure 6.3.4) and, therefore, the binding assay is likely more sensitive to these 
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molecules. The shorter-chain fatty acids resulted in little DPH displacement and, therefore, gave weaker 
signals that were difficult to distinguish. Therefore, the success of the model at categorising the different 
fatty-acids follows the expected trend. 
When the model made an incorrect classification, it did so in a way that made logical sense. For 
example, butyric acid and hexanoic acid, only two methyl groups different in structure, were 
misclassified as each other. One of the nervonic acid arrays was misclassified as myristic acid another 
long chain unsaturated fatty acid. These sensible misclassifications suggested the model discriminated 
between the data in a way that made logical sense.  
Both the training and validation data set used here are small (7 and 1 replicates, respectively). It is 
possible that, with increasing numbers of replicate data, the SVM model might be able to successfully 
categorise the shorter-chain fatty acids. In addition, increasing the concentration of these short-chain 
molecules might also increase DPH displacement and, therefore, allow differentiation by the array. 
Nonetheless, I concluded that, even with this small data set, the SVM model could differentiate between 
the long-chain fatty acid molecules. Further data is likely to improve these predictions. In summary, the 
αHB array described here might act as a novel biosensor for lipophilic compound identification. 
However, the data suggest that less lipophilic compounds are more difficult to distinguish using this 
technique.
 
6.4 Immobilising αHBs on scaffolds and surfaces 
Solution-phase detection of small molecules is an effective method for laboratory based analysis using 
liquid handling robots, plate readers and trained personnel (398). However, most differential sensors 
use receptor molecules immobilised on some form of solid support. These so-called microarrays 
significantly reduce the amount of receptor and analyte required for sensing (398). In addition, it is 
sometimes possible to regenerate the receptors for repeated analyses. Primarily, immobilisation allows 
a sensor to be used in non-lab environments, as part of a sensing device (399-402). Many commercial 
biosensors – such as the glucose sensor or pregnancy test – function through receptor molecules 
6.4 Immobilising αHBs on scaffolds and surfaces 
148 
 
immobilised on glass, paper or plastic chips, onto which a test solution is dispensed (403). A handheld 
reader is often used to detect the presence of a particular analyte. Such devices can be used at point-of-
care in a hospital, or by unskilled workers in industry (403). 
I hypothesised that the αHB peptides in our array could be immobilising on some form of solid surface 
or scaffold to exploit these advantages (Figure 6.4.1). If successful, this would be the first step to 
fabricating a device that might be used for conducting analyses away from the lab. 
 
Figure 6.4.1: Schematic diagram showing the deposition of αHBs loaded with DPH onto a solid surface and 
subsequent detection of analytes by the immobilised peptide. 
Immobilising αHBs on epoxysilane-coated glass 
Proteins, peptides and oligonucleotides are routinely immobilised on 2D surfaces, such as plastic and 
glass, for biochemical assays, for instance enzyme-linked immunosorbent assays (ELISAs) (404), and 
microarray manufacture (405, 406). Therefore, I reasoned that αHB immobilisation on glass would be 
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a sensible initial strategy. Many different approaches have been reported for immobilising peptides and 
proteins on glass. These include passive adsorption, covalent binding, affinity tag- and metal-ion-
mediated association (Figure 6.4.2) (407). 
 
Figure 6.4.2: Examples of common peptide immobilisation strategies on glass. A: Passive adsorption through 
hydrophobic residues. B: Covalent attachment via Lys and Glu NH2 and COOH groups. C: Affinity tag-mediated 
immobilisation. D: Covalent binding of a Cys side chain to a gold-coated surface. 
Functionalised glass products that covalently bind to proteins are commercially available. Initially, I 
chose to use one of these, epoxysilane-coated glass, which covalently binds to primary amine and 
carboxylic acid groups in peptides (Figure 6.4.3A) (408, 409). A notable disadvantage of this strategy 
is the lack of control over the binding site – and, therefore, the orientation – of the peptide on the surface 
(410). Any primary amine or carboxylic acid group in the αHB peptide – of which there are many – 
could bind to the glass. Methods have been reported for further functionalisation of the glass with an 
azide or affinity tag, enabling site-specific protein immobilisation (411-413). However, for this proof-
of-concept work, I used epoxysilane-coated glass without further functionalisation. 
At the outset, it was not known whether the αHBs could be immobilised on such a surface, whether the 
peptides would remain folded in this immobilised state and, critically, whether they would maintain 
their open-barrel structure and allow DPH binding. To address the first of these questions, I synthesised 
a variant of CC-Hept with an N-terminal TAMRA fluorophore (TAMRA-CC-Hept). This would allow 
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the peptide to be detected using fluorescence microscopy after deposition onto the glass. 1 – 100 μM 
TAMRA-CC-Hept was spotted onto an epoxysilane-coated glass slide, incubated in a hybridisation 
chamber for 15 hours, and washed with PBS, methanol and acetone. The slide was then imaged by 
widefield microscopy (Figure 6.4.3B). 
 
Figure 6.4.3: Immobilising TAMRA-CC-Hept onto epoxysilane-coated glass. A: Mechanism for covalent 
peptide attachment to epoxysilane groups on the functionalised surface. B: Widefield fluorescence image of 
TAMRA-CC-Hept deposited onto epoxysilane-coated glass. Peptide concentrations of 1, 10 and 100 μM were 
used. Each column contains three identical replicates. Scale bar = 1 mm. 
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TAMRA-CC-Hept bound to the surface and was easily detectable at 10 and 100 μM. The peptide was 
not removed by extensive washes with PBS, methanol and acetone, indicating it was strongly associated 
with the glass. These data indicate that αHB peptides can be immobilised on epoxysilane-coated glass. 
 
Figure 6.4.4: DPH-peptide mixtures deposited onto epoxysilane-coated glass. Columns show three identical 
replicates. Left panels: Dried spots prior to washing. Right panels: Slides after a single wash with PBS. A: 
10 μM peptide + 1 μM DPH. B: 100 μM peptide + 10 μM DPH. 
While the immobilisation of a fluorescent peptide is promising, it reveals little about the conformation 
of the bound peptide. It is perfectly possible that the individual peptide constituents of the αHB might 
dissociate upon deposition onto a surface, resulting in the loss of the hydrophobic pore required for 
DPH binding. Therefore, I assayed whether DPH fluorescence was detectable within αHBs on a glass 
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surface. For these studies, DPH was preincubated with CC-Hex2 (an open αHB), CC-Tri (an α-helical 
peptide of similar length to CC-Hex2, but which does not form a barrel with a solvent-exposed pore) or 
no peptide. It is possible that DPH fluorescence might increase by binding to a peptide dried onto a 
surface and, therefore, CC-Tri was included to control for this. These DPH-peptide mixes were 
deposited onto epoxysilane-coated glass, incubated for 15 hours in a hybridisation chamber, and imaged 
before and after washing with PBS using a UV transilluminator (Figure 6.4.4). 
Prior to washing, the dried peptide-DPH mixtures followed the expected pattern of fluorescence: DPH 
fluoresced when bound to the open αHB (CC-Hex2), but not in isolation and relatively little when 
incubated with CC-Tri. Fluorescence was detectable for both concentrations tested (Figure 6.4.3A-B). 
However, upon incubating with PBS, all detectable fluorescence was lost, suggesting the signal prior 
to washing was contributed by dried reaction mixture not strongly associated with the slide. 
Fluorescence on these washed slides was also undetectable by widefield microscopy (data not shown). 
I propose four possible explanations for the lack of detectable fluorescence after washing. First, the 
peptide-DPH mix might not bind to the glass slide. Second, upon deposition, the peptides might change 
conformation, disrupting the hydrophobic pore and releasing DPH. Third, any bound DPH is removed 
during the PBS incubation, despite the αHBs retaining their pore upon deposition onto the surface. And 
finally, some peptide-DPH may remain bound to the surface – in a conformation that allows DPH to 
remain associated with the pore and fluoresce – but the concentration of these complexes might be so 
low that fluorescence is undetectable. I suggest that, given TAMRA-CC-Hept was successfully 
deposited, CC-Tri and CC-Hex2 were likely bound to the slides. PBS is not expected to displace DPH 
from the αHB pore – the binding assays outlined in Section 6.3 were carried out in HBS – and therefore, 
I propose that PBS is unlikely to remove DPH from any immobilised αHBs in their assembled state. It 
seems likely that either the peptides disassembled upon deposition, or DPH was not bright enough for 
detection at the low concentrations immobilised on the slide. 
I could use surface plasmon resonance (SPR) (or similar techniques for characterising surfaces) to better 
understand the conformation and quantity of peptide on the surface (414). However, these studies were 
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beyond the scope of this thesis. Instead, I investigated alternative methods of immobilisation that were 
hypothesised to increase the DPH signal for detection. 
Immobilising αHBs on paper 
Suspending the peptide-DPH mixture within a 3-dimensional solid support is one way in which I 
hypothesised the fluorescent signal might be increased. The rationale was that more peptide-DPH could 
be suspended compared to the monolayer of peptide on the 2D glass slide (Figure 6.4.5). This approach 
has been previously described (415, 416), though is not typical for fabricating microarrays. 
 
Figure 6.4.5: Schematic diagram showing rationale for peptide immobilisation in 3D. A: αHB monolayer 
immobilised in 2D on a glass slide. A small number of the total analyte molecules (purple) in solution interact 
with the immobilised αHB.  B: αHBs encapsulated in 3D, allowing a greater number of peptide-DPH complexes 
to be immobilised. Therefore, more of the analyte molecules in solution interact with the immobilised αHBs. The 
same principal applies for DPH interacting with immobilised peptide. 
Paper is commonly used for sensing applications, including in commercial biosensors such as 
pregnancy tests, largely due to its low cost and natural wicking properties (401-403, 417, 418). As paper 
is multi-layered and absorbs liquid, the amount of detectable signal present is also larger than for a 2D 
surface. Therefore, I reasoned that αHB peptides might be immobilised within paper to create a 3-
dimensional environment for detecting DPH fluorescence. Four paper substrates were investigated for 
immobilising αHBs: Whattman qualitative filter paper, grade 1 (Sigma, UK); 80 gsm white inkjet 
printing paper (Euroffice, UK); nitrocellulose membrane, pore size 0.22 μm (Sigma, UK); and 
 
 
6.4 Immobilising αHBs on scaffolds and surfaces 
154 
 
Immobilion PVDF chromatography grade blotting paper (Sigma, UK) (PVDF). 1-1000 μM CC-Hex2 
was deposited onto each of these substrates, before being incubated with 0.1 equivalents DPH. DPH 
fluorescence was then quantified using a ClarioStar plate reader (BMG LabTech, Germany) 
(Figure 6.4.6). 
 
Figure 6.4.6: DPH fluorescence resulting from deposition of 0-1000 μM CC-Hex2, preincubated with 0.1 
equivalents DPH, onto Whattman grade 1 filter paper (A), Inkjet printing paper (B), nitrocellulose membrane (C) 
and PVDF membrane (D). n=3. Error bars show one standard deviation from the mean. All readings are 
normalised to DPH fluorescence in the absence of peptide. Statistical analysis is by one-way ANOVA with 
Tukey’s post-analysis ** = P<0.01. 
DPH fluorescence in the absence of peptide was high on all four substrates. Therefore, there was little 
difference in fluorescence when DPH was preincubated with peptide. This was particularly evident for 
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(Figure 6.4.6B). Similarly, notable increases in DPH fluorescence in the presence of CC-Hex2 on 
nitrocellulose and PVDF were not observed, and fluorescence values were highly variable. Given the 
high level of background fluorescence on these substrates, I suggest that the detected fluorescence can 
almost entirely be attributed to DPH associating with the paper. 
The only substrate where a significant increase in fluorescence was observed upon addition of CC-Hex2 
was Whattman Grade 1 filter paper (Figure 6.4.6A). However, this required a minimum of 100 μM CC-
Hex2 to produce an increase in fluorescence above the background. Filter paper was compared with 
DPH binding in solution, this time incorporating CC-Tri into the assay as described previously 
(Figure 6.4.7). 
 
Figure 6.4.7: DPH fluorescence when bound to CC-Tri and CC-Hex2, as well as in isolation, on either filter paper 
or in solution. A: DPH fluorescence on filter paper. B: DPH fluorescence in solution. Values are normalised to 
those for DPH alone. n=3. 100 μM each peptide and 1 μM DPH in dH2O were used. Statistical analysis is by one-
way ANOVA with Tukey’s post-analysis *** = P<0.001. 
A considerable amount of sensitivity was lost when the assay was performed on filter paper. Mean DPH 
fluorescence was around 17x greater in the presence of CC-Hex2 in solution, but only 4x greater on 
filter paper. This was due to the higher level of DPH fluorescence on filter paper in the absence of 
peptide. For sensing applications, and to perform assays on surfaces in a similar manner to that 
presented in Section 6.3 (where subtle differences in DPH fluorescence for each αHB need to be 
detectable), assay sensitivity is key. In addition, the fact that DPH associates strongly with the paper 
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suggests that other lipophilic analytes, such as those outlined in Section 6.3, are also likely to do so. 
Therefore, I concluded that the paper substrates investigated here were unsuitable for sensing using 
αHBs. 
Immobilising αHBs within hydrogels  
Inspired by the work outlined in Chapters 3-5, I postulated that hydrogels might be another possible 
immobilisation substrate for αHBs. Hydrogels are porous, allow the suspension of biomolecules in 3D 
and, depending on the specific gel, can be relatively cheap. However, their potential for the construction 
of biosensors is only just being realised (419, 420).  
 
Figure 6.4.8: DPH fluorescence resulting from encapsulating either DPH alone, CC-Tri-DPH or CC-Hex2-DPH 
in either agarose (A), polyacrylamide (B), Puramatrix (C) or in solution (D). All readings are normalised to that 
of DPH alone. n=3. Error bars show one standard deviation from the mean. Each assay used 10 μM peptide and 
1 μM DPH in dH2O. Statistical analysis is by one-way ANOVA with Tukey’s post-analysis *** = P<0.001. 
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Initially, I chose three gels to assay compatibility with DPH binding: agarose, polyacrylamide and 
Puramatrix (Corning, USA). These are all commercially available and, in the cases of agarose and 
polyacrylamide, are inexpensive. DPH was preincubated with either no peptide, CC-Tri or CC-Hex2 
and incorporated into each gel during gelation. DPH fluorescence was quantified as previously 
described using a ClarioStar plate reader (BMG LabTech, Germany) (Figure 6.4.8). 
Performing DPH binding in polyacrylamide and Puramatrix resulted in high background fluorescence 
(Figure 6.4.8B-C), with a roughly 6- and 3-fold reduction in assay sensitivity, respectively, compared 
to performing the assay in solution. In contrast, agarose compared favourably with solution sensitivity, 
giving a ~29-fold increase in DPH fluorescence in the presence of CC-Hex2 – comparable to the 19-
fold increase observed in solution. Critically, very little background DPH fluorescence, in the absence 
of peptide, was observed on agarose. 
 
Figure 6.4.9: DPH fluorescence when incubated with agarose, CC-Tri-agarose and CC-Hex2-agarose. Values are 
normalised to that of DPH incubated with agarose alone. n=3. Error bars show one standard deviation from the 
mean. Statistical analysis is by one-way ANOVA with Tukey’s post-analysis *** = P<0.001. 
Though these data are promising, the fluorescence arises from the binding of DPH in the pore of CC-
Hex2 in solution, before encapsulation in agarose. Therefore, the data indicate that any unbound DPH 
does not fluoresce in the presence of agarose and that bound DPH does not dissociate from the peptide 
upon encapsulation. However, these experiments do not assay whether DPH can associate with the αHB 
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in the desired manner while encased in agarose. Therefore, to investigate this, I encapsulated either CC-
Tri or CC-Hex2 within the gel, before incubating with DPH and observing fluorescence (Figure 6.4.9). 
DPH fluorescence in the presence of CC-Hex2 was reduced by 2.7-fold compared with the premixed 
binding assay. This was likely due to a reduction in the accessibility of the αHB encapsulated in agarose 
compared to those in solution. However, the fact that DPH binds CC-Hex2 in agarose is promising and 
suggests that agarose may be a suitable immobilisation substrate for small molecule sensing using 
αHBs.
6.5 Conclusions 
By using the diverse set of αHB peptides designed by the Woolfson group, we have created an array 
that can be used for differential sensing. This αHB array can be used to generate DPH fluorescence 
fingerprints for 13 fatty acid molecules. These fingerprints can be interpreted using machine learning 
approaches, allowing us to classify long-chain, but not short-chain, fatty acids. These conclusions are 
made with the knowledge that the reported data set is small. Further replicates would improve the SVM 
model and might allow the differentiation of fatty acids not categorised in this study. In addition, 
increasing the analyte concentration might allow the short-chain fatty acids to displace DPH and, 
therefore, be differentiated. Nonetheless, to the best of my knowledge this is the first example of de 
novo designed peptides being used as a sensor for differential sensing. Therefore, this work further 
demonstrates that such peptides can be used for real-world applications.  
Distinguishing fatty acids and related molecules using differential sensing has been previously reported 
(375, 421). Such has been the interest in this method of sensing, that most classes of biologically 
relevant small-molecule analyte have been discriminated using differential sensing approaches (422-
424). However, in most of these studies there is a lack of detail about how the receptor and analyte 
molecules interact to produce a signal. This is both the biggest advantage and most notable disadvantage 
to sensing in this manner. Receptors bind rather weakly and non-specifically to a range of analytes, 
meaning that a detectable fingerprint can be produced without any prior knowledge about the analyte 




in a similar manner, differential sensing is not typically able to identify a specific analyte with 100% 
certainty. Ultimately, other techniques such as mass spectrometry or nuclear magnetic resonance 
(NMR) are better suited for this. Therefore, this method of sensing is best suited to complex mixtures 
of analytes, where subtle changes in unknown constituents lead to detectable differences in fingerprint 
(367). Other members of the Woolfson group have begun to apply our αHB array to complex mixtures 
such as tea, plasma and urine (unpublished).  
The Woolfson lab has a great deal of data confirming the pore charge and hydrophobicity, as well as 
the thermal stability and DPH binding affinity, of each αHB in the array (5, 11, 14). In most cases, 
crystal structures confirm that the peptides self-assemble into the well-defined 3D structures shown in 
Figure 6.3.1 (5, 10, 11, 14). This knowledge allows us to rationalise small-molecule binding to each 
component of the array in a way that is rarely reported for differential sensors. For instance, the 
octameric barrel, AIKEIA, has the widest pore of all the αHBs in the array (11). DPH fluorescence is 
increased upon addition of the long-chain fatty acids to this assembly. Therefore, this might suggest 
that AIKEIA can bind both DPH and an analyte in its pore simultaneously. This might increase the 
affinity of DPH for AIKEIA, which is relatively low (a KD of 57.95 μM (11)) and, thus, increase DPH 
fluorescence upon addition of analyte. While these inferences are speculative, our knowledge of the 
αHBs allows these unforeseen outputs to be rationalised. Furthermore, this understanding means that 
additional peptides could be designed with different properties from the 15 used here. This might allow 
the binding and, therefore, sensing of different classes of small molecule, such as polar amino acids or 
sugars. 
I explored the immobilisation of αHBs on glass, paper and within hydrogels. Of the approaches tested, 
immobilisation within agarose allowed DPH fluorescence to be detected in the presence of CC-Hex2, 
in a way analogous to in solution. Obvious next steps would be to incubate αHB-DPH-loaded agarose 
with the fatty acids in Figure 6.3.2, identify whether DPH displacement proceeds as in solution, and 
determine whether the fatty acids can be distinguished. Following this, a device incorporating αHBs 




Peptide immobilisation on glass is well-established for sensing applications and allows detection in 
extremely high throughput, using very little analyte or receptor (405-407). Therefore, despite our initial 
lack of success with detecting DPH fluorescence on glass, this warrants further investigation. I would 
have liked to use surface analysis techniques to probe the state of the peptides on the surface. For 
example, using SPR, I might be able to detect DPH association with a bound αHB with greater 
sensitivity than fluorescence microscopy (414). In addition, CD spectroscopy has been reported on 
peptides immobilised on a surface (425), and this technique might be used to identify whether the αHB 
peptides are still folded when immobilised. Other lipophilic fluorophores that are more strongly 
fluorescent than DPH are commercially available (e.g. the cyanine dyes) (426). These might also be 
used to probe for the presence of an assembled αHB on a 2D surface. 





Conclusions and future directions 
Utilising de novo  designed coiled-coil peptides as a modular scaffold for 
primary neurons 
De novo designed peptides and proteins have huge potential as tools for basic and applied research (1). 
Owing to the relative infancy of the de novo protein design field, this potential is only beginning to be 
realised. Further investigation and development of designed peptide systems for specific applications is 
required before they can be used more broadly by the scientific community. 
In Chapters 3-5, I have described the development of a de novo designed peptide hydrogel, hSAFs, as 
a novel cell culture tool for primary neurons (PNs). PN viability and neurite outgrowth on hSAFs is 
comparable to when cultured on the commercially available peptide hydrogel, Puramatrix, and does not 
require additional adhesive ligands. In addition, through the redesign of hSAFs to shSAFW1,4, I (along 
with Alex Wasmuth) have demonstrated that a suite of gels ranging from 0.2 – 18 kPa can be formed. 
PNs are most viable on softer gels but produce longer processes on 1 kPa hSAFs. These results support 
previous findings (153, 250, 256) and indicate that PNs grow best on gels that closely match the elastic 
modulus of brain tissue (0.1 – 1 kPa). It is likely that the stiffer shSAFW1,4 gels would be better suited 
to the culture of muscle cells (66). A logical next step would be to culture primary muscle cells on the 
different hSAF and shSAFW1,4 gels. This would identify whether shSAFW1,4 gels are suitable for the 
culture of non-neuronal mammalian cells. 
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Whole proteins can be incorporated into hSAFs, in a tuneable manner, via the SpyTag-SpyCatcher 
system. Modifying hSAFs with the neurotrophic factor IGF1 promotes PN survival and neurite 
outgrowth compared to unmodified hSAFs. IGF1-decorated hSAFs perform similarly to Matrigel in 
this regard. Through the adoption of thiol-ene click chemistry, I have demonstrated the incorporation 
of GFP in user-defined patterns. Protein incorporation and spatial patterning have been achieved using 
synthetic and natural polymer gels (161, 185, 196). However, to the best of my knowledge, both 
covalent modification with a full-length protein and spatial patterning of a designed peptide hydrogel 
are novel. Therefore, these studies go beyond that achieved with other designed self-assembling peptide 
hydrogels. An obvious initial next step would be to seed PNs onto an hSAF gel patterned with IGF1, 
RGDS or another neurotrophic factor, and observe effects on neuronal growth. The guidance of 
neuronal processes on a designed peptide hydrogel would also be a novel development. 
Given its novelty, the described approach for photopatterning hSAFs warrants further investigation. 
Further development is required to create patterns with the resolution required to precisely direct cell 
behaviour in vitro as previously reported (223, 224). I hypothesise that the low pattern resolution 
reported here results from difficulties in getting the gel and photomask into close contact. This might 
be rectified by casting shallower gels or using bespoke glass moulds, rather than the 3D-printed ones 
used here. In addition, hSAFs might be patterned with multiple fluorescent proteins by using PEG 
linkers terminated with different functional groups. 
The current study demonstrates the principle advantage of hSAFs compared with some other peptide or 
polymer systems: they are modular and, therefore, tuneable (Figure 7.1). hSAFs consist of two core 
building blocks: hSAF-p1 and hSAF-p2. Simple modification of hSAF-p1 yields hSAF-p1KAz and 
hSAF-p1KAlloc, which allow adhesive ligands and full-length proteins to be introduced through two 
different mechanisms – Cu2+-catalysed azide-alkyne cycloaddition and thiol-ene, maleimide-thiol 
reaction. Both chemistries are tuneable, by varying hSAF-p1KAz concentration and UV light exposure, 
respectively. Furthermore, other simple point mutations yield shSAF-p1W1,4 and shSAF-p2W1,4, which 
can be used to form gels with increased elastic modulus. Different proteins can be incorporated via 
fusion with SpyCatcher and incubating with SpyTag-decorated gels. 




Figure 7.1: Schematic diagram showing the modular nature of hSAFs. 
I envisage that these different modules could be interchanged to allow bespoke scaffolds to be formed 
for specific applications. Thus, hSAFs might form a customisable tool for cell culture, where 
components of the gel could be introduced in a plug-and-play type manner. However, before this could 
be achieved, each of the modules would need to be tested alongside one another to ensure they are 
compatible. For instance, hSAF-p1KAlloc can be used to photopattern hSAFs, while shSAF-p1W1,4 and 
p2W1,4 can be used to form stiffer gels. However, I have not yet shown that a variant of shSAF-p1W1,4, 
shSAF-p1KAllocW1,4, can be used to form photopatternable gels with increased elastic modulus. 
Demonstrating that each of the components can function orthogonally would be a logical next step. This 
might also involve the development of an orthogonal method for protein attachment, such as utilising 
the biotin-streptavidin binding system. 
Despite the development of novel techniques for extensively modifying hSAFs, it must be noted that 
the cell biology presented here is at the proof-of-concept stage. Cell viability and neurite outgrowth are 
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relatively general cell health parameters. These were chosen as the focus of this work remained on 
developing the scaffold, however, a more in-depth study of cell behaviour would be desirable, assessing 
electrophysiological and molecular responses to the various hSAF modifications. The current study has 
provided the component building blocks (Figure 7.1), and developed the methods for directing neuronal 
behaviour, which a future study might be able to exploit more fully. However, the limited cell culture 
studies described here highlight practical difficulties with the hSAF system. The synthesis and 
purification of the different 28-residue peptide components requires time, reagents and expertise, all of 
which increase the experimental lead time. In comparison, synthesis of di-phenylalanine requires a 
single coupling step and minimal purification, and many synthetic polymer components are available 
commercially. This possibly limits the wide-spread adoption of hSAFs as a novel cytoscaffold for cell 
culture. 
Other more explorative routes of investigation might be the application of hSAFs in vivo. This thesis 
has purposefully focused on using hSAFs for cell culture, rather than tissue engineering, as hSAFs have 
not yet been shown to be compatible in vivo. However, one might envisage that a growth factor-
decorated gel, loaded with NSCs or neurons, might be used to promote neuronal regrowth in vivo after 
damage or disease (109, 222, 228, 427). Initially, immunogenicity studies would be required in order 
to assess whether hSAFs can be applied in vivo. 
Finally, other discrete assemblies designed by the Woolfson group (such as trimeric, tetrameric, 
pentameric, hexameric and heptameric coiled coils (3, 5)) might be modified to self-assemble into 
biomaterials for cell culture. Burgess et al. have already demonstrated that these peptides can be 
modified to form nanotubes (36). It is possible that residues away from the cores of these assemblies 
might be modified to promote entangling of nanotubes into larger scaffolds. These scaffolds might have 
different properties compared with hSAFs and would increase the tool kit of peptides available for 
forming novel cytoscaffolds. 
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Utilising de novo designed coiled-coil peptides as a sensor for small-molecule 
detection 
Chapter 6 outlines the development of a differential sensor for lipophilic small-molecule detection. By 
using an array of 15 de novo designed α-helical barrel peptides (αHBs) preloaded with 
diphenylhexatriene (DPH), molecule-specific fingerprints can be generated for 13 different fatty acids. 
By using machine learning methods, longer-chain, but not shorter-chain fatty acids can be correctly 
categorised using their fingerprints. To the best of my knowledge, this is the first example of using de 
novo designed peptides for sensing in this way. 
The shorter-chain fatty acids might be correctly categorised by increasing the concentration of analyte 
or number of replicates used to train the SVM model. These are logical initial next steps to take. 
However, certain other classes of small-molecule that are less lipophilic (e.g. amino acids, nucleobases 
and sugars) are less likely to displace DPH from the αHBs and, therefore, be correctly categorised by 
the array. Additional αHB peptides might be included in the array, with polar residues lining the pore. 
These αHBs might allow the binding and, therefore, detection of polar analytes. 
Ultimately though, the strength of this type of sensing lies with complex mixture detection, where the 
exact molecules – or combination of molecules – that one seeks to detect are not known (367). The 
Woolfson group is currently investigating whether the array can be used to differentiate between 
different complex mixtures, such as subtypes of tea, and urine samples from healthy volunteers (all 
unpublished work). Depending on the outcome of these proof-of-concept experiments, the array of 
αHBs developed here could be applied to disease diagnostics using patient whole blood, serum, urine, 
breath or sweat samples. Other differential sensors have been used to attempt to diagnose Alzheimer’s 
disease (428) and cancer (376) based on subtle changes in the makeup of blood and breath samples, 
respectively. It is possible that our array of αHBs might be used to similarly differentiate between 
healthy patients and disease sufferers. In its current embodiment, the success of this would likely rely 
on detectable alterations in the patient lipidome or in other lipophilic compounds. 
In addition, I have demonstrated that αHBs can be immobilised within an agarose hydrogel in a way 
that maintains their DPH-binding capacity. A logical next step would be to identify whether analyte 
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binding can proceed in a similar way to in solution. Following this, the solution-phase assays outlined 
in Chapter 6.3 would be repeated using peptides suspended in agarose. I envisage that this method of 
peptide immobilisation might form the basis for miniaturisation and device manufacture in the future. 
Attempts to immobilise the peptides by more traditional methods, i.e. on a glass surface, were largely 
unsuccessful. It remains unclear whether the peptides remain in their native conformation when 
immobilised. More detailed analyses to determine the secondary structure, oligomeric state and DPH 
binding capacity of the immobilised peptides are required before any firm conclusions can be drawn. 
Concluding remarks 
Both the development of hSAFs as a tuneable scaffold for neurons, and utilisation of αHBs as a 
differential sensor for small-molecule detection, demonstrate the application of de novo designed 
coiled-coil peptides as customisable tools for real-world applications. Both systems are modular and 
tuneable and, thus, demonstrate key assets of designed peptides. Therefore, this work contributes to the 
idea that de novo designed peptides are no longer simply exemplars of our firm understanding of protein 





Chapter 8  
Appendix 
8.1: Peptide sequences 
hSAF-p1 H-KIAALKA KIAALKA EIAALEW ENAALEA-OH 
hSAF-p2 H-KIAALKA KNAALKA EIAALEW EIAALEA-OH 
hSAF-p1KAz H-KazIAALKA KIAALKA EIAALEW ENAALEA-OH 
hSAF-p1KAlloc H-KalIAALKA KIAALKA EIAALEW ENAALEA-OH 
hSAF-p1Cys H-CIAALKA KIAALKA EIAALEW ENAALEA-OH 
shSAF-p1W1,4 H-WKIAALK AKIAALK AEIAALE WENAALE-OH 
shSAF-p2W1,4 H-WKIAALK AKNAALK AEIAALE WEIAALE-OH 
alk-RGDS H-pGSGYG RGDS-NH2 
mal-RGDS mal-GSGYG RGDS-NH2 
Cys-RGDS H-CGSGYG RGDS-NH2 
norb-RGDS norb-GSGYG RGDS-NH2 
alk-IKVAV H-pGSGYG IKVAV-NH2 
alk-SpyTag H-pGSGSG AHIVMVDAYKPTK-NH2 
Cys-SpyTag H-CGSGSG AHIVMVDAYKPTK-NH2 





















Table 8.1.1: Sequences for all peptides described in this thesis. Blue denotes an unnatural amino acid residue or 
functional group not native to proteins. 
 
8.2 Peptide HPLC and MALDI-TOF-MS data 
All peptides used in the α-helical barrel array described in Chapter 6 were synthesised and purified by 





Figure 8.2.1: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for hSAF-p1. 
Expected mass: 2922.0 Da. Recorded mass:2921.9 Da. 
 
Figure 8.2.2: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for hSAF-p2. 





Figure 8.2.3: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for hSAF-p1KAz. 
Expected mass: 2947.9 Da. Recorded mass: 2949.1 Da. 
 
Figure 8.2.4: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for alk-RGDS. 





Figure 8.2.5: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for alk-IKVAV. 
Expected mass: 988.25 Da. Recorded mass: 987.6 Da. 
 
Figure 8.2.6: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for shSAFW1,4-p1. 





Figure 8.2.7: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for shSAFW1,4-p2. 
Expected mass: 3037.1 Da. Recorded mass: 3036.9 Da. 
 
Figure 8.2.8: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for alk-SpyTag. 





Figure 8.2.9: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for hSAF-p1KAlloc. 
Recorded mass: 3005.9 Da. Expected mass:  Recorded mass: 3006.1 Da. 
 
Figure 8.2.10: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for hSAF-p1Cys. 





Figure 8.2.11: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for Cys-RGDS. 
Expected mass: 958.3 Da. Recorded mass: 958.5 Da. 
 
Figure 8.2.12: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for norb-RGDS. 





Figure 8.2.13: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for mal-RGDS. 
Expected mass: 1006.1 Da. Recorded mass: 1005.6 Da 
 
Figure 8.2.14: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for mal-SpyTag. 





Figure 8.2.15: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for CC-Tri. 
Expected mass: 3465.9 Da. Recorded mass: 3468.3 Da. 
 
Figure 8.2.16: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for CC-Hex2. 





Figure 2.17: HPLC chromatograms (left panels) and MALDI-TOF-MS spectra (right panel) for CC-Hept-
TAMRA. Expected mass: 3965.3 Da. Recorded mass: 3965.4 Da. 
 
8.3 Protein sequences and plasmid maps 
SpyCatcher Dark blue 
GFP Green 
Flexible linker Yellow 
His-Tag Red 
Periplasm-targeting sequence Purple 















































Figure 8.3.4: Sequence of SpyCatcher-GFP-insulin-like growth factor 1 (SC-GFP-IGF1) 
 
Figure 8.3.5: Map of the pET28a-SC-GFP vector used for expression of SC-GFP. The pET28a-SC-GFP-IGF1 
expression vector was identical, but with the coding sequence for IGF1 inserted 3’ of GFP and the HisTag gene 









8.4: Supplementary data  
 
Figure 8.4.1: Widefield fluorescence images showing primary cortical neuronal cultures cultured on hSAFs (A), 
Puramatrix (B) and Matrigel (C). Cultures were grown in medium containing serum to 14 days in vitro to promote 





Figure 8.4.2: Bulk rheology data showing G’ (circles) and G’’ (crosses) for all hSAF and shSAFW1,4 gel 
concentrations. Data were collected at 20 oC using a strain of 0.5%. These data were collected by Alex Wasmuth. 





























Figure 8.4.3: HPLC chromatograms of thiol-ene click reaction mixtures using Eosin Y as the photoinitiator and 
visible light. A: HPLC chromatograms of the individual reaction components; hSAF-p1KAz (red), C-SpyTag 
(green), Eosin Y (orange) and TEAO (pink). B: HPLC chromatograms of the reaction mixtures after 1 hour visible 
light exposure, varying Eosin Y concentration; 0 (grey), 1 (cyan), 10 (blue) and 100 (black) mg/ml. 
 
 
Figure 8.4.4: HPLC chromatograms and MALDI-MS spectra for p1KAlloc:p2 hSAFs reacted with 2 mM L-Cys 
via thiol-ene click chemistry in the presence of 10 equivalents (20 mM) TCEP, using Irgacure 2959 as the 
photoinitiator. The mass spectrum is of the peak labelled * and corresponds to the mass of hSAF-p1KAlloc + 






Figure 8.4.5: HPLC chromatograms showing mal-SpyTag reaction with p1KAlloc:p2-PEGSH hSAFs. 
p1KAlloc:p2 hSAFs (grey); p1KAlloc:p2 hSAFs + PEG2SH +UVB for 3 minutes (pink); p1KAlloc:p2 hSAFs + 
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